日本臨牀　別冊　感染症症候群(第2版)下

出版社： 日本臨牀社
発行日： 2013-09-20
分野： 臨床医学：一般  >  雑誌
ISSN： 00471852
雑誌名：
特集： 感染症症候群（第2版）下　臓器別感染症編
電子書籍版： 2013-09-20 （第2版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

20,350 円(税込)

購入する
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

20,350 円(税込)

購入する

目次

  • 日本臨牀　別冊　感染症症候群（第2版）下

    ―目次―

    特集　感染症症候群（第2版）下　臓器別感染症編

    序文

    I． 敗血症(sepsis，セプシス)，心血管系感染症 　 　
    　1 敗血症(sepsis，セプシス) 　 　
    　2 心血管系感染症 　 　
    　3 発熱性好中球減少症(FN)
    　4 ウイルス関連血球貪食症候群(VAHS)

    II． 中枢神経系感染症 　 　
    　1 髄膜炎 　 　
    　2 感染性脳炎
    　3 脳膿瘍
    　4 脊髄感染症 　 　
    　5 その他の中枢神経系感染症 　 　

    III． 呼吸器感染症 　 　
    　1 肺炎 　 　
    　2 インフルエンザ 　 　
    　3 肺膿瘍、膿胸、胸膜炎 　
    　4 気道感染症 　 　

    IV． 腹膜炎，肝・胆道系感染症，膵臓感染症，消化管感染症
    　1 腹膜炎，腹腔内膿瘍 　 　
    　2 肝・胆道系感染症 　 　
    　3 膵臓感染症：急性膵炎に伴う膵感染 　
    　4 消化管感染症 　 　

    V． 尿路感染症，男性性器感染症 　 　
    　1 膀胱炎 　 　
    　2 腎盂腎炎
    　3 小児尿路感染症
    　4 尿道炎
    　5 無症候性細菌尿
    　6 ウロセプシス
    　7 腎周囲膿瘍、気腫性腎盂腎炎
    　8 溶連菌感染後急性糸球体腎炎5
    　9 溶血性尿毒症症候群
    　10 男性性器感染症 　 　
    　11 尿路性器結核

    VI． 女性生殖器感染症(産婦人科領域感染症) 　 　
    　1 内性器感染症(骨盤内炎症性疾患：PID) 　 　
    　2 子宮頸管炎　
    　3 外性器感染症　
    　4 腟炎・細菌性腟症　
    　5 周産期感染症

    VII． 性感染症 　 　
    　1 性感染症(概論) 　
    　2 性器クラミジア感染症　
    　3 非クラミジア性非淋菌性尿道炎 　
    　4 性器ヘルペスウイルス感染症(性器ヘルペス) 　
    　5 性器パピローマウイルス感染症　
    　6 性器カンジダ症 　
    　7 腟トリコモナス症　7
    　8 軟性下疳 　

    VIII． 皮膚軟部組織感染症 　 　
    　1 皮膚の防御機能と表在性皮膚細菌感染症　
    　2 深在性皮膚感染症　
    　3 全身性皮膚軟部組織感染症 　 　
    　4 Gianotti病とGianotti-Crosti症候群 　
    　5 感染褥瘡 　

    IX． 骨・関節感染症 　 　
    　1 成人骨髄炎　
    　2 小児骨髄炎　
    　3 化膿性関節炎 　
    　4 人工関節感染　

    X． 眼感染症 　 　
    　1 結膜炎 　
    　2 角膜炎 　
    　3 眼内炎 　4
    　4 網膜炎 　8
    　5 眼瞼・涙道感染症 　

    XI． 耳鼻咽喉感染症 　 　
    　1 耳鼻咽喉科感染症(概論)　
    　2 中耳炎 　
    　3 内耳炎 　
    　4 外耳炎　4
    　5 急性乳様突起炎 　
    　6 鼻副鼻腔炎 　
    　7 扁桃炎，扁桃周囲炎，扁桃周囲膿瘍 　

    XII． 歯性・口腔内・頸部感染症 　 　
    　1 歯性感染症 　
    　2 口内炎　
    　3 化膿性唾液腺炎，化膿性耳下腺炎 　
    　4 急性化膿性甲状腺炎　
    　5 深頸部感染症、レミエール症候群

    XIII． 先天性・母子感染症 　 　
    　1 TORCH症候群　
    　2 先天性トキソプラズマ症　
    　3 先天性風疹症候群 　
    　4 先天性サイトメガロウイルス感染症 　
    　5 先天性梅毒
    　6 新生児ヘルペス
    　7 先天性ヒトパルボウイルスB19感染症
    　8 B型・C型肝炎ウイルス母子感染
    　9 HIV母子感染
    　10 HTLV-1母子感染
    　11 早発型・遅発型B群レンサ球菌感染症2
    　12 新生児TSS様発疹症(NTED)

    XIV． 感染症特論 　 　
    　1 術後感染症と術後感染予防
    　2 AIDS関連の日和見感染症
    　3 感染症により誘発される悪性腫瘍
    　4 感染症により誘発される免疫疾患
    　5 病院感染

    XV． 上巻の補遺 　 　
    　ロタウイルス感染症(ロタウイルス性胃腸炎)

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I 敗血症 ( sepsis, セプシス ) , 心血管系感染症

P.12 掲載の参考文献
1) Russell JA : Management of sepsis. N Engl J Med 355 : 1699-1713, 2006.
PubMed
2) Members of the American College of Chest Physicians/Society of Critical Care Medicine consensus conference committee : American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference : definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20 : 864-874, 1992.
 
3) Bone RC, et al : A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317 : 653-658, 1987.
PubMed
4) Bone RC, et al : Sepsis syndrome : A valid clinical entity. Crit Care Med 17 : 389-393, 1989.
PubMed
5) Levy MM, et al : 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definition conference. Crit Care Med 31 : 1250-1256, 2003.
PubMed
6) Kumar G, et al : Nationwide trends of severe sepsis in the 21st century (2000-2007). Chest 140 : 1223-1231, 2011.
PubMed
7) Kumar A, et al ; Cooperative Antimicrobial Therapy of Septic Shock Database Research Group : Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 136 : 1237-1248, 2009.
 
8) 織田成人ほか : 重症感染症の病態とメディエーター. 日外会誌 104 : 511-517, 2003.
 
9) Gando S, et al : A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients : Comparing current criteria. Crit Care Med 34 : 625-631, 2006.
PubMed
10) Hotchkiss RS, Karl IE : The pathophysiology and treatment of sepsis. N Engl J Med 348 : 138-150, 2003.
PubMed
11) Slade E, et al : The Surviving Sepsis Campaign : raising awareness to reduce mortality. Crit Care 7 : 1-2, 2003.
PubMed
12) Dellinger RP, et al : Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32 : 858-872, 2004.
PubMed
13) Levy MM, et al : The Surviving Sepsis Campaign : results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med 38 : 367-374, 2010.
PubMed
14) 日本集中治療医学会Sepsis Registry委員会 : 日本版敗血症診療ガイドライン. 日集中医誌 20 : 124-173, 2013.
 
P.16 掲載の参考文献
1) Bone RC, et al : Sepsis : a new hypothesis for pathogenesis of the disease process. Chest 112 (1) : 235-243. 1997.
PubMed
2) Daniels R : Surviving the first hours in sepsis : getting the basics right (an intensivist's perspective). J Antimicrob Chemother 66 (Suppl 2) : ii11-23, 2011.
 
3) Dellinger RP, et al : Surviving Sepsis Campaign : international guidelines for management of severe sepsis and septic shock : 2008. Crit Care Med 36 : 296-327, 2008.
PubMed
4) Dellinger RP, et al : Surviving Sepsis Campaign : The Internationai Guidelines for Management of Severe Sepsis and Septic Shock 2012. Crit Care Med 41 : 580-637, 2013.
 
5) Levy MM, et al : The Surviving Sepsis Campaign : results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med 38 : 367-374, 2010.
PubMed
6) Gomes Silva BN, et al : De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock. Cochrane Database Syst Rev 12 : CD007934, 2010.
PubMed
P.20 掲載の参考文献
1) Finfer S, et al : Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med 30 : 580-588, 2004.
 
2) Vincent JL, et al : Sepsis in European intensive care units : results of SOAP study. Crit Care Med 34 : 344-353, 2006.
PubMed
3) Bouza E, et al : Is the volume of blood cultured still a significant factor in the diagnosis of bloodstream infections? J Clin Microbiol 45 : 2765-2769, 2007.
 
4) Blot F, et al : Earlier positivity of central-venous- versus peripheral-blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol 36 : 105-109, 1998.
PubMed
5) Kortgen A, et al : Implementation of an evidence-based "standard operating procedure" and outcome in septic shock. Crit Care Med 34 : 943-949, 2006.
PubMed
6) Giamarellos-Bourboulis EJ, et al : Should procalcitonin be introduced in the diagnostic criteria for the systemic inflammatory response syndrome and sepsis? J Crit Care 19 : 152-157, 2004.
 
7) Rivers E, et al : Early Goal-Directed Therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345 : 1368-1377, 2001.
PubMed
8) Micek ST, et al : Before-after study of a standardized hospital order set for the management of septic shock. Crit Care Med 34 : 2707-2713, 2006.
PubMed
9) Reinhart K, et al : Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill. Intensive Care Med 30 : 1572-1578, 2004.
PubMed
10) Dellinger RP, et al ; Surviving Sepsis Campaign Guidelines Committee : Surviving Sepsis Campaign : International Guidelines for Management of Severe Sepsis and Septic Shock : 2012. Crit Care Med 41 : 580-637, 2013.
PubMed
11) Jones AE, et al : Cost-effectiveness of an emergency department-based early sepsis resuscitation protocol. Crit Care Med 39 : 1306-1312, 2011.
PubMed
12) Vincent JL, et al : A pilot-controlled study of polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 23 : 400-405, 2005.
PubMed
13) Cruz DN, et al : Early use of polymyxin B hemoperfusion in abdominal septic shock : the EUPHAS randomized controlled trial. JAMA 17 : 2445-2452, 2009.
 
14) Rachoin JS, et al : Endotoxin removal : how far from the evidence? From EUPHAS to EUPHRATES. Contrib Nephrol 167 : 111-118, 2010.
PubMed
P.24 掲載の参考文献
1) Bone RC, et al : Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101 (6) : 1644-1655, 1992.
PubMed
2) 日本救急医学会 [http://www.jaam.jp/index.htm]
 
3) Talan DA, et al : Severe sepsis and septic shock in the emergency department. Infect Dis Clin North Am 22 (1) : 1-31, 2008.
PubMed
4) Valles J, et al : Community-acquired bloodstream infection in critically ill adult patients : impact of shock and inappropriate antibiotic therapy on survival. Chest 123 (5) : 1615-1624, 2003.
 
5) Mylotte J, et al : Epidemiology of bloodstream infection in nursing home residents : evaluation in a large cohort from multiple homes. Clin Infect Dis 35 (12) : 1484-1490, 2002.
 
6) 日本集中治療医学会Sepsis Registry委員会 : 日本版敗血症診療ガイドライン, 2012. [cited 2013 ; Available from : http://www.jsicm.org/SepsisJapan2012.pdf]
 
7) 厚生労働省院内感染対策サーベイランス事業JANIS (2013年1月31日にアクセス). [http://www.nih-janis.jp/]
 
8) Rangel-Frausto MS, et al : The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273 (2) : 117-123, 1995.
PubMed
9) Tokuda Y, et al : The degree of chills for risk of bacteremia in acute febrile illness. Am J Med 118 (12) : 1417, 2005.
PubMed
10) Dellinger RP, et al ; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup : Surviving Sepsis Campaign : International Guidelines for Management of Severe Sepsis and Septic Shock : 2012. Crit Care Med 41 (2) : 580-637, 2013.
PubMed
P.29 掲載の参考文献
1) Goldstein B, et al : International pediatric sepsis consensus conference : definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 6 : 2-8, 2005.
 
2) Watson RS, et al : The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 167 : 695-701, 2003.
PubMed
3) Shoji K, et al : Dermatologic manifestations of human parechovirus type 3 infection in neonates and infants. Pediatr Infect Dis J 32 : 233-236, 2013.
PubMed
4) Baraff LJ, et al : Effect of antibiotic therapy and etiologic microorganism on the risk of bacterial meningitis in children with occult bacteremia. Pediatrics 92 : 140-143, 1993.
PubMed
5) Baraff U, et al : Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Pediatrics 92 : 1-12, 1993.
 
6) Herz AM, et al : Changing epidemiology of outpatient bacteremia in 3-to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine. Pediatr Infect Dis J 25 : 293 -300, 2006.
 
7) 西村龍夫ほか : 小児科外来におけるoccult bacteremiaの前方視的調査. 日小児会誌 108 : 620-624, 2004.
 
8) Tunkel AR, et al : Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 39 : 1267-1284, 2004.
PubMed
9) Pediatric Advanced Life Support ; Provider manual, p 7-29, American Heart Association, Illinois, 2011.
 
10) Dellinger RP, et al : Surviving Sepsis Campaign : International Guidelines for Management of Severe Sepsis and Septic Shock. Crit Care Med 41 : 580-637, 2012.
PubMed
P.33 掲載の参考文献
1) Edwards MS, Baker JB : Bacterial infections in the neonatae. In : Principles and Practice of Pediatric Infectious Diseases (ed by Long SS), 4th ed, p 532-539, Saunders, Philadelphia, 2012.
 
2) Bailt JL et al : Maternal and neonatal outcomes by labor onset type and gestational age. Am J Obstet Gynecol 202 : 245, 2010.
 
3) Cohen-Wolkowiez, et al : Early and late onset sepsis in late preterm infants. Pediatric Infect Dis J 28 : 1052-1056, 2009.
 
4) Haque KN : Neonatal sepsis in the very low birth weight preterm infants : part 1 : review of pathophyiology. J Med Sci 3 : 1-10, 2010.
 
5) Centers for Disease Control and Pevention : Prevention of perinatal Group B Streptococcal disease-revised guidelines from CDC, 2010. MMWR Recomm Rep 59 (RR10) : 1-36, 2010.
 
6) 城裕之 : ブドウ球菌新生児感染症up to date. 周産期医学 41 : 375-381, 2011.
 
7) Polin RA ; Committee on Fetus and Newborn : Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics 129 : 1006-1015, 2012.
PubMed
8) 城裕之 : 院内感染への対応 III. 部署別感染対策 NICU. 小児科診療 12 : 1895-1901, 2006.
 
9) 日本新生児感染対策研究会. [http://plaza.umin.ac.jp/~nippon/]
 
10) Schelonika BL, et al : Volume of blood required to detect common neonatal pathogens. J Pediatr 129 : 275-278, 1996.
PubMed
11) Wiswell TE, et al : No lumbar puncture in the evaluation for early neonatal sepsis : will meningitis be missed? Pediatrics 95 : 803 -806, 1995.
 
12) Stocker M, et al : Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis : prospective, randomized intervention trial. Neonatology 97 : 165-174, 2009.
PubMed
13) INIS Collaborative Group ; Brocklehurst P, et al : Treatment of neonatal sepsis with intravenous immune globuline. N Engl J Med 365 : 1201-1211, 2011.
 
14) Sato H, et al : Probiotic supplementation dramatically decreases infection deaths in extremely and very low birth weight infants. Juntendo Medical Journal 55 : 136-141, 2009.
 
15) Stoll BJ, et al ; National Institute of Child Health and Human Development Neonatal Research Network : Neurodevelopment and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 292 : 2357-2365, 2004.
 
P.39 掲載の参考文献
1) Mermel LA : Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection : 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49 (1) : 1-45, 2009.
 
2) Safdar N : Meta-analysis : methods for diagnosing intravascular device-related bloodstream infection. Ann Intern Med 142 (6) : 451-466, 2005. Erratum in Ann Intern Med 142 (9) : 803, 2005.
 
3) Maki DG, et al : The risk of bloodstream infection in adults with different intravascular devices : a systematic review of 200 published prospective studies. Mayo Clin Proc 81 (9) : 1159-1171, 2006.
PubMed
4) Fontela PS : Epidemiology of central line-associated bloodstream infections in Quebec intensive care units : a 6-year review. Am J Infect Control 40 (3) : 221-226, 2012.
PubMed
5) Hidron AI ; National Healthcare Safety Network Team ; Participating National Healthcare Safety Network Facilities : NHSN annual update : antimicrobial-resistant pathogens associated with healthcare-associated infections : annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 29 (11) : 996-1011, 2008.
 
6) 血管内留置カテーテル感染予防の基礎と最新動向 (第6回クリティカルケア看護学会学術集会ランチョンセミナー). 月刊 'ナーシング' 第30巻第11号/通巻392号2010年10月号抜刷.
 
7) 白石正, 仲川義人 : 病院感染原因菌の増殖に及ぼす各種輸液の影響. 環境感染 22 : 165-169, 2007.
 
8) Raad II : Infectious complications of indwelling vascular catheters. Clin Infect Dis 15 (2) : 197-208, 1992.
PubMed
9) Raad I : Management of the catheter in documented catheter-related coagulase-negative staphylococcal bacteremia : remove or retain? Clin Infect Dis 49 (8) : 1187-1194, 2009.
 
10) Dugdale DC : Staphylococcus aureus bacteremia in patients with Hickman catheters. Am J Med 89 (2) : 137-141, 1990.
PubMed
11) Ghanem GA : Catheter-related Staphycoloccus aureus bacteremia in cancer patients : high rate of complications with therapeutic implications. Medicine (Baltimore) 86 (1) : 54-60, 2007.
 
P.45 掲載の参考文献
1) Benito N, et al : Health care-associated native valve endocarditis : importance of non-nosocomial acquisition. Ann Intern Med 5 : 586-594, 2009.
 
2) Federspiel JJ, et al : Increasing US rates of endocarditis with Staphylococcus aureus : 1999-2008. Arch Intern Med 172 : 363-365, 2012.
PubMed
3) Nakatani S, et al : Recent trend in infective endocarditis in Japan : An analysis of 848 cases in 2000 and 2001. Circ J 67 : 901-905, 2003.
 
4) Murdoch DR, et al : Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century. The International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 169 : 463-473, 2009.
PubMed
5) Lepeschkin E : On the relation between the site of valvular involvement in endocarditis and the blood pressure resting on the valve. Am J Med Sci 224 : 318-319, 1952.
PubMed
6) Switalski LM, et al : Binding of laminin to oral and endocarditis strains of viridans streptococci. J Bacteriol 169 : 1095-1101, 1987.
PubMed
7) Hienz SA, et al : Collagen binding of Staphylococcus aureus is a virulence factor in experimental endocarditis. J Infect Dis 174 : 83-88, 1996.
PubMed
8) Overholser CD, et al : Experimental bacterial endocarditis after dental extractions in rats with periodontitis. J Infect Dis 155 : 107-112, 1987.
PubMed
9) Li JS, et al : Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30 : 633-638, 2000.
 
10) DGK ; German Society for Cardiology, Heart, and Circulatory Research : German guidelines for the diagnosis and management of infective endocarditis. Int J Antimicrob Agents 29 : 643-657, 2007.
PubMed
11) 感染性心内膜炎. JAID/JSC感染症治療ガイド 2011 (JAID/JSC感染症治療ガイド委員会編), 日本感染症学会・日本化学療法学会, 2012.
 
12) Ohara T, et al : Clinical predictors of in-hospital death and early surgery for infective endocarditis : Results of CArdiac Disease REgistration (CADRE), a nation-wide survey in Japan. Int J Cardiol, 2012. [Epub ahead of print]
 
13) Kang DH, et al : Early surgery versus conventional treatment for infective endocarditis. N Engl J Med 28 : 2466-2473, 2012.
PubMed
P.50 掲載の参考文献
1) 後藤道彦 : 心血管系感染症. 感染症診療スタンダードマニュアル第2版, p217-242, 羊土社, 2011.
 
2) Calderwood SB, et al : Prosthetic valve endocarditis. Analysis of factors affecting outcome of therapy. J Thorac Cardiovasc Surg 92 : 776-783, 1986.
PubMed
3) Habib G, et al : Prosthetic valve endocarditis : who needs surgery? Amulticentre study of 104 cases. Heart 91 : 954-959, 2005.
 
4) Vongpatanasin W, et al : Prosthetic heart valves. N Engl J Med 335 : 407-416, 1996.
PubMed
5) Habib G, et al : Prosthetic valve endocarditis : current approach and therapeutic options. Prog Cardiovasc Dis 50 : 274-281, 2008.
PubMed
6) 日本感染症学会 (編) : Prosthetic valve endocarditis. 感染症専門医テキスト第1部解説編, p568-571, 南江堂, 2011.
 
7) 日本循環器学会 : 「循環器病の診断と治療に関するガイドライン (2007年度合同研究班報告)」感染性心内膜炎の予防と治療に関するガイドライン (2008年改訂版). [http://www.j-circ.or.jp/guideline/pdf/JCS2008_miyatake_h.pdf]
 
8) Li JS, et al : Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30 : 633-638, 2000.
 
9) Baddour LM, et al : Infective Endocarditis Diagnosis, Antimicrobial Therapy, and Management of Complications : A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association-Executive Summary : Endorsed by the Infectious Diseases Society of America. Circulation 111 : 3167-3184, 2005.
 
10) Mahesh B, et al : Prosthetic valve endocarditis. Ann Thorac Surg 80 : 1151-1158, 2005.
PubMed
11) Wilson W, et al : Prevention of infective endocarditis. Guidelines from the American Heart Association. Circulation 116 : 1736-1754, 2007.
PubMed
P.55 掲載の参考文献
1) Friedberg CK : Disease of the Heart, p 933-983, WB Saunders, Philadelphia, 1990.
 
2) Wood P : Disease of the Heart and Circulation, Eyre & Spottiswoode, London, 1968.
 
3) Hurst JW, Logue RB : The Heart, p 1647-1674, McGraw-Hill Book, New York, 1990.
 
4) Larrieu AJ, et al : Recent experience with tuberculous pericarditis. Ann Thorac Surg 29 : 464-468, 1980.
PubMed
5) Connolly DC, Burchell HB : Pericarditis : A ten-year survey. Am J Cardiol 7 : 7-14, 1961.
 
6) Rooney JJ, et al : Tuberculous pericarditis. Ann Intern Med 72 : 73-81, 1970.
PubMed
7) Carmichael DB, et al : Acute nonspecific pericarditis ; clinical, laboratory, and follow-up considerations. Circulation 3 : 321-331, 1951.
PubMed
P.59 掲載の参考文献
1) 和泉徹班長 (日本循環器学会, 日本胸部外科学会, 日本小児循環器学会, 日本心臓血管外科学会, 日本心臓病学会, 日本心不全学会2008年度合同研究班報告) : 急性および慢性心筋炎の診断・治療に関するガイドライン (2009年改訂版), 日本循環器学会, 2009. [http://www.j-circ.or.jp/guideline/pdf/JCS2009_izumi_h.pdf]
 
2) Cooper LT Jr : Myocarditis. N Engl J Med 360 : 1526-1538, 2009.
PubMed
3) Guideline for diagnosing chronic myocarditis. Japanese Circulation Society (JCS) Task Force Committee on Chronic Myocarditis. Jpn Circ J 60 : 263 -264, 1996.
 
4) Okada R, et al : Nonspecific myocarditis. A statistical and clinicopathological study of autopsy cases. Jpn Circ J 53 : 40-48, 1989.
PubMed
5) Koide H, et al : Genomic detection of enteroviruses in the myocardium-studies on animal hearts with coxsackievirus B3 myocarditis and endomyocardial biopsies from patients with myocarditis and dilated cardiomyopathy. Jpn Circ J 56 (10) : 1081-1093, 1992.
PubMed
6) 河村慧四郎ほか ; 厚生省特定疾患特発性心筋症調査研究班病因分科会 : ウイルス性あるいは特発性心筋炎に関する全国アンケート調査, 第3報-昭和57年度および昭和60年度における調査の集計-厚生省特定疾患特発性心筋症調査研究班昭和60年度研究報告集, p23-36, 1986.
 
7) Bowles NE, et al : Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 42 : 466-472, 2003.
PubMed
8) Ukimura A, et al : Anational survey on myocarditis associated with influenza H1N1pdm2009 in the pandemic and postpandemic season in Japan. J Infect Chemother 19 : 426-431, 2013.
 
9) Aoyama N, et al ; Japanese Investigators of Fulminant Myocarditis : National survey of fulminant myocarditis in Japan : therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis (special report from a scientific committee). Circ J 66 : 133-144, 2002.
PubMed
P.64 掲載の参考文献
1) Osler W : The Gulstonian lectures, on malignant endocarditis. Br Med J 1 : 467-470, 1885.
PubMed
2) Macedo TA, et al : Infected aortic aneurysms : imaging findings. Radiology 231 : 250-257, 2004.
PubMed
3) Hsu RB, et al : Infected aortic aneurysms : clinical outcome and risk factor analysis. J Vasc Surg 40 : 30-35, 2004.
PubMed
4) Naganuma H, et al : Mycotic abdominal aneurysm : report of a case with emphasis on the presence of gas echoes. Abdom Imaging 26 : 420-422, 2001.
PubMed
5) 山下修ほか : 感染性腹部大動脈瘤の診断におけるPET-CT検査の有用性. 脈管学 51 : 473-479, 2011.
 
6) Schuetz P, et al : Procalcitonin for diagnosis of infection and guide to antibiotic decisions : past, present and future. BMC Med 9 : 107, 2011.
PubMed
7) Kasashima S, Zen Y : IgG4-related inflammatory abdominal aortic aneurysm. Curr Opin Rheumatol 23 : 18-23, 2011.
PubMed
8) Miyazato A, et al : Comparative molecular and microbiological diagnosis of 19 infective endocarditis cases in which causative microbes were identified by PCR-based DNA sequencing from the excised heart valves. J Infect Chemother 18 : 318-323, 2012.
 
9) Riesenman PJ, et al : Thoracic endovascular aortic repair of aortobronchial fistulas. J Vasc Surg 50 : 992-998, 2009.
PubMed
10) Jonker FH, et al : Outcome of thoracic endovascular aortic repair for aortobronchial and aortoesophageal fistulas. J Endovasc Ther 16 : 428-440, 2009.
PubMed
11) Bacourt F, Koskas F : Axillobifemoral bypass and aortic exclusion for vascular septic lesions : a multicenter retrospective study of 98 cases. French University Association for Research in Surgery. Ann Vasc Surg 6 : 119-126, 1992.
 
12) Yu SY, et al : Treatment of primary infected aortic aneurysm without aortic resection. J Vasc Surg 56 : 943-950, 2012.
PubMed
13) Razavi MK, Tazavi MD : Stent-graft treatment of mycotic aneurysms : a review of the current literature. J Vasc Interv Radiol 19 : 51-56, 2008.
 
P.68 掲載の参考文献
1) Leroy O, et al : Vascular graft infections. Curr Opin Infect Dis 25 : 154-158, 2012.
PubMed
2) Tatterton MR, Homer-Vanniasinkam S : Infections in vascular surgery. Injury 42 (Suppl 5) : S35-41, 2011.
 
3) Baddour LM, et al : Nonvalvular cardiovascular device-related infections. Circulation 108 : 2015-2031, 2003.
PubMed
4) Atshan SS, et al : Comparative characterisation of genotypically different clones of MRSA in the production of biofilms. J Biomed Biotechnol 2012 : 417247, 2012.
PubMed
5) FitzGerald SF, et al : Diagnosis and treatment of prosthetic aortic graft infections : confusion and inconsistency in the absence of evidence or consensus. J Antimicrob Chemother 56 : 996-999, 2005.
PubMed
6) Orton DF, et al : Aortic prosthetic graft infections : radiologic manifestations and implications for management. Radiographics 20 : 977-993, 2000.
PubMed
7) Bunt TJ : Vascular graft infections : an update. Cardiovasc Surg 9 : 225-233, 2001.
PubMed
8) Liu C, et al : Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children : executive summary. Clin Infect Dis 52 : 285-292, 2011.
 
9) Bisdas T, et al : Cryopreserved arterial homografts vs silver-coated Dacron grafts for abdominal aortic infections with intraoperative evidence of microorganisms. J Vasc Surg 53 : 1274-1281, 2011.
PubMed
10) Golan JF : Vascular graft infection. Infect Dis Clin North Am 3 : 247-258. 1989.
PubMed
11) Saito A, et al : Outcome of surgical repair of aorto-eosophageal fistulas with cryopreserved aortic allografts. Interact Cardiovasc Thorac Surg 14 : 532 -537, 2012.
 
12) Saleem BR, et al : Conservative treatment of vascular prosthetic graft infection is associated with high mortality. Am J Surg 200 : 47-52, 2010.
PubMed
13) Brown KE, et al : Arterial reconstruction with cryopreserved human allografts in the setting of infection : A single-center experience with midterm follow-up. J Vasc Surg 49 : 660-666, 2009.
PubMed
14) Vogt PR : Arterial allografts in treating aortic graft infections : something old, something new. Semin Vasc Surg 24 : 227-233, 2011.
PubMed
15) Saito A, et al : Vascular allografts are resistant to methicillin-resistant Staphylococcus aureus through indoleamine 2, 3-dioxygenase in a murine model. J Thorac Cardiovasc Surg 136 : 159-167, 2008.
 
16) Acosta S, Monsen C : Outcome after VAC (R) therapy for infected bypass grafts in the lower limb. Eur J Vasc Endovasc Surg 44 : 294-299, 2012.
 
P.74 掲載の参考文献
1) Yoshida M, et al : Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991. Int J Hematol 70 : 261-267, 1999.
 
2) Bodey GP, et al : Pseudomonas bacteremia. Retrospective analysis of 410 episodes. Arch Intern Med 145 : 1621-1629, 1985.
PubMed
3) Schimpff S, et al : Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 284 : 1061-1065, 1971.
PubMed
4) Klastersky J : Febrile neutropenia. Curr Opin Oncol 5 : 625-632, 1993.
PubMed
5) Donnelly JP, et al : Infections in the immunocompromised host : general principles. In : Principles and Practice of Infectious Diseases, 7th ed (ed by Mandell GL, et al), p 3781-3791, Churchill Livingstone, Philadelphia, 2010.
 
6) Hughes WT, et al : From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis 161 : 381-396, 1990.
 
7) Hughes WT, et al : 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin Infect Dis 25 : 551-573, 1997.
 
8) Hughes WT, et al : 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34 : 730-751, 2002.
PubMed
9) Freifeld AG, et al : Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer : 2010 update by the infectious diseases society of america. Clin Infect Dis 52 : e56-e93, 2011.
 
10) Masaoka T : Conclusions and recommendations : evidence-based recommendations on antimicrobial use in febrile neutropenia in Japan. Int J Hematol 68 (Suppl 1) : S39-S40, 1998.
 
11) Masaoka T : Evidence-based recommendations for antimicrobial use in febrile neutropenia in Japan : executive summary. Clin Infect Dis 39 (Suppl 1) : S49-S52, 2004.
 
12) 発熱性好中球減少症 (FN) 診療ガイドライン (日本臨床腫瘍学会編), p 1-70, 南江堂, 2012.
 
13) Paul M, et al : β lactam monotherapy versus β lactam-aminoglycoside combination therapy for fever with neutropenia : systematic review and meta-analysis. BMJ 326 : 1111-1120, 2003.
 
14) Fujita H, et al : Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group. Int J Hematol 90 : 191-198, 2009.
 
15) Empiric antifungal therapy in febrile granulocytopenic patients. EORTC International Antimicrobial Therapy Cooperative Group. Am J Med 86 : 668-672, 1989.
PubMed
P.77 掲載の参考文献
1) Ishii E, et al : Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol 86 : 58 -65, 2007.
 
2) Tang YM, Xu XJ : Advances in hemophagocytic lymphohistiocytosis : pathogenesis, early diagnosis/differential diagnosis, and treatment. Scientific World Journal 22 : 697-708, 2011.
 
3) Jordan MB, et al : How I treat hemophagocytic lymphohistiocytosis. Blood 118 : 4041-4052, 2011.
 
4) Huck K, et al : Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation. J Clin Invest 119 : 1350-1358, 2009.
 
5) Suzuki N, et al ; HLH/LCH Committee of the Japanese Society of Pediatric Hematology : Characteristics of hemophagocytic lymphohistiocytosis in neonates : a nationwide survey in Japan. J Pediatr 155 : 235-238, 2009.
PubMed
6) Behrens EM, et al : Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice. J Clin Invest 121 : 2264-2277, 2011.
PubMed
7) Zhang K, et al : Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. Blood 118 : 5794-5798, 2011.
PubMed
8) Risma K Jordan MB : Hemophagocytic lymphohistiocytosis : updates and evolving concepts. Curr Opin Pediatr 24 : 9-15, 2012.
PubMed
9) Henter JI, et al : HLH-2004 : Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48 : 124-131, 2007.
PubMed
10) Okano M, et al : Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol 80 : 64-69, 2005.
PubMed
11) http://pidj.rcai.riken.jp/
 
12) Shiraishi A, et al : Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 59 : 265-270, 2012.
PubMed
13) Marsh RA, et al : Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation. Blood 116 : 5824-5831, 2010.
PubMed
14) Ohga S, et al : Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan. Pediatr Blood Cancer 54 : 299-306, 2010.
PubMed

II 中枢神経系感染症

P.92 掲載の参考文献
1) 岩田敏 : ペニシリン耐性肺炎球菌-臨床の立場から. 小児感染免疫 10 : 139-146, 1998.
 
2) 新庄正宜ほか : 本邦における小児細菌性髄膜炎の動向 (2009～2010). 感染症誌 86 : 582-591, 2012.
 
3) 加藤達夫ほか : わが国における全身型Hib (Haemophilus influenza b型) 感染とワクチン導入の必要性 わが国におけるHib髄膜炎の発生状況 1996～1997年のプロスペクティブ調査結果. 小児感染免疫 10 : 209 -214, 1998.
 
4) 国立感染症研究所感染症疫学センター : 7価肺炎球菌結合型ワクチン (PCV7) 導入が侵襲性細菌感染症に及ぼす効果 : 2012. 病原微生物検出情報 34 : 62-63, 2013. [http://www.nih.go.jp/niid/ja/typhi-m/iasr-reference/2249-related-articles/related-articles-397/3286-dj3975.html]
 
5) 生方公子ほか : 本邦において1998年から2000年の間に分離されたStreptococcus pneumoniaeの分子疫学解析. 肺炎球菌等による市中感染症研究会収集株のまとめ. 日化療会誌 51 : 60-70, 2003.
 
6) Ubukata K, et al : Antibiotic susceptibility in relation to penicillin-binding protein genes and serotype distribution of Streptococcus pneumoniae strains responsible for meningitis in Japan, 1999 to 2002. Antimicrob Agents Chemother 48 : 1488-1494, 2004.
PubMed
7) 生方公子ほか : 本邦において1998年から2000年の間に分離されたHaemophilus influenzaeの分子疫学解析. 肺炎球菌等による市中感染症研究会収集株のまとめ. 日化療会誌 50 : 794-804, 2002.
 
8) 長谷川恵子ほか : 化膿性髄膜炎例から分離されたHaemophilus influenzaeの疫学解析 1999年から2003年の分離株について. 感染症誌 78 : 835-845, 2004.
 
9) 国立感染症研究所感染症情報センター : 無菌性髄膜炎関連エンテロウイルスの動向2008年12月現在. 病原微生物検出情報 30 : 1-3, 2009. [http://idsc.nih.go.jp/iasr/30/347/tpc347-j.html]
 
10) 国立感染症研究所感染症情報センター : 急性脳炎 2004～2007. 8. 病原微生物検出情報 28 : 339-340, 2007. [http://idsc.nih.gojp/iasr/28/334/tpc334-j.html]
 
11) 堀田一 : 【感染症迅速検査アップデート】各種迅速検査法 全身, その他の感染症 その他 PASTOREXメニンジャイティス. Medical Technology 36 : 1511, 2008.
 
12) Radstrom P, et al : Detection of bacterial DNA in cerebrospinal fluid by an assay for simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and streptococci using a seminested PCR strategy. J Clin Microbiol 32 : 2738-2744, 1994.
PubMed
13) Corless CE, et al : Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J Clin Microbiol 39 : 1553-1558, 2001.
PubMed
14) Uzuka R, et al : Rapid diagnosis of bacterial meningitis by using multiplex PCR and real time PCR. Pediatr Int 46 : 551-554, 2004.
PubMed
15) Boving MK, et al : Eight-plex PCR and liquid-array detection of bacterial and viral pathogens in cerebrospinal fluid from patients with suspected meningitis. J Clin Microbiol 47 : 908-913, 2009.
PubMed
16) Chiba N, et al : Rapid detection of eight causative pathogens for the diagnosis of bacterial meningitis by real-time PCR. J Infect Chemother 15 : 92-98, 2009.
PubMed
17) 細菌性髄膜炎の診療ガイドライン作成委員会 (編) : 治療. 細菌性髄膜炎の診療ガイドライン, p33-65, 医学書院, 2007.
 
18) Rana SV, et al : To compare CSF adenosine deaminase levels and CSF-PCR for tuberculous meningitis. Clin Neurol Neurosurg 112 : 424-430, 2010.
PubMed
P.98 掲載の参考文献
1) Kamei S, Takasu T : Nationwide survey of the annual prevalence of viral and other neurological infections in Japanese inpatients. Intern Med 39 : 894-900, 2000.
PubMed
2) Schuchat A, et al : Bacterial meningitis in the United States in 1995. Active Surveillance Team. NEnglJMed 337 : 970-976, 1997.
PubMed
3) Hsu HE, et al : Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med 360 : 244-256, 2009.
PubMed
4) Hasegawa K, et al : High prevalence of type b beta-lactamase-non-producing ampicillin-resistant Haemophilus influenzae in meningitis : the situation in Japan where Hib vaccine has not been introduced. J Antimicrob Chemother 57 : 1077-1082, 2006.
 
5) Tunkel AR, et al : Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 39 : 1267-1284, 2004.
PubMed
6) McCullers JA, et al : Isolation and characterization of vancomycin-tolerant Streptococcus pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis. J Infect Dis 181 : 369-373, 2000.
PubMed
7) 細菌性髄膜炎の診療ガイドライン作成委員会 (糸山泰人ほか) : 細菌性髄膜炎の診療ガイドライン. 神経治療 24 : 71-132, 2007.
 
8) Ubukata K, et al : Antibiotic susceptibility in relation to penicillin-binding protein genes and serotype distribution of Streptococcus pneumoniae strains responsible for meningitis in Japan, 1999 to 2002. Antimicrob Agents Chemother 48 : 1488-1494, 2004.
PubMed
9) Gilbert DN, et al : The Sanford Guide to Antimicrobial Therapy 2012, 42th ed, p 8-9, Antimicrobial Therapy Inc, Sperryville, 2012.
 
10) Tunkel AR, et al : Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 39 : 1267-1284, 2004.
PubMed
11) Kim KS : Acute bacterial meningitis in infants and children. Lancet Infect Dis 10 : 32-42, 2010.
PubMed
12) Tunkel AR, Scheld WM : Acute bacterial meningitis. Lancet 346 (8991-8992) : 1675-1680, 1995.
 
13) van de Beek D, et al : Adjunctive dexamethasone in bacterial meningitis : a meta-analysis of individual patient data. Lancet Neurol 9 : 254-263, 2010.
PubMed
14) Chaudhuri A, et al : EFNS guideline on the management of community-acquired bacterial meningitis : report of an EFNSTask Force on acute bacterial meningitis in older children and adults. Eur J Neurol 15 : 649-659, 2008.
PubMed
15) van de Beek D, et al : Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 351 : 1849-1859, 2004.
PubMed
16) Ishihara M, et al : Hospital-based study of the prognostic factors in adult patients with acute community-acquired bacterial meningitis in Tokyo, Japan. Intern Med 48 : 295-300, 2009.
PubMed
P.102 掲載の参考文献
1) 細菌性髄膜炎の診療ガイドライン作成委員会 (編) : 細菌性髄膜炎の診療ガイドライン, 日本神経治療学会他監修, 医学書院, 2007.
 
2) 荒川創一ほか : 細菌性髄膜炎. JAID/JSC感染症治療ガイド 2011 (JAID/JSC感染症治療ガイド委員会編), 日本感染症学会, 日本化学療法学会, ライフサイエンス出版, 2011.
 
3) 庵原俊昭ほか : インフルエンザ菌b型 (Hib) ワクチンおよび7価肺炎球菌結合型ワクチン (PCV7) 導入が侵襲性細菌感染症に及ぼす効果について. IASR 33 : 71-72, 2012.
 
4) Hasegawa K, et al ; Nationwide Surveillance for Bacterial Meningitis : High prevalence of type b beta-lactamase-non-producing ampicillin-resistant Haemophilus influenzae in meningitis : the situation in Japan where Hib vaccine has not been introduced. J Antimicrob Chemother 57 : 1077-1082, 2006.
 
5) Sakata H, et al : Results of a multicenter survey of diagnosis and treatment for bacterial meningitis in Japan. J Infect Chemother 16 : 396-406, 2010.
PubMed
6) 新庄正宜ほか : 本邦における小児細菌性髄膜炎の動向 (2009～2010). 感染症誌 86 : 582-591, 2012.
 
7) Ubukata K, et al : Antibiotic susceptibility in relation to penicillin-binding protein genes and serotype distribution of Streptococcus pneumoniae strains responsible for meningitis in Japan, 1999 to 2002. Antimicrob Agents Chemother 48 : 1488-1494, 2004.
PubMed
8) 砂川慶介ほか : 本邦における小児細菌性髄膜炎の動向 (2005-2006). 感染症誌 82 : 187-197, 2006.
 
9) Tunkel AR, et al : Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 39 : 1267-1284, 2004.
PubMed
10) Chaudhuri A, et al : EFNS guideline on the management of community-acquired bacterial meningitis : report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol 15 : 649-659, 2008.
PubMed
11) McIntyre PB, et al : Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA 278 : 925-931, 1997.
PubMed
P.107 掲載の参考文献
1) Kamei S, Takasu T : Nationwide survey of the annual prevalence of viral and other neurological infections in Japanese inpatients. Intern Med 39 : 894-900, 2000.
PubMed
2) 高橋輝行ほか : 結核性髄膜炎に対する迅速・高感度診断方法. Annual Review神経 2011, p 150-161, 中外医学社, 2011.
 
3) 山口英世 : 補助診断法 (2) : 血清診断法. 病原真菌と真菌症, p91-102, 南山堂, 2007.
 
4) 日本結核病学会 : 結核診療ガイドライン, 南江堂, 2009.
 
5) Thwaites G, et al : British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect 59 : 167-187, 2009,
 
6) American Thoracic Society ; CDC ; Infectious Diseases Society of America : Treatment of tuberculosis. MMWR Recomm Rep 52 (RR-11) : 1-77, 2003.
 
7) 深在性真菌症のガイドライン作成委員会 (編) : 深在性真菌症の診断・治療ガイドライン 2007, 協和企画, 2007.
 
8) Perfect JR, et al : Clinical practice guidelines for the management of cryptococcal disease : 2010 update by the infectious diseases society of America. Clin Infect Dis 50 : 291-322. 2010.
 
9) Pappas PG, et al : Clinical practice guidelines for the management of candidiasis : 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48 : 503-535, 2009.
 
10) Sanchez-Portocarrero J, et al : The central nervous system and infection by Candida species Diagn Microbiol Infect Dis 37 : 169-179, 2000.
PubMed
11) Walsh TJ, et al : Infectious Diseases Society of America : Treatment of aspergillosis : clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46 : 327-360, 2008.
 
P.112 掲載の参考文献
1) 渡邊浩, 土橋佳子 : 髄膜炎. 日内会誌 95 : 2232-2237, 2006.
 
2) 塚本哲朗 : ウイルス性髄膜炎. 最新内科学体系 第67巻神経感染症と脱髄疾患 (井村裕夫ほか編), p51-57, 中山書店, 1996.
 
3) Jubelt B : Viral infections and postviral syndromes. In : Merritt's Neurology, 12th ed (ed by Rowland LP, Pedley TA), p 156-185, Lippincott Williams & Wilkins, Philadelphia, 2010.
 
4) 厚生労働省/国立感染症研究所 : グラフ総覧 (52週). 感染症週報 (IDWR) 14 (12) : 19-24, 2012.
 
5) 厚生労働省/国立感染症研究所 : 2006年第12週 (9月11日～9月17日). 感染症週報 (IDWR) 8 (37) : 17-18, 2006.
 
6) 大井静雄 : ウイルス性髄膜炎の病原ウイルス. 神経疾患データブック (大井静雄編), p356-357, 中外医学社, 1996.
 
7) 高瀬貞夫, 野村宏 : 髄膜検査の臨床的意義. 神経内科 37 : 215-232, 1992.
 
8) 大井静雄 : 主要髄膜炎にみられる髄液所見 (急性期). 神経疾患データブック (大井静雄編), p355, 中外医学社, 1996.
 
9) 伊藤彰一 : ウイルス感染症. 神経MRI診断学, p 81-88, シービーアール, 2009.
 
P.118 掲載の参考文献
1) 「結核の統計」資料編 2011, 財団法人結核予防会結核研究所疫学情報センター. [http://jata.or.jp/rit/ekigaku/]
 
2) Kleinnijenhuis J, et al : Innate immune recognition of Mycobacterium tuberculosis. Clin Dev Immunol 2011 : 405310, 2011.
PubMed
3) Thwaites G, et al : British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect 59 : 167-187, 2009.
 
4) Suzuki Y : [Tuberculosis infection in the nervous system]. Nihon Rinsho 69 : 1422-1426, 2011.
PubMed
5) Marais S, et al : Tuberculous meningitis : a uniform case definition for use in clinical research. Lancet Infect Dis 10 : 803-812, 2010.
PubMed
6) Takahashi T, et al : The PCR-Based Diagnosis of Central Nervous System Tuberculosis : Up to Date. Tuberc Res Treat 2012 : 831292, 2012.
PubMed
7) Xu HB, et al : Diagnostic value of adenosine deaminase in cerebrospinal fluid for tuberculous meningitis : a meta-analysis. Int J Tuberc Lung Dis 14 : 1382」387, 2010.
 
8) Thwaites GE, et al : Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis. J Infect Dis 192 : 79-88, 2005.
PubMed
9) American Academy of Pediatrics Committee on Infectious Diseases : Chemotherapy for tuberculosis in infants and children. Pediatrics 89 : 161-165, 1992.
 
10) Prasad K, Singh MB : Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev (1) : CD002244, 2008.
PubMed
11) Thwaites GE, et al : Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 351 : 1741-1751, 2004,
PubMed
12) Heemskerk D, et al : Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT) : protocol for a randomized controlled trial. Trials 12 : 25, 2011.
PubMed
13) Torok ME, et al : Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV) -associated tuberculous meningitis. Clin Infect Dis 52 : 1374-1383, 2011.
PubMed
14) Misra UK, et al : Role of aspirin in tuberculous meningitis : a randomized open label placebo controlled trial. J Neurol Sci 293 : 12-17, 2010.
 
15) Kennedy DH, Fallon RJ : Tuberculous meningitis. JAMA 241 : 264-268, 1979.
PubMed
P.125 掲載の参考文献
1) Kamei S, Takasu T : Nationwide survey of the annual prevalence of viral and other neurological infections in Japanese inpatients. Intern Med 39 : 894-900, 2000.
PubMed
2) 深在性真菌症のガイドライン作成委員会 : 深在性真菌症の診断・治療ガイドライン 2007, 協和企画, 2007.
 
3) 山口英 : Cryptococcus neoformansとクリプトコッカス症. NEUROINFECTION 10 : 7-12, 2005.
 
4) Galanis E, Macdougall L : Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999-2007. Emerg Infect Dis 16 : 251-257, 2010.
PubMed
5) Okamoto K, et al : Cryptococcus gattii genotype VGIIa infection in man, Japan, 2007. Emerg Infect Dis 16 : 1155-1157, 2010.
PubMed
6) Multistate outbreak of fungal infection associated with injection of methylprednisolone acetate solution from a single compounding pharmacy-United States, 2012. MMWR Morb Mortal Wkly Rep 61 : 839-842, 2012.
PubMed
7) Zhao Y, et al : A Real-Time PCR Assay for Rapid Detection and Quantification of Exserohilum rostratum, a Causative Pathogen of Fungal Meningitis Associated with Injection of Contaminated Methylprednisolone. J Clin Microbiol 51 (3) : 1034-1036, 2013.
 
8) Jarvis JN, Harrison TS : HIV-associated cryptococcal meningitis. AIDS 21 : 2119-2129, 2007.
PubMed
9) Viscoli C, et al : Aspergillus galactomannan antigen in the cerebrospinal fluid of bone marrow transplant recipients with probable cerebral aspergillosis. J Clin Microbiol 40 : 1496-1499, 2002.
PubMed
10) Verduyn Lunel FM, et al : Detection of the Candida antigen mannan in cerebrospinal fluid specimens from patients suspected of having Candida meningitis. J Clin Microbiol 42 : 867-870, 2004.
PubMed
11) Perfect JR, et al : Clinical practice guidelines for the management of cryptococcal disease : 2010 update by the infectious diseases society of america. Clin Infect Dis 50 : 291-322, 2010.
 
12) Walsh TJ, et al : Treatment of aspergillosis : clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46 : 327-360, 2008.
 
13) Kourkoumpetis TK, et al : Central nervous system aspergillosis : a series of 14 cases from a general hospital and review of 123 cases from the literature. Medicine (Baltimore) 91 : 328-336, 2012.
PubMed
14) Pappas PG, et al : Clinical practice guidelines for the management of candidiasis : 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48 : 503 -535, 2009.
 
15) Singh N, et al : Cryptococcosis in solid organ transplant recipients : current state of the science. Clin Infect Dis 47 : 1321-1327, 2008.
PubMed
P.130 掲載の参考文献
1) Hoshino A, et al : Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes. Brain Dev 34 : 337-343, 2012.
PubMed
2) Zhang SY, et al : TLR3 deficiency in patients with herpes simplex encephalitis. Science 317 : 1522-1527, 2007.
PubMed
3) Chen Y, et al : Thermolabile phenotype of carnitine palmitoyltransferase II variations as a predisposing factor for influenza-associated encephalopathy. FEBS Lett 579 : 2040-2044, 2005.
PubMed
4) Mizuguchi M, et al : Acute encephalopathy associated with influenza and other viral infections. Acta Neurol Scand 115 (4 Suppl) : 45-56, 2007.
 
5) Mizuguchi M, et al : Acute necrotising encephalopathy of childhood : a new syndrome presenting with multifocal, symmetric brain lesions. J Neurol Neurosurg Psychiatry 58 : 555-561, 1995.
PubMed
6) Levin M, et al : Haemorrhagic shock and encephalopathy : a new syndrome with a high mortality in young children. Lancet 2 : 64-67, 1983.
PubMed
7) Takanashi J, et al : Diffusion MRI abnormalities after prolonged febrile seizures with encephalopathy. Neurology 66 : 1304-1309, 2006.
PubMed
8) Takanashi J, et al : Excitotoxicity in acute encephalopathy with biphasic seizures and late reduced diffusion. Am J Neuroradiol 30 : 132-135, 2009.
PubMed
9) Tada H, et al : Clinically mild encephalitis/encephalopathy with a reversible splenial lesion. Neurology 63 : 1854-1858, 2004.
PubMed
10) Sakuma H : Acute encephalitis with refractory, repetitive partial seizures. Brain Dev 31 : 510-514, 2009.
PubMed
11) Okumura A, et al : Outcome of acute necrotizing encephalopathy in relation to treatment with corticosteroids and gammaglobulin. Brain Dev 31 : 221-227, 2009.
PubMed
12) Hayashi N, et al : Prognostic factors in acute encephalopathy with reduced subcortical diffusion. Brain Dev 34 : 632-639, 2012.
PubMed
13) Greiner HM, et al : Nonconvulsive status epilepticus : the encephalopathic pediatric patient. Pediatrics 129 : e748-755, 2012.
PubMed
P.135 掲載の参考文献
1) Mathisen GE, Johnson JP : Brain abscess. Clin Infect Dis 25 : 763-781, 1997.
PubMed
2) Calfee DP, Wispelwey B : Brain abscess. Semin Neurol 20 : 353-360, 2000,
PubMed
3) Moorthy RK, Rajshekhar V : Management of brain abscess : an overview. Neurosurg Focus 24 : E3, 2008.
PubMed
4) Ebisu T, et al : Discrimination of brain abscess from necrotic or cystic tumors by diffusion-weighted echo planar imaging. Magn Reson Imaging 14 : 1113-1116, 1996.
PubMed
P.139 掲載の参考文献
1) Nakajima H, et al : Herpes simplex virius myelitis : Clincial manifestations and diaganosis by the polymerase chain reaction method. Eur Neurol 39 : 163-167, 1998.
 
2) Hung CH, et al : Features of varicella zoster virus myelitis and dependence on immune status. J Neurol Sci 318 : 19-24, 2012.
 
3) Bouguila J, et al : Epstein-Barr virus infection and acute transverse myelitis. Med Mal Infect 42 : 83-84, 2012.
PubMed
4) Irani DN : Aseptic meningitis and viral myelitis. Neurol Clin 26 : 635-655, 2008.
PubMed
5) Bhattacharya M, Joshi N : Spinal epidural abscess with myelitis and meningitis caused by Streptococcus pneumoniae in a young child. J Spinal Cord Med 34 : 340-343, 2011.
 
6) 中嶋秀人 : HSV-2型脊髄炎・髄膜炎. ヘルペス脳炎-診療ガイドラインに基づく診断. 基準と治療指針 (日本神経感染症学会編), p93-104, 中山書店, 2007.
 
7) 犬飼晃ほか : 抗体価指数による髄腔内抗体産生の硫価が病因診断確定に有用であったzoster sine herpeteにともなう脊髄炎の1例. 臨床神経 50 : 634-640, 2010.
 
8) Aoki K, et el : Human herpes virus 6-associated myelitis following allogeneic bone marrow transplantation. Ann Hematol 91 : 1663-1665, 2012.
 
9) 大石真莉子ほか : 二相性の運動麻痺をきたしたワクチン関連麻痺性ポリオ (Vaccine-associated paralytic poliomyelitis, VAPP) の38歳男性例. 臨床神経 52 : 744-749, 2012.
 
10) 長嶋淑子 : Post-poliomyelitic muscular atrophy. 脊椎脊髄ジャーナル 4 : 471-475, 1991,
 
11) Chang BL, et al : Acute neuroborreliosis with involvement of the central nervous system. J Neurol Sci 295 : 10-15, 2010.
PubMed
12) Kira J, et al : Acute myelitis associated with hyperIgEemia and atopic dermatitis. J Neurol Sci 148 : 199-203, 1997.
PubMed
P.143 掲載の参考文献
1) Hemrika DJ, et al : Elsberg syndrome : a neurologic basis for acute urinary retention in patients with genital herpes. Obstet Gynecol 68 : S37-S39, 1986.
 
2) 野原道子ほか : 急性性. 器ヘルペスに排尿障害を伴うElsberg症候群の1例. 日産婦東京会誌 37 : 383-386, 1988.
 
3) 木戸道子, 川名尚 : 単純ヘルペス神経根炎 (Elsberg症候群). 別冊日本臨牀 感染症症候群 (II), p52-54, 日本臨床社, 1999.
 
4) Wildgruber D, et al : Elsberg syndrome due to infarction of the conus medullaris associated with a prothrombin mutation. J Neurol 246 : 507-508, 1999.
PubMed
5) Eberhardt O, et al : HSV-2 sacral radiculitis (Elsberg syndrome). Neurology 63 : 758-794, 2004.
PubMed
6) Yoritaka A, et al : Herpetic lumbosacral radiculoneuropathy in patients with human immunodeficiency virus infection. Eur Neurol 53 : 179-181, 2005.
PubMed
7) Sakakibara R, et al : Meningitis-retention syndrome. An unrecognized clinical condition. J Neurol 252 : 1495-1499, 2005.
PubMed
8) Sakakibara R, et al : Acute urinary retention due to benign inflammatory nervous diseases. J Neurol 253 : 1103-1110, 2006.
PubMed
9) Furugen M, et al : Elsberg syndrome with eosinophilic meningoencephalitis caused by Angiostrongylus cantonensis. Intern Med 45 : 1333-1336, 2006.
PubMed
10) 川村眞智子ほか : 尿閉をきたしたウイルス性髄膜脳炎の幼児例. Brain Nerve 59 : 1287-1291, 2007.
 
11) Suarez-Calvet M, et al : Polyradiculoneuropathy associated to human herpesvirus 2 in an HIV-1-infected patient (Elsberg syndrome) : case report and literature review. Sex Transm Dis 37 : 123-125, 2010.
 
12) Matsumoto H, et al : Rectal ulcer in a patient with VZV sacral meningoradiculitis (Elsberg syndrome). Intern Med 51 : 651-654, 2012.
 
13) Brostrem S : Motor evoked potentials from the pelvic floor. Neurourol Urodyn 22 : 620-637, 2003.
 
14) Matsumoto H, et al : Magnetic stimulation of the cauda equina in the spinal canal with a flat, large round coil. J Neurol Sci 284 : 46-51, 2009.
 
15) 日本神経感染症学会 : ヘルペス脳炎-診療ガイドラインに基づく診断基準と治療指針, 中山書店, 2007.
 
P.147 掲載の参考文献
1) Lotze TE, Chadwick DJ : Acute disseminated encephalomyelitis in children : Pathogenesis, clinical features, and diagnosis. UpToDate 2013.
 
2) Goverman J : Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 9 : 393-407, 2009.
PubMed
3) Callen DJ, et al : Role of MRI in the differentiation of ADEM from MS in children. Neurology 72 : 968-973, 2009.
PubMed
4) Krupp LB, et al : Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 68 : S7-S12, 2007.
 
5) Lotze TE : Differential diagnosis of acute central nervous system demyelination in children. UpToDate 2013.
 
6) Lotze TE, Chadwick DJ : Acute disseminated encephalomyelitis in children : Prognosis and treatment. UpToDate 2013.
 
7) Menge T, et al : Acute disseminated encephalomyelitis ; an update. Arch Neurol 62 : 1637-1680, 2005.
 
8) Yeh EA, et al : Pediatric multiple sclerosis. Nat Rev Neurol 5 : 621-631, 2009.
PubMed
9) Mikaeloff Y, et al : Acute disseminated encephalomyelitis cohort study : prognostic factors for relapse. Eur J Paediatr Neurol 11 : 90-95, 2007.
PubMed
P.151 掲載の参考文献
1) Mizuguchi M, et al : Acute encephalopathy associated with influenza and other viral infections. Acta Neurol Scand 115 : 45-56, 2007.
PubMed
2) Reye RD, et al : Encephalopathy and fatty degeneration of the viscera : A disease entity in childhood. Lancet 2 : 749-752, 1963.
PubMed
3) 厚生労働科学研究費補助金難治性疾患克服研究事業 重症・難治性急性脳症の病因解明と診療確立に向けた研究班 : 平成22年度総括・分担研究報告書, p13-34, 2011.
 
4) Hoshino A, et al : Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes. Brain Dev 34 : 337-343, 2012.
PubMed
5) Fugate JH : Metabolic encephalopathy including Reye's syndrome. In : Critical Care of Infants and Children (ed by Todres ID, Fugate JH), p 396-402, Little, Brown and Company, Boston, 1996.
 
6) Orlowski JP : Whatever happened to Reye's syndrome? Did it ever really exist? Crit Care Med 27 (8) : 1582-1587, 1999.
PubMed
7) Shinohara M, et al : Carnitine palmitoyl transferase II polymorphism is associated with multiple syndromes of acute encephalopathy with various infectious diseases. Brain Dev 33 : 512-517, 2011.
PubMed
8) Saitoh M, et al : Mutations of the SCN1A gene in acute encephalopathy. Epilepsia 53 : 558-564, 2012.
PubMed
9) Shinohara M, et al : ADORA2A polymorphism predisposes children to encephalopathy with febrile status epilepticus. Neurology 80 : 1571-1576, 2013.
PubMed
10) 水口雅 : 急性脳症-発症の遺伝的背景-. Neuroinfection, 2013. (in press)
 
11) 水口雅 : 急性脳症の治療. 日小児科会誌 114 : 1381-1388, 2010.
 
P.157 掲載の参考文献
1) Ghanem KG : Neurosyphilis : A historical perspective and review. CNS Nuerosci Ther 16 : e157-168, 2010.
PubMed
2) Ghanem KG, et al : Neurosyphilis in a clinical cohort of HIV-1-infected patients. AIDS 19 : 1145-1151, 2008.
 
3) 北川泰久 : 進行麻痺. 別冊日本臨牀 感染症症候群 (1), p318-323, 日本臨牀社, 1999.
 
4) 長根亜紀子ほか : 進行麻痺および梅毒感染症. 精神科治療学 21 : 258 -259, 2006.
 
5) 加藤博子ほか : 急速に進行する片麻痺を呈したLissauer型進行麻痺の1剖検例. Clin Neurol 49 : 348-353, 2009.
 
6) 柳下三郎 : 神経梅毒 (2) 進行麻痺・脊髄瘍. 臨床医のための神経病理. Clin Neurosci 26 : 1064-1065. 2008.
 
7) Peng F, et al : CT and MR findings in HIV negative neurosyphilis Eur J Radiol 66 : 1-6, 2008.
 
8) 日本性感染症学会 : 性感染症診断・治療ガイドライン 2008. 日性感染症会誌 19 : 46-48, 2008.
 
9) Misra UK, et al : Usefulness of various MRI sequences in the diagnosis of viral encephalitis. Acta Trop 116 : 206-211, 2010.
PubMed
10) 梅崎博敏 : 周期性異常波. 神経内科 9 : 538-546, 1978.
 
11) Pichler R, et al : SPECT and FDG-PET in diagnostics of neurolues. Wien Klin Wochenschr 120 : 20-23, 2008.
PubMed
12) Workwski KA ; Centers for Disease Control and Prevention (CDC) : Sexually transmitted diseases treatment guidelines, 2010. MMWR Rrecomm Rep 59 (RR-12) : 1-110, 2010.
 
13) Kingston M, et al : UK National Guidelines on the Management of Syphilis 2008. Int J STD AIDS 19 : 729-740, 2008.
 
14) French P, et al : IUSTI : 2008 European Guidelines on the Management of Syphilis. Int J STD AIDS 20 : 300-309, 2009.
PubMed
15) Zifko U, et al : Jarisch-Herxheimer reaction in a patient with neurosyphilis. J Neurol Neurosurg Psychiatry 57 : 865-867, 1994.
 
P.162 掲載の参考文献
1) Hunt JR : On herpetic inflammation of the geniculate ganglion, a new syndrome and its complication. J Nerv Ment Dis 34 : 73-96, 1907.
 
2) 小池吉郎 : 発生状況に関する全国統計の分析. 特発性顔面神経麻痺に関する疫学・臨床的研究, p4-9, 1987.
 
3) Thomas JE, Howard FM Jr : Segmental zoster paresis-a disease profile. Neurology 22 : 459-466, 1972.
PubMed
4) 脇坂浩之, 柳原尚明 : 顔面神経障害の疫学. CLIENT 21 21世紀 耳鼻咽喉科領域の臨床No. 9 顔面神経障害 (青柳優編), p131-135, 中山書店, 2001.
 
5) 蓑和田寛子 : 顔面神経麻痺の臨床的研究. 耳鼻臨床 62 : 735-798, 1969.
 
6) 山河和博, 演田昌史 : Ramsay Hunt症候群のマネージメント. Hunt症候群の診断のピットフォール. Facial N Res Jpn 27 : 33-36, 2008.
 
7) Kukimoto N, et al : Viral infections in acute peripheral facial paralysis. Nationwide analysis centering on CF. Acta Otolaryngol Suppl 446 : 17-22, 1988.
 
8) Hamada M, Yamakawa K : How much associated is varicella-zoster virus with facial palsy? Otol Jpn 22 : 555, 2012.
 
9) Peitersen E : Bell' s palsy : the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl 549 : 4-30, 2002.
PubMed
10) Devriese PP, Moesker WH : The natural history of facial paralysis in herpes zoster. Clin Otolaryngol Allied Sci 13 : 289-298, 1988.
PubMed
11) Murakami S, et al : Treatment of Ramsay Hunt syndrome with acyclovir-prednisone : significance of early diagnosis and treatment. Ann Neurol 41 : 353-357, 1997.
PubMed
12) 稲村博雄ほか : ベル麻痺, ハント症候群の保存的治療法. ベル麻痺及びハント症候群に対するアシクロビル (Acyclovir) 併用ステロイド大量療法の治療効果. Facial N Res Jpn 21 : 30-32, 2001.
 
13) 日本顔面神経研究会治療効果判定委員会 : 末梢性顔面神経麻痺の治療効果判定についての申し合わせ事項試案. Facial N Res Jpn 15 : 227-230, 1995.
 
14) 濱田昌史ほか : Ramsay Hunt症候群に対するステロイド・抗ウィルス薬併用療法. Facial N Res Jpn 32 : 131-133, 2012.
 
15) 竹田泰三, 浜田昌史 : 顔面神経減荷術. CLIENT 21 21世紀 耳鼻咽喉科領域の臨床No. 9 顔面神経障害 (青柳優編), p245-252, 中山書店, 2001.
 

III 呼吸器感染症

P.170 掲載の参考文献
1) 日本呼吸器学会成人市中肺炎診療ガイドライン作成委員会 (編) : 成人市中肺炎診療ガイドライン, 社団法人日本呼吸器学会, 2007.
 
2) 日本呼吸器学会「呼吸器感染症に関するガイドライン作成委員会」 (編) : 成人院内肺炎診療ガイドライン, 社団法人日本呼吸器学会, 2008.
 
3) 日本呼吸器学会医療・介護関連肺炎 (NHCAP) 診療ガイドライン作成委員会 (編) : 医療・介護関連肺炎診療ガイドライン, 社団法人日本呼吸器学会, 2011.
 
P.174 掲載の参考文献
1) 日本呼吸器学会呼吸器感染症に関するガイドライン作成委員会 : 成人市中肺炎診療ガイドライン, 日本呼吸器学会, 2007.
 
2) Miyashita N, et al : Atypical Pathogen Study Group : Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia. BMC Infect Dis 12 : 126, 2012.
 
3) Mandell LA, et al ; Infectious Diseases Society of America ; American Thoracic Society : Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44 (Suppl 2) : S27-72, 2007.
 
4) British Thoracic Society Standards of Care Committee : BTS Guidelines for the Management of Community Acquired Pneumonia in Adults. Thorax 56 (Suppl 4) : iv1-64, 2001.
 
P.180 掲載の参考文献
1) Seki M, et al : Revision of the severity rating and classification of hospital-acquired pneumonia in the Japanese Respiratory Society guidelines. Respirology 13 : 880-885, 2008.
 
2) Watanabe A, et al : Multicenter survey on hospital-acquired pneumonia and the clinical efficacy of first-line antibiotics in Japan. Intern Med 47 : 245-254, 2008.
PubMed
3) American Thoracic Society ; Infectious Diseases Society of America : Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171 : 388-416, 2005.
 
4) Leu HS, et al : Hospital-acquired pneumonia. Attributable mortality and morbidity. Am J Epidemiol 129 : 1258-1267, 1989.
PubMed
5) Sopnea N, Sabria M ; Neunos 2000 Study Group : Multicenter study of hospital-acquired pneumonia in non-ICU patients. Chest 127 : 213-219, 2005.
 
6) Maruyama T, et al : A prospective comparison of nursing home-acquired pneumonia with hospital-acquired pneumonia in non-intubated elderly. Respir Med 102 : 1287-1295, 2008.
PubMed
7) Esperatti M, et al : Nosocomial pneumonia in the intensive care unit acquired by mechanically ventilated versus nonventilated patients. Am J Respir Crit Care Med 182 : 1533-1539, 2010.
PubMed
8) Delisle MS, et al : The clinical significance of Candida colonization of respiratory tract secretions in critically ill patients. J Crit Care 23 : 11-17, 2008.
PubMed
9) Scheithauer S, et al : Impact of herpes simplex virus detection in respiratory specimens of patients with suspected viral pneumonia. Infection 38 : 401-405, 2010.
PubMed
10) Torres A, et al : Defining, treating and preventing hospital acquired pneumonia : European perspective. Intensive Care Med 35 : 9-29, 2009.
PubMed
11) 日本呼吸器学会呼吸器感染症に関するガイドライン作成委員会 : 成人院内肺炎診療ガイドライン, 日本呼吸器学会, 2008.
 
12) Fartoukh M, et al : Diagnosing pneumonia during mechanical ventilation. The clinical pulmonary infection score revisited. Am J Respir Crit Care Med 168 : 173-179, 2003.
PubMed
13) Masterton RG, et al : Guidelines for the management of hospital-acquired pneumonia in the UK : report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 62 : 5-34, 2008.
 
14) Ferrer M, et al : Validation of the American Thoracic Society-Infectious Diseases Society of America guidelines for hospital-acquired pneumonia in the intensive care unit. Clin Infect Dis 50 : 945-952, 2010.
 
15) Kett DH, et al : Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care : an observational, multicentre cohort study. Lancet Infect Dis 11 : 181-189, 2011.
PubMed
16) Rello J, et al : Determinants of prescription and choice of empirical therapy for hospitalacquired and ventilator-associated pneumonia. Eur Respir J 37 : 1332-1339, 2011.
PubMed
17) Kollef MH, et al : Clinical characteristics and treatment patterns among patients with ventilatorassociate pneumonia. Chest 129 : 1210-1218, 2006.
 
18) Rotstein C, et al : Clinical practice guidelines for hospital-acquired pneumonia and ventilatorassociated pneumonia in adults. Can J Infect Dis Med Microbiol 19 : 19-53, 2008.
 
19) Chastre J, et al ; Pneum A Trial Group : Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults : a randomized trial. JAMA 290 : 2588-2598, 2003.
PubMed
P.184 掲載の参考文献
1) 日本呼吸器学会呼吸器感染症に関するガイドライン作成委員会 : 医療・介護関連肺炎診療ガイドライン, 日本呼吸器学会, 2011.
 
2) American Thoracic Society and Infection Diseases Society of America : Guidelines for the management of adults with hospital acquired pneumonia, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171 : 388-416, 2005.
PubMed
3) Ishida T, et al : Clinical characteristics of nursing and healthcare-associated pneumonia : a Japanese variant of healthcare -associated pneumonia. Intern Med 51 : 2537-2544, 2012.
PubMed
4) Brito V, Niederman MS : Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia. Curr Opin Infect Dis 22 : 316-325, 2009.
 
5) Kett DH, et al : Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care : an observational, multicentre cohort study. Lancet Infect Dis 11 : 181-189, 2011.
PubMed
6) Teramoto S, et al : Health-care-associated pneumonia is primarily due to aspiration pneumonia. Chest 136 : 1702-1703, 2009.
PubMed
7) 福山一ほか : 在宅介護寝たきり肺炎の臨床的検討. 日呼吸会誌 48 : 906-911, 2010.
Medical*Online
8) Metlay JP, et al : Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med 157 : 1453-1459, 1997.
PubMed
9) El Solh M, et al : Indicators of potentially drug-resistant bacteria in severe nursing home-acquired pneumonia. Clin Infect Dis 39 : 474-480, 2004.
 
10) Shindo Y, et al : Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital. Chest 135 : 633-640, 2009.
 
11) Rello J, et al : Why mortality is increased in health-care-associated pneumonial lessons from pneumococcal bacteremic pneumonia. Chest 137 : 1138-1144, 2010.
 
12) Fukuyama H, et al : A prospective comparison of nursing- and healthcare-associated pneumonia (NHCAP) with community-acquired pneumonia (CAP). J Infect Chemother, 2013. [Epub ahead of print]
 
P.190 掲載の参考文献
1) American Thoracic Society ; Infectious Diseases Society of America : Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171 : 388-416, 2005.
 
2) Suka M, et al : Epidemiological approach to nosocomial infection surveillance data : the Japanese Nosocomial infection Surveillance System. Environ Health Prev Med 13 : 30-35, 2008.
PubMed
3) http://www.nih-janis.jp/report/open_report/2012/2/3/ICU_Open_Report_201201.pdf
 
4) http://www.cdc.gov/nhsn/acute-care-hospital/vae/index.html
 
5) http://www.jsicmorg/pdf/2010VAP.pdf
 
6) Muscedere J, et al : Subglottic secretion drainage for the prevention of ventilator-associated pneumonia : a systematic review and meta-analysis. Crit Care Med 39 : 1985-1991, 2011.
PubMed
7) Labeau SO, et al : Prevention of ventilator-associated pneumonia with oral antiseptics : a systematic review and meta-analysis. Lancet Infect Dis 11 : 845-854, 2011.
PubMed
8) Alhazzani W, et al : Toothbrushing for critically ill mechanically ventilated patients : a systematic review and meta-analysis of randomized trials evaluating ventilator-associated pneumonia. Crit Care Med 41 : 646-655, 2013.
PubMed
9) Fabregas N, et al : Clinical diagnosis of ventilator associated pneumonia revisited : comparative validation using immediate post-mortem lung biopsies. Thorax 54 : 867-873, 1999.
PubMed
10) Bregeon F, et al : Relationship of microbiologic diagnostic criteria to morbidity and mortality in patients with ventilator-associated pneumonia. JAMA 277 : 655-662, 1997.
PubMed
11) Singh N, et al : Shortcourse empirical antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. Am J Respir Crit Care Med 162 : 505-511, 2000.
PubMed
12) Morris AC, et al : Evaluation of diagnostic methodology on the reported incidence of ventilator-associated pneumonia. Thorax 64 : 516-522, 2009.
PubMed
13) Fagon JY, et al : Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med 132 : 621-630, 2000.
PubMed
14) Luna CM, et al : Is an endotracheal routine cultures-based strategy the best way to prescribe antibiotics in ventilator-associated pneumonia? Chest, 2013. [Epub ahead of print]
 
15) Kollef MH : The importance of appropriate initial antibiotic therapy for hospital-acquired infections. Am J Med 115 : 582-584, 2003.
PubMed
16) Niederman MS : De-escalation therapy in ventilator-associated pneumonia. Curr Opin Crit Care 12 : 452-457, 2006.
PubMed
17) 成人院内肺炎診療ガイドライン (日本呼吸器学会「呼吸器感染症に関するガイドライン」, 日本呼吸器学会「呼吸器感染症に関するガイドライン作成委員会」編), (社) 日本呼吸器学会, 2008.
 
18) Kett DH, et al ; Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Investigators : Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care : an observational, multicentre cohort study. Lancet Infect Dis 11 : 181-189, 2011.
PubMed
19) Stolz D, et al : Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia : a randomised study. Eur Respir J 34 : 1364-1375, 2003.
 
20) Chastre J, et al : PneumA Trial Group : Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults : a randomized trial. JAMA 290 : 2588-2598, 2003.
PubMed
21) Micek ST, et al : A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest 125 : 1791-1799, 2004.
PubMed
P.195 掲載の参考文献
1) 日呼吸器学会呼吸器感染症に関するガイドライン作成委貝会 : 第IX章 誤嚥性肺炎. 成人院内肺炎診療ガイドライン (正本版), 2008.
 
2) Teramoto S, et al ; Japanese Study Group on Aspiration Pulmonary Disease : High incidence of aspiration pneumonia in community-and hospital-acquired pneumonia in hospitalized patients : amulti-center, prospective study in Japan. J Am Geriatr Soc 56 : 577-579, 2008.
 
3) Sekizawa K, et al : Lack of cough reflex in patients with aspiration pneumonia. Lancet 335 : 1228-1229, 1990.
 
4) Ebihara S, et al : Aging deteriorated perception of urge-to-cough without changing cough renex threshold to citric acid in female never-smokers. Cough 7 : 2-6, 2011.
 
5) Teramoto S, et al : Simple two-step swallowing provocation test for elderly patients with aspiration pneumonia. Lancet 353 : 1243, 1999.
PubMed
6) Matsuse T, et al : Importance of diffuse aspiration bronchiolitis caused by chronic occult aspiration in the elderly. Chest 110 : 1289-1293, 1996.
PubMed
7) Marumo K, et al : Postgastrectomy aspiration pneumonia. Chest 107 : 453-456, 1995.
PubMed
8) 日本呼吸器学会医療・介護関連肺炎 (NHCAP) 診療ガイドライン作成委員会 (編) : 日本呼吸器学会医療・介護関連肺炎診療ガイドライン, 日本呼吸器学会, 2011.
 
P.201 掲載の参考文献
1) 尾内一信ほか (編) : 小児呼吸器感染症診療ガイドライン 2011, 協和企画, 2011.
 
2) 砂川慶介, 尾内一信 (編) : 小児感染症治療ハンドブック 2013-2014, 診断と治療, 2012.
 
3) 坂田宏 : 新生児の肺炎. 小児内科 36 : 104-107, 2004.
 
4) Hamano-Hasegawa K, et al : Comprehensive detection of causative pathogens using real-time PCR to diagnose pediatric community-acquired pneumonia. J Infect Chemother 14 : 424-432, 2008,
PubMed
5) 中村明 : 気管支肺感染症病因診断の問題点EBMの時代を迎えて. 日児誌 107 : 1067-1073, 2003.
 
6) 荻田純子ほか : 小児市中肺炎および血液培養陽性肺炎球菌性肺炎の罹患状況. 感染症誌 82 : 624-627, 2008.
 
7) 石和田稔彦 : 感染症の種類別に小児感染症を考える-2. 気管支炎, 肺炎-. 化学療法の領域 25 : 899-905, 2009.
 
8) 成田光生 : 小児疾患の診断治療基準マイコプラズマ感染症. 小児内科 44 (増) : 344-345, 2012.
 
P.206 掲載の参考文献
1) Miller MA, et al : The signature features of influenza pandemics-implications for policy. N Engl J Med 360 (25) : 2595-2598, 2009.
PubMed
2) Morens DM, et al : Predominant role of bacterial pneumonia as a cause of death in pandemic influenza : implications for pandemic influenza preparedness. J Infect Dis 198 : 962-970, 2008.
PubMed
3) Centers for Disease Control and Prevention (CDC) : Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) -United States, May-August 2009. MMWR Morb Mortal Wky Rep 58 : 1071-1074, 2009.
 
4) Centers for Disease Control and Prevention (CDC) : Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) Virus-United States, 2009. MMWR Morb Mortal Wky Rep 58 : 826-829, 2009.
 
5) 社団法人日本感染症学会・新型インフルエンザ対策委員会 : 社団法人日本感染症学会提言～抗インフルエンザ薬の使用適応について (改訂版) ～, 日本感染症学会 (2011年3月2日). [http://www.kansensho.or.jp/influenza/pdf/110301soiv_teigen.pdf]
 
6) 日本感染症学会インフルエンザ委員会 : 社団法人日本感染症学会提言 2012～インフルエンザ病院内感染対策の考え方について～ (高齢者施設を含めて), 日本感染症学会 (2012年8月20日). [http://www.kansensho.or.jp/influenza/1208_teigen.html]
 
P.210 掲載の参考文献
1) World Health Organization : Transmission dynamics and impact of pandemic influenza A (H1N1) 2009 virus. Weekly Epidemiological Record 84 : 481-484, 2009.
 
2) World Health Organization : WHO global influenza preparedness plan. The role of WHO and recommendations for national measures before and during pandemics. [http://www.who.int/csr/resources/publications/influenza/WHO_CDS_CSR_GIP2005_5.pdf]
 
3) World Health Organization : Pandemic influenza preparedness and response. [http://www.who.int/csr/disease/influenza/PIPGuidance09.pdf]
 
4) 厚生労働省 : 新型インフルエンザ対策行動計画・ガイドライン. [http://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou04/13.html]
 
5) 厚生労働省新型インフルエンザ対策推進本部 : 新型インフルエンザの発生動向～医療従事者向け疫学情報～ver. 3. 2010年4月23日. [http://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou04/pdf/100423-01.pdf]
 
6) 厚生労働省新型インフルエンザ対策推進本部 : 各国の状況について. 第6回新型インフルエンザ (A/H1N1) 対策総括会議 (平成22年5月28日) 参考資料 1. [http://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou04/dl/infu100528-05.pdf]
 
7) 岩附 (堀本) 研子, 河岡義裕 : Pandemic (H1N1) 2009 ウイルスの特徴. インフルエンザ 11 : 223-229, 2010.
Medical*Online
8) World Health Organization : Clinical management of human infection with pandemic (H1N1) 2009 : revised guidance. November 2009. [http://www.who.int/csr/resources/publications/swineflu/clinical_management/en/index.html]
 
9) World Health Organization : WHO guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses. February 2010. [http://www.who.int/csr/resources/publications/swineflu/h1n1_use_antivirals_20090820/en/index.html]
 
10) 国立感染症研究所感染症情報センター : パンデミック (H1N1) 2009の臨床像. [http://idsc.nih.go.jp/disease/swine_influenza/2009idsc/case0902.html]
 
11) 岡部信彦, 安井良則 : わが国における新型インフルエンザ第1波の流行を振り返って. インフルエンザ 11 : 231-238, 2010.
Medical*Online
12) 日本感染症学会 : 社団法人日本感染症学会提言～新規薬剤を含めた抗インフルエンザ薬の使用適応について～2010年1月25日. [http://www.kansensho.or.jp/topics/100122soiv_teigen.html]
 
13) 厚生労働省新型インフルエンザ対策推進本部 : 新型インフルエンザワクチン接種に係る輸入ワクチンの特例承認及び健康成人への接種開始について. 平成22年1月15日. [http://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou04/pdf/inful100118-01.pdf]
 
14) Centers for Diseases Control and Prevention : Interim Guidance on Infection Control Measures for 2009 H1N1 influenza in healthcare settings, including protection of healthcare personnel. May 3, 2010. [http://www.cdc.gov/h1n1flu/guidelines_infection_control.htm]
 
15) 西浦博 : 新型インフルエンザの国境検疫 (水際対策) の効果に関する理論疫学的分析. 科学 79 : 945-950, 2009.
 
P.215 掲載の参考文献
1) World Health Organization : Cumulative number of confirmed human cases of avian influenza A (H5N1) reported to WHO. [http://www.who.int/influenza/human_animaLinterface/H5N1_cumulative_table_archives/en/index.html]
 
2) Shinya K, et al : Avian flu : influenza virus receptors in the human airway. Nature 440 : 435-437, 2006.
PubMed
3) Liem NT, et al : H5N1-infected cells in lung with diffuse alveolar damage in exudative phase from a fata1 case in Vietnam. Jpn J Infect Dis 61 : 157-160, 2008.
 
4) Hien ND, et al : Human infection with highly pathogenic avian influenza virus (H5N1) in northern Vietnam, 2004-2005. Emerg Infect Dis 15 : 19-23, 2009.
 
5) Kandun IN, et al : Factors associated with case fatality of human H5N1 virus infections in Indonesia : case series. Lancet 372 : 744-749, 2008.
PubMed
6) Manabe T, et al : Knowledge, attitudes, practices and emotional reactions among residents of avian influenza (H5N1) hit communities in Vietnam. PLoS One 7 : e47560, 2012.
PubMed
7) Yu H, et al : Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China. PloS ONE 3 : e2985, 2008.
PubMed
8) 国立感染症研究所インフルエンザウイルス研究センター編 : 高病原性鳥インフルエンザ診断マニュアル (第3版), 2012. [http://www.nih.go.jp/niid/images/lab-manual/avian_influenza_2003.pdf]
 
9) World Health Organization (WHO) : Clinical management of human infection with avian influenza A (H5N1) virus. [http://who.int/csr/disease/avian_influenza/guidelines/en/]
 
10) Kudo K, et al : Clinical preparedness for severe pneumonia with highly pathogenic avian influenza A (H5N1) : experiences with cases in Vietnam. Respir Investig 50 : 140-150, 2012.
PubMed
11) Imai M, et al : Experimental adaptation of an influenza H5 haemagglutinin (HA) confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486 : 420-428, 2013.
 
P.221 掲載の参考文献
1) Light RW : Clinical practice. Pleural effusion. N Engl J Med 346 (25) : 1971-1977, 2002.
PubMed
2) Weese WC, et al : Empyema of the thorax then and now. A study of 122 cases over four decades. Arch Intern Med 131 (4) : 516-520, 1973.
PubMed
3) Vianna NJ : Nontuberculous bacterial empyema in patients with and without underlying diseases. JAMA 215 (1) : 69-75, 1971.
PubMed
4) Sahn SA : Diagnosis and management of parapneumonic effusions and empyema. Clin Infect Dis 45 (11) : 1480-1486, 2007.
PubMed
5) Colice GL, et al : Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline. Chest 118 (4) : 1158-1171, 2000.
PubMed
6) Kim TS, et al : Thoracic actinomycosis : CT features with histopathologic correlation. AJR Am J Roentgenol 186 (1) : 225-231, 2006.
PubMed
7) Tsujimoto N, et al : High-resolution CT findings of patients with pulmonary nocardiosis. J Thorac Dis 4 (6) : 577-582, 2012.
PubMed
8) Diacon AH, et al : Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Respir Crit Care Med 170 (1) : 49-53, 2004.
PubMed
9) Tokuda Y, et al : Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions : a meta-analysis. Chest 129 (3) : 783-790, 2006.
PubMed
P.225 掲載の参考文献
1) Monto AS : Studies of the commullity and family : acute respiratory illness aiitd infection. Epidemiol Rev 16 : 351 373, 1994.
 
2) Cohen S, et al : Psychological stress and susceptibility to the common cold. N Engl J Med 325 : 606 612, 1991.
 
3) Cohen S, et al : Sleep habits and susceptibility to the common cold. Arch Intern Med 169 : 62-67, 2009.
 
4) Heikkinen T, Jarvinen A : The common cold. Lancet 361 : 51-59, 2003.
PubMed
5) Winther B, et al : Rhinovirus contamination of surfaces in homes of adults with natural colds : transfer of virus to fingertips during nornal daily activities. J Med Virol 83 : 906-909, 2011.
 
6) Utsumi M, et al : Types of in fectious outbreaks and their impact in elderly care facilities : a review of the literature. Age Ageing 39 : 299-305. 2010.
 
7) Makela MJ, et al : Viruses and bacteria in the etiology of the commob cold. J Clin Microbiol 36 : 539-542, 1998.
 
8) Lieberman D, et al : Etiology of respiratory tract infection in adults in a general practice setting. Eur J Clin Microbiol Infect Dis 17 : 685-689, 1998.
 
9)Tyrrell DA, et al : Signs and symptoms in common colds. Epidemiol Infect 111 : 143-156, 1993.
PubMed
10) Humair Jp, et al : Management of acute pharyngitis in adults : reliability of rapid streptococcal tests and clinical findings. Arch Intern Med 166 : 640-644, 2006.
PubMed
11) Uchihara TL Tsukagoshi H : Jolt accentuation of hcadache : the most sensitive sign of CSF pleocytosis. Headache 31 : 167-171, 1991.
 
12) 中泉博幹ほか : 髄膜刺激症状の検出におけるNeck Flexion Testの有用性. 家庭医療 6 : 11-15, 1999.
 
13) 加地正郎ほか : 普通感冒に対するTJ-1ツムラ葛根湯の臨床効果. 臨床と研究 70 : 3266-3272, 1993.
Medical*Online
P.230 掲載の参考文献
1) 二本柳伸ほか : A群連鎖球菌集団感染における迅速検出用キットの有用性評価. 感染症誌 81 : 441-448, 2007.
 
2) Carapetis JR, et al : The global burden of group A streptococcal diseases. Lancet Infect Dis 5 : 685-694, 2005.
 
3) Casey JR, Pichichero ME : Meta-analysis of cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis in children. Pediatrics 113 : 866-882, 2004.
 
4) Casey JR, Pichichero ME : Meta-analysis of short course antibiotic treatment for group A streptococcal tonsillopharyngitis. Pediatr Infect Dis J 24 : 909-917, 2005.
 
5) 小児呼吸器感染症診療ガイドライン作成委員会 : 小児呼吸器感染症診療ガイドライン 2011. 協和企画, p15-19, 2011.
 
6) 坂田宏 : 溶連菌感染症を反復した児から検出されたA群溶血連鎖球菌におけるemm型別とPFGEパターン解析. 感染症誌 83 : 647-651, 2008.
 
7) Zwart S, et al : Penicillin for acute sore throat in children : randomised, double blind trial. BMJ 327 : 1324-1327, 2003.
PubMed
P.234 掲載の参考文献
1) 厚生労働省 感染症法に基づく医師及び獣医師の届出について咽頭結膜熱. [http://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou11/01-05-16.html]
 
2) 国立感染症研究所 : IDWR感染症発生動向調査週報2012年第52週. [http://www.nih.go.jp/niid/ja/data/3063-idwr-sokuho-data-j-1252.html]
 
3) 国立感染症研究所 : IDWR 2012年第19号 <注目すべき感染症> 咽頭結膜熱. [http://www.nih.go.jp/niid/ja/adeno-pfc-m/adeno-pfc-idwrc/2183-idwrc-1219.html]
 
4) 堤裕幸 : アデノウイルス感染症. 日本臨床 65 (増刊号 3) : 304-308, 2007.
 
5) 西村章ほか : アデノウイルス7型感染症. 小児科診療 63 : 1012-1016, 2000.
Medical*Online
6) 岡藤輝夫ほか : スイミングスクールを介したと推定されるアデノウイルス4型による咽頭結膜熱の流行. 臨床とウイルス 30 : 270-274, 2002.
Medical*Online
7) 渡辺厚一ほか : 日本における "プール熱" 流行の背景とプールでの感染性. 水と健康医学研究会誌 10 : 19-25, 2007.
 
8) Gordon YJ, et al : Prolonged recovery of desiccated adenoviral serotypes 5, 8, and 19 from plastic and metal surfaces in vitro. Ophthalmology 100 : 1835-1840, 1993.
 
9) 後藤幹生ほか : アデノウイルスによる急性上気道炎150例の臨床的検討. 小児科臨床 57 : 2035-2042, 2004.
Medical*Online
10) 原三千丸 : アデノウイルス迅速診断キットチェックAd(R) の有用性と限界. 小児科臨床 59 : 2357-2361, 2006.
 
11) King CK, et al ; Centers for Diseas Control and Prevention : Managing acute gastroenteritis among children : oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep 52 (RR-16) : 1-16, 2003.
 
12) 黒羽根郁夫ほか : アデノウイルス感染症における上咽頭培養と治療について. 小児科臨床 58 : 2199-2202, 2005.
Medical*Online
13) 西村章 : アデノウイルス感染症. 小児科診療 68 : 2110-2114, 2005.
 
14) 天羽清子, 塩見正司 : アデノウイルス感染症重症例の画像所見を中心に. 小児科診療 66 : 2171-2177, 2003.
 
15) 薄井紀夫 : 患者だけの問題ではない? 「アデノウイルス感染症」対策のポイント. INFECTION CONTROL 15 : 575-581, 2006.
 
P.238 掲載の参考文献
1) 福田宏之 : 外来で必要となる緊急処置-急性喉頭蓋炎における急激な炎症-. JOHNS 13 (7) : 1035-1037, 1997.
 
2) 橋本大門ほか : 急性喉頭蓋炎237例の臨床的検討. 日気管食道会報 55 (3) : 245-252, 2004.
 
3) 山口太郎ほか : 急性喉頭蓋炎. JOHNS 15 (9) : 1404-1406, 1999.
 
4) 高木英朗ほか : 急性喉頭蓋炎の疫学. ENTONI No. 40 : 1-6, 2004.
 
5) 宇和信浩ほか : 急性喉頭蓋炎症例の検討. 耳鼻臨床 96 : 811-817, 2003.
 
6) 山本英一 : 成人における喉頭の炎症 (主に喉頭蓋炎). ENTONI No. 8 : 21-26, 2001.
 
7) 菊池正弘ほか : 急性喉頭蓋炎の病期分類. ENTONI No. 40 : 20-24, 2004.
 
8) 外科的気道マニュアル (日本気管食道科学会編). 金原出版, 2009.
 
9) Herbert PC, et al : Adult epiglottitis in a Canadian setting. Laryngoscope 108 (1 Pt 1) : 64-69, 1998.
 
10) 鳩崎俊樹ほか : 当科における急性喉頭蓋炎症例の臨床的検討. 日耳鼻感染症研会誌 14 : 5-9, 1996.
 
11) 北村貴裕 : 咽後膿瘍類似の画像所見を呈した川崎病例. 小児耳鼻 31 (1) : 29-31, 2010.
 
12) 米田真紀子ほか : 急性咽後膿瘍と類似の画像所見を示した不全型川崎病の1例. 小児科臨床 64 (8) 111-115, 2011.
 
13) 増田文子ほか : 咽後膿瘍と鑑別を要した急性石灰沈着性頸長筋腱炎の2症例. 耳鼻咽喉科展望 52 (5) : 300-306, 2009.
 
14) 中嶋大介ほか : 咽後膿瘍が疑われた石灰沈着性長頸筋炎症例. 口咽頭科 19 (3) : 309-315, 2007.
 
P.243 掲載の参考文献
1) Balfour-Lynn IM, Davies JC : Acute infections producing upper airway obstruction. In : Kendig's Disorders of the Respiratory Tract in Children, 7th ed, p404-415, Saunders Elsevier, Philadelphia, 2006.
 
2) Cherry JD : Croup. N Engl J Med 358 : 384-391, 2008.
PubMed
3) Bjornson CL, Johnson DW : Croup. Lancet 371 : 329-339, 2008.
PubMed
4) Johnson D : Croup. Clin Evid (Online) 2009 : pii : 0321, 2009.
 
5) Westley CR, et al : Nebulized racemic epinephrine by IPPB for the treatment of croup : a double-blind study. Am J Dis Child 132 : 484-487, 1978.
PubMed
6) Alberta Medical Association : Guideline for the diagnosis and management of croup (2008 update). [http://www.topalbertadoctors.org/download/252/croup_guideline.pdf]
 
7) Mazza D, et al : Evidence based guideline for the management of croup. Aust Fam Physician 37 : 14-20, 2008.
PubMed
8) Tibballs J, Watson T : Symptoms and signs differentiating croup and epiglottitis. J paediatr Child Health 47 : 77-82, 2011.
PubMed
9) Wall SR, et al : The viral aetiology of croup and recurrent croup. Arch Dis Child 94 : 359-360, 2009.
PubMed
10) 坂口由一ほか : クループ症候群の治療に関する全国アンケート調査. 小児科臨床 58 : 2031-2036, 2005.
Medical*Online
11) Bjornson C, et al : Nebulized epinephrine for croup in children. Cochrane Database Syst Rev (2) : CD006619, 2011.
PubMed
12) Russell KF, et al : Glucocorticoids for croup. Cochrane Database Syst Rev (1) : CD001955, 2011.
PubMed
13) Dobrovolijac M, Geelhoed GC : How fast does oral dexamethasone work in mild to moderately severe croup? A randomized double-blinded clinical trial. Emerg Med Australas 24 : 79-85, 2012.
 
14) Moore M, Little P : WITHDRAWN : Humidified air inhalation for treating croup. Cochrane Datebase Syst Rev (6) : CD002870, 2011.
 
15) 錦戸知喜ほか : 軽症・中等症クループに対するデキサメサゾン内服単独療法の有用性について. 日小児呼吸器会誌 21 : 156-162, 2010.
 
P.248 掲載の参考文献
1) 日本呼吸器学会呼吸器感染症に関するガイドライン作成委員会 : 成人気道感染症診療の基本的考え方, 日本呼吸器学会, 2003.
 
2) Gonzales R, Sande M : Uncomplicated acute bronchitis. Ann Intern Med 133 : 981-991, 2000.
PubMed
3) Braman SS : Chronic cough due to acute bronchitis : ACCP evidence-based clinical practice guidelines. Chest 129 (1 Suppl) : 95S-103S, 2006.
 
4) Gonzales R, et al : Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adult : background. Ann Intern Med 134 : 490-494, 2001.
PubMed
5) Wenzel RP, Fowler AA 3rd : Clinical practice. Acute bronchitis. N Engl J Med 355 : 2125-2130, 2006.
PubMed
6) Flaherty KR, et al : The spectrum of acute bronchitis. Using baseline factors to guide empirical therapy. Postgrad Med 109 : 39-47, 2001.
PubMed
7) 日本呼吸器学会 : 咳嗽に関するガイドライン第2版, メディカルレビュー社, 2012.
 
8) Badham C : Observations on the inflammatory affections of mucous membranes of the bronchaie. Gallow, London, England, 1808.
 
9) Fletcher CM : Chronic bronchitis ; its prevalence, nature, and pathogenesis. Am Rev Respir Dis 80 : 483-494, 1959.
PubMed
10) Ciba Guest Symposium Report. Terminology, definitions, and classification of chronic pulmonary emphysema and related conditions. Thorax 14 : 286-299, 1959.
 
11) Burrows B, et al : Clinical types of chronic obstructive lung disease in London and in Chicago. A study of one hundred patients. Am Rev Respir Dis 90 : 14-27, 1964.
PubMed
12) Fletcher CM, et al : American emphysema and British bronchitis. A standardized comparative study. Am Rev Respir Dis 90 : 1-13, 1964.
PubMed
13) American Thoracic Society : Standard for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 136 : 225-244, 1987.
PubMed
14) The Global Initiative for Chronic Obstructive Lung Disease : Global Strategy for Diagnosis, Management, and Prevention of COPD updated 2013.
 
15) Kim V, Criner GJ : Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 187 : 228-237, 2013.
PubMed
16) Barman SS : Chronic cough due to chronic bronchitis : ACCP evidence-based clinical practice guidelines. Chest 129 (Suppl) : 104S-115S, 2006.
 
P.254 掲載の参考文献
1) 中田紘一郎 : DPBの診断指針改訂と重症度分類策定. 厚生省特定疾患びまん性肺疾患調査研究班平成10年度研究報告書, p109-111, 1999.
 
2) 杉山幸比古 : びまん性汎細気管支炎. COPD FRONTIER 3 : 27-32, 2004.
Medical*Online
3) Homma H, et al : Diffuse panbronchiolitis. A disease of the transitional zone of the lung. Chest 83 : 63-69, 1983.
PubMed
4) Kudoh S, et al : Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 157 : 1829-1832, 1998.
PubMed
5) Kono C, et al : Historical change of epidemiology in diffuse panbronchiolitis. Sarcoidosis Vasc Diffuse Lung Dis 29 : 19-25, 2012.
 
6) Keicho N, Hijikata M : Genetic predispos ition to diffUse panbronchiolitis. Respirology 16 : 581-588, 2011.
 
7) 村田喜代史ほか (編) : 胸部のCT, 第2版, p 372-376, メディカルサイエンスインターナショナル, 2004.
 
8) Kudoh S, et al : Novel activity of erythromycin and its derivatives. In : Macrolide Antibiotics (ed by Omura S). p 533-569, Academic Press, Berllingham, 2002.
 
9) Cameron EJ, et al : Long-term macrolide treatment of chronic inflammatory airway diseases : risks, benefits and future developments. Clin Exp Allergy 42 : 1302-1312, 2012.
PubMed
10) Ray WA, et al : Oral erythromycin and the risk of sudden death from cardiac causes. N Engl J Med 351 : 1089-1096, 2004.
PubMed
11) Schembri S, et al : Cardiovascular events after clarithromycin use in lower respiratory tract infections : analysis of two prospective cohort studies. BMJ 346 : f1235, 2013.
PubMed

IV 腹膜炎, 肝・胆道系感染症, 膵臓感染症, 消化管感染症

P.260 掲載の参考文献
1) Rimola A, et al : Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis : a consensus document. International Ascites Club. J Hepatol 32 : 142-153, 2000.
PubMed
2) 福井博, 山崎正晴 : 特発性細菌性腹膜炎の診断基準. 消化. 器疾患の診断基準・病型分類・重症度の用い方 (棟形昭博ほか編), p 241 -243, 日本メディカルセンター, 2006.
 
3) 持田智 : 特発性細菌性腹膜炎. 肝胆膵 54 : 103-108, 2007.
Medical*Online
4) Moore KP, Aithal GP : Guidelines on the management of ascites in cirrhosis. Gut 55 (Suppl 6) : vi1-12, 2006.
 
5) Garcia-Tsao G, Lim JK ; Members of Veterans Affairs Hepatitis C Resource Center Program : Management and treatment of patients with cirrhosis and portal hypertension : recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol 104 : 1802-1829, 2009.
PubMed
6) Runyon BA : Management of adult patients with ascites due to cirrhosis : an update. Hepatology 49 : 2087-2107, 2009.
PubMed
7) European Association for the Study of the Liver : EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 53 : 397-417, 2010.
 
8) Wiest R, et al : Spontaneous bacterial peritonitis : recent guidelines and beyond. Gut 61 : 297-310, 2012.
PubMed
9) 日本消化器病学会 (編) : 3. 肝硬変合併症の診断・治療 (2) 腹水. 肝硬変診療ガイドライン, p116-149, 南江堂, 2010.
 
10) Nousbaum JB, et al : Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis. Hepatology 45 : 1275-1281, 2007.
PubMed
11) Enomoto H, et al : Development of a new in situ hybridization method for the detection of global bacterial DNA to provide early evidence of a bacterial infection in spontaneous bacterial peritonitis. J Hepatol 56 : 85-94, 2012.
PubMed
12) Wu SS, et al : Ascitic fluid carcinoembryonic antigen and alkaline phosphatase levels for the differentiation of primary from secondary bacterial peritonitis with intestinal perforation. J Hepatol 34 : 215-221, 2001.
PubMed
13) Runyon BA, et al : Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients. Gastroenterology 100 : 1737-1742, 1991.
PubMed
14) Sort P, et al : Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 341 : 403-409, 1999.
PubMed
15) Sigal SH, et al : Restricted use of albumin for spontaneous bacterial peritonitis. Gut 56 : 597-599, 2007.
PubMed
P.266 掲載の参考文献
1) Solomkin JS, et al : Diagnosis and management of complicated intra-abdominal infection in adults and children : guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect (Larchmt) 11 (1) : 79-109, 2010.
 
2) Finlayson EV. et al : Hospital volume and operative mortality in cancer surgery : a national study, Arch Surg 138 (7) : 721-725, 2003.
PubMed
3) 後藤満一ほか : 日本消化器外科学会データベース委員会2009年度調査報告 [http://www.jsgs.or.jp/modules/oshirase/index.php?content_id=212]
 
4) 光岡知足 : 腸内菌叢の形成, 推移, 分布. 腸内細菌学, p105, 朝倉書店, 1990.
 
5) Shinagawa N, et al : Bacteria isolated from surgical infections and its susceptibilities to antimicrobial agents-special references to bacteria isolated between April 2009 and March 2010. Jpn J Antibiot 64 (3) : 125-169, 2011. (Japanese)
PubMed
6) Kumar A, et al : Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34 (6) : 1589-1596, 2006.
PubMed
7) Takesue Y, et al : Nationwide surveillance of antimicrobial susceptibility patterns of pathogens isolated from surgical site infections (SSI) in Japan. J Infect Chemother 18 (6) : 816-826, 2012.
PubMed
8) Kusachi S, et al : Antibiotic time-lag combination therapy with fosfomycin for postoperative intra-abdominal abscesses. J Infect Chemother 17 (1) : 91-96, 2011.
PubMed
P.271 掲載の参考文献
1) Li PK, et al : Peritoneal dialysis-related infections recommendations : 2010 update. Perit Dial Int 30 : 393-423, 2010.
PubMed
2) Kern EO, et al : Abdominal catastrophe revisited : the risk and outcome of enteric peritoneal contamination. Perit Dial Int 2 : 323, 2002.
PubMed
3) Ghali JR, et al : Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit Dial Int 31 : 651-662, 2011.
PubMed
4) 日本透析医学会統計調査委員会 : 2011年末の慢性透析患者に関する基礎集計. 図説わが国の慢性透析療法の現況, 日本透析医学会, 2011 (2013年2月閲覧).
 
5) 伊藤恭彦ほか : IV 課題と対策 (2) 腹膜炎-名古屋大学関連施設レジストリーからみたPD腹膜炎の問題点-. 腹膜透析法-ポストガイドラインの方向性. 臨牀透析 28 : 571-577. 2012.
 
6) Nouwen J, et al : Staphylococcus aureus carriage patterns and the risk of infections associated with continuous peritoneal dialysis. J Clin Microbiol 44 : 2233-2236, 2006.
PubMed
7) Szeto CC, et al : Staphylococcus aureus peritonitis complicates peritoneal dialysis : review of 245 consecutive cases. Clin J Am Soc Nephrol 2 : 245-251, 2007.
PubMed
8) Oliveira LG, et al : Peritonitis in recent years : clinical findings and predictors of treatment response of 170 episodes at a single Brazilian center. Int Urol Nephrol 44 : 1529-1537, 2012.
 
9) Kawanishi H, et al : Encapsulating Peritoneal sclerosis in Japan : a prospective, controlled, multicenter study. Am J Kidney Dis 44 : 729, 2004.
PubMed
10) 浅井さとみ, 宮地勇人 : 感染症診療における遺伝子関連検査. Med Technol 40 : 1425-1431, 2012.
Medical*Online
11) Stuart S, et al : Complications of continuous ambulatory peritoneal dialysis. Radiographics 29 : 441-460, 2009.
PubMed
12) JAID/JSC感染症治療ガイドライン委員会 (編) : JAID/JSC感染症治療ガイドライン 2011. p 129, 日本感染症学会・日本化学療法学会, 2011.
 
13) 藤本壮八ほか : CAPD腹膜炎. 維持透析患者にみられる病態. 別冊日本臨牀 腎臓症候群 (下), p147-150, 日本臨床社, 2012.
 
14) Asai S, et al : Differential co-expression of Mex efflux pumps in a clinical strain of metallo-beta-lactamase producing-Pseudomonas aeruginosa during the stepwise evolution of resistance to aminoglycosides. Inf Dis Clin Practice 19 : 38-42, 2011.
 
15) Teitelbaum I, Burkart J : Peritoneal dialysis. Am J Kidney Dis 42 : 1082-1096, 2003.
PubMed
P.276 掲載の参考文献
1) Miriam JB, Dennis LK : Intraabdominal Infections and Abscesses. In : Harrison's Principles of Internal Medicine, 17th ed, p 807-811, McGraw Hill Medical, New York, 2008.
 
2) Matthew EL, Larry MB : Peritonitis and Intraperitoneal Abscesses. In : Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th ed, p 1030-1034, Churchill Livingstone, United States, 2010.
 
3) Colovic R, et al : Intraabdominal abscesses of unknown etiology. Srp Arh Celok Lek 140 (1-2) : 94-96, 2012.
PubMed
4) Tsai HL, et al : Computed tomography guided precutaneous drainage in the management of intraperitoneal abscess. Fooyin J Health 2 (2) : 53-57, 2010.
 
5) Saini S, et al : Improved localization and survival in patients with intraabdominal abscesses. Am J Surg 145 : 136-142, 1983.
PubMed
6) 小野聡ほか : 術後腹腔内膿瘍. 化学療法の領域 17 (11) : 47-52, 2001.
 
7) Solomkin JS, et al : Diagnosis and management of complicated intra-abdominal infection in adults and children : guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect (Larchmt) 11 (1) : 79-109, 2010.
 
8) Di Carlo P, et al : Two cases of monomicrobial intraabdominal abscesses due to KPC-3 Klebsiella pneumoniae ST258 clone. BMC Gastroenterol 11 : 103, 2011.
PubMed
9) Hoerauf A, et al : Intra-abdominal Candida infection during acute necrotizing pancreatitis has a high prevalence and is associated with increased mortality. Crit Care Med 26 (12) : 2010-2015, 1998.
 
10) Pfaller MA, Diekema DJ : Epidemiology of invasive candidiasis : a persistent public health problem. Clin Microbiol Rev 20 (1) : 133-163, 2007.
PubMed
11) Cope VZ : Actinomycosis. Practitioner 142 : 319-326, 1939.
 
12) 松村幸次郎ほか : 腹部放線菌症の1例, 自験例と本邦集計例の検討. 日外会誌 5 : 629-632, 1987.
 
13) Milne GA, et al : Chronic subphrenic abscess : the missed diagnosis. Can J Surg 20 (2) : 162-165, 1977.
PubMed
14) 川崎誠一ほか : 腹腔鏡診断が有用であった魚骨による不顕性穿孔に続発した大網放線菌症の1例. 日鏡外会誌 16 : 601-605, 2011.
 
15) 川村弘之ほか : 多臓器切除を要した腹部放線菌症の1例. 日消外会誌 26 (4) : 1100-1104, 1993.
 
16) Haubrich WS, et al : Intraperitoneal abscess. In : Bockus Gastroenterology, 5th ed, p 3073-3077, W B Saunders, Pennsylvania, 1995.
 
17) Altemeier WA, et al : Intra-abdominal abscesses. Am J Surg 125 : 70-79, 1973.
PubMed
P.283 掲載の参考文献
1) 急性胆道炎の診療ガイドライン作成出版委員会 (編) : 科学的根拠に基づく急性胆管炎・胆嚢炎の診療ガイドライン, 医学図書出版, 2005.
 
2) 池上覚俊ほか : 急性胆管炎. 別冊日本臨牀 肝・胆道系症候群 III 肝外胆道編, p5-8, 日本臨床社, 2011.
 
3) 炭山嘉伸ほか : 胆道感染症に対する抗菌薬の選択は? 臨床に直結する肝・胆・膵疾患治療のエビデンス (跡見裕ほか編), p154-156, 文光堂, 2007.
 
4) 栗田亮ほか : 急性胆管炎に対する内視鏡ドレナージとしてENBDおよびステント留置のどちらが有用か? 肝胆膵 58 : 31-35, 2009.
 
5) 急性膵炎診療ガイドライン2010改訂出版委員会 (編) : 急性膵炎診療ガイドライン 2010, 第3版, p116-122, 金原出版, 2009.
 
P.286 掲載の参考文献
1) Hinchey EJ, et al : Acute cholesystitis. Surg Gynecol Obstet 120 : 475-480, 1962.
 
2) McDonald JA : Perforation of the gallbladder associated with acute cholesystitis. Ann Surg 164 : 849-852, 1966.
 
3) Abu-Dalu J, Urca I : Acute cholecystitis with perforation into peritoneal cavity. Arch Surg 102 : 108-110, 1971.
PubMed
4) 高田忠敬ほか : 急性胆嚢炎による胆嚢周囲膿瘍-臨床像ならびに超音波所見からの検討-. 日消外会誌 20 (11) : 2561-2565, 1987.
 
5) Derici H, et al : Diagnosis and treatment of gallbladder perforation. World J Gastoenterol 28 : 7832-7836, 2006.
 
6) Niemeier OW : Acute free perforation of the gall-bladder. Ann Surg 99 : 922 -924, 1934.
 
7) Takada T, et al : Pericholecystic abscess : classification of US findings to determine the proper therapy. Radiology 172 : 693-697, 1989.
PubMed
8) Bergman AB, et al : Ultrasonographic evaluation of pericholecystic abscesses. AJR Am J Roentgenol 132 : 201-203, 1979.
PubMed
9) Bennett G, et al : CT findings in acute gangrenous cholecystitis. AJR Am J Roentgenol 178 : 275-281, 2002.
PubMed
10) Altun E, et al : Acute Cholecystitis : MR findings and differentiation from chronic cholecystits. Radiology 244 : 174-183, 2007.
 
11) Menakura SR, et al : Current management of gall bladder perforations. ANZ J Surg 74 : 843-846, 2004.
 
12) Lo CM, et al : Early versus delayed laparoscopic cholecystectomy for treatment of acute cholecystitis. Ann Surg 223 : 37-42, 1996.
PubMed
13) Borzellino G, et al : Laparoscopic cholesystectomy for severe acute cholecystitis. A meta-analysis of results. Surg Endosc 22 : 8-15, 2008.
 
14) Bingerner J, et al : Early conversion for gangrenous chilecystitis. Impact on outcome. Surg Endosc 19 : 1139-1141, 2005.
 
15) Chikamori F, et al : Early scheduled laparoscopic cholecystectomy following percutaneous transhepatic gallbladder drainage for patients with acute cholecystitis. Surg Endosc 16 : 1704-1707, 2002.
PubMed
P.291 掲載の参考文献
1) 山上裕晃, 森山光彦 : 肝膿瘍. 消化器疾患診療のすべて, p276-277, メジカルビュー社, 2012.
 
2) 道免和文 : アメーバ性肝膿瘍. 別冊日本臨牀 肝・胆道系症候群 (I), p135-139, 日本臨牀社, 2011.
 
3) 林茂樹, 山下寛子 : 細菌感染症と肝 (1) 肝膿瘍の成因と治療. 臨床消化器内科 16 (4) : 433-439, 2001.
 
4) Tatsuta T, et al : A case of gas-forming liver abscess with diabetes mellitus. Intern Med 50 (20) : 2329-2332, 2011.
PubMed
5) 岸尭之ほか : Clostridium perfringensによる肝ガス壊疽の1例. 臨床放射線 56 (3) : 378-382, 2011.
 
6) 蒲田敏文, 松井修 : 肝良性腫瘍および腫瘍類似病変の画像診断 : 肝炎症性腫瘤-肝膿瘍を中心に-. 画像診断 25 : 318-327, 2005.
 
7) 吉岡哲也ほか : 経皮経肝的アプローチ-肝膿瘍ドレナージ. 肝胆膵画像 11 (2) : 111-115, 2009.
 
8) Itoi T, et al : Endoscopic ultrasonography-guided drainage for tuberculous liver abscess drainage. Dig Endosc 23 (Suppl 1) : 158-161, 2011.
 
P.300 掲載の参考文献
1) Curtis AH : A Cause of adhesions in the right upper quadrant. J Am Med Assoc 94 (16) : 1221-1222, 1930.
 
2) Fitz-Hugh T Jr : Acute gonococcic peritonitis of the right upper quadrant in women. J Am Med Assoc 102 (25) : 2094-2096, 1934.
 
3) Wolner H, et al : Isolation of Chlamydia trachomatis from the liver capsule in Fitz-Hugh-Curtis syndrome. N Engl J Med 306 : 113, 1982.
 
4) 佐藤英子ほか : 癒着剥離術が右季肋部痛の改善に有効であったFitz-Hugh-Curtis症候群の1例. 日性感染症会誌 6 (1) : 30-34, 1995.
 
5) 松田静治ほか : Transcription Mediated Amplification法を用いたRNA増幅によるChlamydia trachomatis及びNeisseria gonorrhoeaeの同時検出 : 産婦人科および泌尿器科における臨床評価. 日性感染症会誌 15 : 116-126, 2004.
 
6) 野口靖之ほか : 子宮頸管および咽頭擦過検体, 尿検体に対するSDA法を原理とする新しい核酸増幅法を用いたChtamydia trachomatisおよびNeisseria gonorrhoeaeの検出. 感染症誌 80 : 251-256, 2006.
 
7) 性感染症診断・治療ガイドライン2011年版 (日本性感染症学会編), 2011.
 
8) Muratani T, et al : Outbreak of cefozopran (penicillin, oral cephems, and aztreonam) -resistant Neisseria gonorrhoeae in Japan. Antimicrob Agents Chemother 45 (12) : 3603-3606, 2001.
PubMed
9) 山本博貴ほか : 淋菌感染症におけるセフトリアキソン (CTRX) 耐性の1例. 日性感染症会誌 21 (1) : 98-102, 2010.
 
10) CDC : Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomme Rep 59 (RR-11) : 38-42, 2010.
 
P.309 掲載の参考文献
1) Bladley EL III : A clinical based classification system for acute pancreatitis. Arch Surg 128 : 586-590, 1993.
 
2) 竹山宜典ほか : 急性膵炎診療のガイドラインにおける外科治療の問題点-特に膵膿瘍の診断と治療について- 膵臓 21 : 504 -509, 2006.
 
3) 小川道雄ほか : 急性膵炎の実態調査厚生労働省特定疾患対策研究事業 重症急性膵炎の救命率を改善するための研究班 平成12年度研究報告書, p17-33, 2001.
 
4) Buggy BP, et al : Lethal pancreatitis. Am J Gasrtroenterol 78 : 810-814, 1983.
 
5) Renner IG, et al : Death due to acute pancreatitis. A retrospective analysis of 405 autopsy cases. Dig Dis Sci 30 : 1005-1018, 1985.
PubMed
6) Beger HG, et al : Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology 91 : 433-438, 1986.
PubMed
7) Gerzof SG, et al : Early diagnosis of pancreatic infection by computed tomography-guided aspiration. Gastroenterology 93 : 1315-1320, 1987.
PubMed
8) Bassi C, et al : Microbiologocal findings in severe acute pancreatitis. Surg Res Commun 5 : 1-4, 1989.
 
9) Buchler M, et al : Human pancreatic tissue concentration of bacterial antibiotics. Gastroenterology 103 : 1902-11908, 1992.
PubMed
10) Widdison AL : Microbiology and sources of pancreatic pathogens in acute pancreatitis. Acute Pancreatitis (ed by Beger HG, Buchler M), p 291-300, Springer-Verlag, Berlin, 1987.
 
11) 松野正紀ほか : 重症急性膵炎の外科的治療に関する検討. 日本における重症急性膵炎診断と治療の手びき. (斉藤洋一編), p55-59, 国際医書出版, 1991.
 
12) Runkel NS, et al : The role of the gut in the development of sepsis in acute pancreatitis. J Surg Res 51 : 18-23, 1991.
PubMed
13) Gianotti L, et al : Bacterial translocation : apotential source for infection in acute pancreatitis. Pancreas 8 (5) : 551-558, 1993.
 
14) Kazantsev GB, et al : Plasmid labeling confirms bacterial translocation in pancreatitis. Am J Surg 167 : 201-206, 1994.
PubMed
15) Ammori BJ, et al : Early increase in intestinal permeability in patients with severe acute pancreatitis : correlation with endotoxemia, organ failure, and mortality. J Gastrointest Surg 3 (3) : 252-262, 1999.
PubMed
16) Ammori BJ, et al : Altered intestinal morphology and immunity in patients with acute necrotizing pancreatitis. J Hepatobiliary Pancreat Surg 9 (4) : 490-496, 2002.
PubMed
17) Yasuda T, et al : Breakdown of intestinal mucosa via accelerated poptosis increases intestinal permeability in experimental severe acute pancreatitis. J Surg Res 135 (1) : 18-26, 2006.
 
18) Yasuda T, et al : Protective effect of caspase inhibitor on intestinal integrity in experimental severe acute pancreatitis. J Surg Res 138 (2) : 300-307, 2007.
PubMed
19) Shinzeki M, et al : Intraperitoneal administration of oxygenated perfluorochemical inhibits bacterial translocation associated with severe acute pancreatitis. Kobe J Med Sci 49 : 17-24, 2003.
PubMed
20) Yasuda T, et al : Non-occlusive Visceral Ischemia Associated with Severe Acute Pancreatitis. Pancreas 26 (1) : 95-96, 2003.
 
21) Hirota M, et al : Non-occlusive mesenteric ischemia and its associated intestinal gangrene in acute pancreatitis. Pancreatology 3 (4) : 316-322, 2003.
PubMed
22) Antal L, et al : Immunological investigations in acute and chronic human pancreatitis. Digestion 20 : 100-105, 1980.
PubMed
23) Christophi C, et al : Prognostic significance of the absolute lymphocyte count in acute pancreatitis. Am J Surg 150 : 295-296, 1985.
PubMed
24) Curley PJ, et al : Reduction in circulating levels of CD4-positive lymphocytes in acute pancreatitis : relationship to endotoxin, interleukin 6 and disease severity. Br J Surg 80 : 1312-1315, 1993.
PubMed
25) Takeyama Y, et al : Peripheral lymphocyte reduction in severe acute pancreatitis is caused by apoptotic cell death. J Gastrointest Surg 4 : 379-387, 2000.
PubMed
26) Ueda T, et al : Immunosuppression in patients with severe acute pancreatitis. J Gastroenterol 41 (8) : 779-784, 2006.
PubMed
27) Takeyama Y, et al : Thymic atrophy caused by thymocyte apoptosis in experimental severe acute pancreatitis. J Surg Res 78 : 97-102, 1998.
PubMed
28) Yasuda T, et al : Splenic atrophy in experimental severe acute pancreatitis. Pancreas 24 : 365-372, 2002.
PubMed
29) Ueda T, et al : Functional alterations of splenocytes in severe acute pancreatitis. J Surg Res 102 : 161-168, 2002.
PubMed
30) Buchler M, et al : Human pancreatic tissue concentration of bacterial antibiotics. Gastroenterology 103 : 1902-1908, 1992.
PubMed
31) Mazaki T, et al : Meta-analysis of prophylactic antibiotic use in acute necrotizing pancreatitis. Br J Surg 93 (6) : 674-684, 2006.
PubMed
32) Xiong GS, et al : Role of prophylactic antibiotic administration in severe acute pancreatitis : a meta-analysis. Med Princ Pract 15 (2) : 106-110, 2006.
PubMed
33) De Campos T, et al : Questions about the use of antibiotics in acute pancreatitis. World J Emerg Surg 1 : 1-6, 2006.
PubMed
34) Jan J, et al : Emergence of Antibiotic Resistance in Infected Pancreatic Necrosis. Arch Surg 139 : 1371-1375, 2004.
 
35) Isenmann R, et al : Characteristics of infection with Candida species in patients with necrotizing pancreatitis. World J Surg 26 : 372-376, 2002.
PubMed
36) Yousaf M, et al : Management of severe acute pancreatitis. Br J Surg 90 : 407-420, 2003.
PubMed
37) Mitchell R, et al : Pancreatitis. The Lancet 361 (26) : 1447-1455, 2003.
 
38) Paul E. et al : Meta-analysis of parenteral nutrition versus enteral nutrition in patients with acute pancreatitis. BMJ 328 : 407-420, 2004.
 
39) Kumar A, et al : Early enteral nutrition in severe acute pancreatitis : a prospective randomized controlled trial comparing nasojejunal and nasogastric routes. J Clin Gastroenterol 40 : 431-434, 2006.
 
40) Jiang K, et al : Early nasogastric enteral nutrition for severe acute pancreatitis : a systematic review. World J Gastroenterol 13 : 5253 -5260, 2007.
 
41) Takeda K, et al : Continuous regional arterial infusion of protease inhibitor and antibiotics in acute necrotizing Pancreatitis. Am J Surg 171 (4) : 394-398, 1996.
PubMed
42) Yasuda T, et al : Treatment strategy against infection : Clinical outcome of continuous regional arterial infUsion, enteral nutrition, and surgery in severe acute pancreatitis. J Gasteroenterol 42 (8) : 681-689, 2007.
 
43) Banks PA, et al : CT-guided aspiration of suspected pancreatic infection : bacteriology and clinical outcome. Int J Pancreatol 18 : 265-270, 1995.
PubMed
44) Sivasankar A, et al : Outcome of severe acute pancreatitis : is there a role for conservative treatment of infected pancreatic necrosis? Hepatobilialy Pancreat Dis Int 5 (4) : 599-604, 2006.
 
45) Parekh D, et al : Laparoscopic-assisted pancreatic necrosectomy : Anew surgical option for treatment of severe necrotizing pancreatitis. Arch Surg 141 (9) : 895-903, 2006.
 
P.316 掲載の参考文献
1) 厚生労働省医薬食品局食品安全部監視安全課 : 食中毒統計, 各年. [http://www.mhlw.go.jp/topics/syokuchu/04.html]
 
2) Sodha SV : Food borne disease. In : Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th ed (ed by Mandell GL, et al), p 1413 -1427, Churchill Livingstone Elsevier, Philadelphia, 2010.
 
3) 相楽裕子 : 腸管感染症Q&A, p78-97, p143-146, 医薬ジャーナル社, 2005.
 
4) Guerrant RL, et al : Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 32 : 331-351, 2001.
PubMed
5) Chitkara YK, et al : Development and implementation of cost-effective guidelines in the laboratory investigation of diarrhea in a community hospital. Arch Intern Med 156 : 1445-1448, 1996.
 
6) Choi SW, et al : To culture or not to culture : fecal lactoferrin screening for inflammatory bacterial diarrhea. J Clin Microbiol 34 : 928-932, 1996.
 
7) 衛生微生物技術協議会カンピロバクター・レファレンスグループ : わが国における腸炎由来Campylobacter jejuniの血清型別検出動向およびキノロン剤に対する耐性菌の出現状況, 2005-2008-カンピロバクター・レファレンスセンター. LASR 31 : 15-17, 2010.
 
8) Gu B, et al : Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Sh igella between Europe-America and Asia-Africa from 1998 to 2009. Int J Antimicrob Agents 40 : 9-17, 2012.
 
9) Wong CS, et al : Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157 : H7 : a multivariable analysis. Clin Infect Dis 55 : 33-41, 2012.
PubMed
10) Safdar N, et al : Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157 : H7 enteritis : a meta-analysis. JAMA 288 : 996-1001, 2002.
PubMed
11) Ohnishi K, Nakamura-Uchiyama F : Does levofloxacin induce hemolytic uremic syndrome in patients infected with verotoxin-producing Escherichia coli O157 infections? Jpn J Infect Dis 65 : 442-443, 2012.
PubMed
12) Sazawal S, et al : Efficacy of probiotics in prevention of acute diarrhoea : a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis 6 : 374-382, 2006.
PubMed
13) Thielman NM, Guerrant RL : Clinical practice. Acute infectious diarrhea. N Engl J Med 350 : 38-47, 2004.
PubMed
P.319 掲載の参考文献
1) 国立感染症研究所 : 5類感染症小児科定点把握疾患. 感染症発生動向調査 (週報). [http://www.nih.go.jp/niid/ja/idwr/2085-ydata/1617-report-jb.html]
 
2) 国立感染症研究所 : 感染性胃腸炎由来細菌. 病原微生物検出情報2008-2012年. [http://nih.go.jp/niid/ja/iasr/510-surveillance/iasr/graphs/1524-iasrgb.html]
 
3) 磯部順子ほか : 腸管出血性大腸菌O111による焼肉チェーン店での集団食中毒事件-富山県-. 病原微生物検出情報 33 : 119-120, 2012.
 
4) King LA, et al : Outbreak of Shiga toxin-producing Escherichia coli O104 : H4 associated with organic fenugreek sprouts, France, June 2011. Clin Infect Dis 54 : 1588-1594, 2012.
PubMed
5) Hughes RAC, Cornblath DR : Guillain-Barre/syndrome. Lancet 366 : 1653-1666, 2005.
PubMed
6) Wbng CS, et al : The risk of hemolytic -uremic syndrome after antibiotic treatment of Escherichia coli O157 : H7 infections. N Engl J Med 325 : 1371-1372, 2000.
 
7) 清田浩ほか : 腸管出血性大腸菌感染症の諸問題 (座談会). 感染症誌 85 : 611-619, 2011.
 
8) 坂本光男, 相楽裕子 : 腸管出血性大腸菌感染症におけるHUS/脳症合併状況に関する調査. 第51回感染性腸炎研究会総会抄録集, 2012.
 
P.324 掲載の参考文献
1) Cunliffe NA, Nakagomi O : Reoviruses. In : Medical Microbiology, 18th ed (ed by Greenwood D, et al), p 559-565, Saunders, Elsevier, 2012.
 
2) Nakagomi O, Cunliffe NA : Viral Gastroenteritis. In : Hunter's Tropical Medicine and Emerging Infectious Diseases, 9th ed (ed by Magill AJ, et al), p 275-276, Saunders, Elsevier, 2012.
 
3) Nakagomi O, et al : Rotavirus. In : Hunter'sTropical Medicine and Emerging Infectious Diseases, 9th ed (ed by Magill AJ, et al), p 276-279, Saunders, Elsevier, 2012.
 
4) Hall AJ, et al : Norovirus. In : Hunter's Tropical Medicine and Emerging Infectious Diseases (ed by Magill AJ, et al), 9th ed, p 280-283, Saunders, Elsevier, 2012.
 
5) Gray JJ, Kang G : Enteric adenoviruses. In : Hunter's Tropical Medicine and Emerging Infectious Diseases, 9th ed (ed by Magill AJ, et al), p 283-285, Saunders, Elsevier, 2012.
 
6) Kang G, Gray JJ : Astroviruses. In : Hunter'sTropical Medicine and Emerging Infectious Diseases, 9th ed (ed by Magill AJ, et al), p 286-288, Saunders, Elsevier, 2012.
 
7) Nakagomi O, et al : Sapoviruses. In : Hunter's Tropical Medicine and Emerging Infectious Diseases, 9th ed (ed by Magill AJ, et al), p 289, Saunders, Elsevier, 2012,
 
8) Hart CA, et al : Diarrhoea caused by viruses. In : Manson's Tropical Diseases, 22nd ed (ed by Cook GC, Zumla AI), p 815-824, Saunders, Elsevier, 2009.
 
9) Gastanaduy AS, Begue RE : Acute gastroenteritis viruses. In : Infectious Diseases 3rd ed (ed by Cohen J, et al), p 1511-1519, Mosby-Elsevier, 2010.
 
10) Bishop RF, Kirkwood CD : Enteric viruses. In : Desk Encyclopedia of Human and Medical Virology (ed by Mahy BWJ, van Regenmortel MHV), p 69-77, Academic Press, 2010.
 
11) Glass RI, et al : Norovirus gastroenteritis. N Engl J Med 361 : 1776-1785, 2009.
PubMed
P.330 掲載の参考文献
1) WHO model prescribing information : drug used in parasitic disease, 2nd ed, WHO, Genova,
 
2) Harrison's Principles of lnternal Medicine (ed by Longo DL, et al), 18th ed, McGraw-Hill New YOrk, 2012.
 
P.334 掲載の参考文献
1) Rolston KV, et al : Diarrhea caused by 'nonpathogenic amoebae' in patients with AIDS. N Engl J Med 315 (3) : 192, 1986.
PubMed
2) Shah M, et al : Blastocystis hominis and Endolimax nana Co-Infection Resulting in Chronic Diarrhea in an Immunocompetent Male. Case Rep Gastroenterol 6 (2) : 358-364, 2012.
 
3) Johnson EH, et al : Emerging from obscurity : biological, clinical, and diagnostic aspects of Dientamoeba fragilis. Clin Microbiol Rev 17 (3) : 553-570, 2004.
PubMed
4) 山本徳栄ほか : クリプトスポリジウム症患者におけるオーシスト排出数の推移と排出期間. Clin Parasitol 16 (1) : 73-75, 2005.
 
5) Nozaki T : Current problems of amebiasis in Japan and recent advances in amebiasis research. Jpn J Infect Dis 53 : 229-237, 2000.
PubMed
6) 井関基弘, 木俣勲 : 感染者等の免疫不全患者におけるクリプトスポリジウム症, イソスポーラ症, サイクロスポーラ症-流行の実態と診断・治療の問題点-. Clin Parasitol 11 (1) : 69-71, 2000.
 
7) 生食用生鮮食品による病因物質不有症事例への対応について (平成23年6月17日). [http://www.mhlw.go.jp/topics/bukyoku/iyaku/syoku-anzen/gyousei/dl/110617_02.pdf]
 
8) Stanley SL Jr : Amoebiasis. Lancet 361 (9362) : 1025-1034, 2003.
PubMed
9) Schuster FL, Ramirez-Avila L : Current world status of Balantidium coli. Clin Microbiol Rev 21 (4) : 626-638, 2008.
PubMed
10) Casemore DP : Foodborne protozoal infection. Lancet 336 (8728) : 1427-1432, 1990.
PubMed
11) Kosek M, et al : Cryptosporidiosis : an update. Lancet Infect Dis 1 (4) : 262-269, 2001.
PubMed
12) Lindsay DS, et al : Biology of Isospora spp. from humans, nonhuman primates, and domestic animals. Clin Microbiol Rev 10 (1) : 19-34, 1997.
 
13) Ortega YR, Sanchez R : Update on Cyclospora cayetanensis, a food-borne and waterborne parasite. Clin Microbiol Rev 23 (1) : 218-234, 2010.
PubMed
14) Barta JR, et al : The genus Atoxoplasma (Garnham 1950) as a junior objective synonym of the genus Isospora (Schneider 1881). species infecting birds and resurrection of Cystoisospora (Frenkel 1977) as the correct genus for Isospora species infecting mammals. J Parasitol 91 (3) : 726-727, 2005.
PubMed
15) Fayer R. Sarcocystis spp. in human infections. Clin Microbiol Rev 17 (4) : 894-902, 2004.
PubMed
16) Drugs for Parasitic Infections, 2nd edition, The Medical Letter, New York, 2010.
 
17) 寄生虫症薬物治療の手引き改訂 (2010年) 第7.0.1版, 「国内未承認薬の使用も含めた熱帯病・寄生虫症の最適な診療体制の確立」に関する研究班. [http://www.miyazaki-med.ac.jp/parasitology/orphan/index.html]
 
P.337 掲載の参考文献
1) Schneider R : Tuberculous esophagitis. Gastroinst Radiol 1 : 143-145, 1976.
PubMed
2) Bodey G, et al : Effect of systemic antimicrobial prophylaxis on microbial flora. Antimicrob Agents Chemother 21 (3) : 367-372, 1982.
PubMed
3) Mcdonald G, et al : Esophagial infections in immunosuppressed patients after marrow transplantation. Gastroenterology 82 : 1127-1133, 1982.
 
4) 山田義也 : AIDS診療の最新知識-AIDSにみられる消化器疾患の臨床像. 臨床成人病 28 : 933-937, 1998.
 
5) 山田義也ほか : HIV感染に合併した食道潰瘍122例の検討. 京都医会誌 41 : 69-80, 1994.
 
6) 藤原崇ほか : HIV感染症患者の上部消化管病変. 胃と腸 46 : 240-253, 2011.
 
7) 永田尚義ほか : 免疫不全患者におけるサイトメガロウィルスのヒ部消化管病変-内視鏡像と臨床像の検討. Gastroenterol Endosc 51 : 2414-2425, 2009.
 
8) Levine MS, et al : Herpes esophagitis ; sensitivity of double-contrast esophagography. AJR Am J Roentgenol 151 : 57-62, 1988.
PubMed
9) 青山友三 : ウィルス感染症-その歴史と現状. 病理と臨床 3 : 482-488, 1985.
 
P.340 掲載の参考文献
1) Fitz RH : Perforating inflammation of the vermiform appendix with special reference to its early diagnosis and treatment. Trans Assoc Am Physicians 1 : 107-136, 1886.
 
2) Brown JJ : Acute appendicitis : The radiologist's role. Radiology 180 : 13-14, 1991.
PubMed
3) 高瀬真ほか : 腹部超音波検査による急性虫垂炎の診断と治療法の選択. 腹部急進量の進歩 13 : 199-204, 1993.
 
4) 安田秀喜ほか : 救急医療と超音波検査法. Pharma Medica 8 : 67-74, 1990.
 
5) Balthazar EJ, et al : Acute appendicitis : CT and US correlation in 100 patients. Radiology 190 : 31-35, 1994.
PubMed
6) Hoffmann J, et al : Aids in the diagnosis of acute appendicitis. Br J Surg 76 : 774-779, 1989.
PubMed
7) Bennett J, et al : Choice of approach for appendectomy : a meta-analysis of open verses laparoscopic appendectomy. Surg Laparosc Endosc Percutan Tech 17 : 245-255, 2007.
 
8) Billingham MJ, et al : Pediatric surgical technique : laparoscopic or open approach? A systematic review and meta-analysis. Eur J Pediatr Surg 20 : 73-77, 2010.
PubMed
9) Wilasruamee C, et al : Sytematic review and meta-analysis of safety of laparoscopic versus open appendectomy for suspected appendicitis in pregnancy. Br J Surg 99 : 1470-1479, 2012.
 
10) Meshikes A, et al : Management of appendiceal mass : controversial issues revisited. J Gastrointest Surg 12 : 767-775, 2008.
PubMed
11) 土岐文彰ほか : Interval appendectomyの適応. 小児外科 39 : 557-560, 2007.
Medical*Online
12) 家入里志ほか : Interval appendectomyの適応と至適手術時期についての検討. 日腹部救急医会誌 32 (4) : 771-774, 2012.
 
13) Vons C, et al : Amoxicillin plus clavulanic acid versus appendectomy for treatment of acute uncomplicated appendicitis : an open label, non-inferiority, randomized controlled trial. Lancet 377 : 1573-1579, 2011.
PubMed
14) Ansaloni L, et al : Surgery versus conservative antibiotic treatment in acute appendicitis : a systematic review and meta-analysis of randomized controlled trials. Dig Surg 28 : 210-221, 2011.
PubMed
15) 炭山喜伸, 草地信也 : 急性腹膜炎-病態と治療の最前線. II. 治療法の選択とタイミング. 2. 急性腹膜炎周術期の抗菌薬療法. 臨外 53 : 1125-1128, 1998.
 
P.345 掲載の参考文献
1) 八尾恒良ほか : 最近の腸結核-10年間の本邦報告例の解析. 胃と腸 30 : 485-490, 1995.
 
2) 鈴木弘文ほか : 病理剖検輯報の記載からみた腸結核の動向と問題点. 結核 77 : 355-360, 2002.
 
3) Paustian FF, Bochus HL : So-called primary ulcerohypertorophic ileocecal tuberculosis. Am J Med 27 : 509-518, 1959.
 
4) 飯田三雄 : 腸結核・結核性腹膜炎. 臨床と研究 73 : 1730-1735, 1996.
Medical*Online
5) 藤田孝義ほか : 全血インターフェロンγアッセイが補助診断として有用であった小腸結核の1例. Gastroenterol Endosc 49 : 2846-2851, 2007.
 
6) 稲葉直樹ほか : 腸結核におけるQuantiFERON(R) TBの意義 : QuantiFERON(R) TB陰性の腸結核2症例. Gastroenterol Endosc 53 : 3310-3316, 2011.
 
7) 黒丸五郎 : 腸結核症の病理. 結核新書 12, 医学書院, 1952.
 
8) 望月福治ほか : まれな腹膜炎 (2) 結核性腹膜炎, 肉芽腫性腹膜炎. 臨床消化器内科 10 : 1389-1394, 1995.
 
9) Bhargava DK, Shriniwas C : Peritoneal tuberculosis : Laparoscopic patterns and its diagnostic accuracy. Am J Gastroenterol 87 : 109-112, 1992.
 
10)槇哲夫, 白鳥常男 : 結核性腹膜炎, 現代外科学大系 34, p236-239, 中山書店, 1974.
 
11) Sanai FM, Bzeizi KI : Systemic review : tuberculous peritonitis-presenting features, diagnostic strategies and treatment. Aliment Pharmacol Ther 22 : 685-700, 2005.
 
12) Marshall JB : Tuberculosis of the gastrointestinal tract and peritoneum. Am J Gastroenterol 88 : 989-999, 1983.
 
13) 頼冠名ほか : 腹水中ADA高値が診断に寄与した若年女性結核性腹膜炎の1例. 感染症誌 78 : 916-922, 2004.
 
14) Miura T, et al : Laproscopic peritoneal biopsy can be cruicial for diagnosis of tuberculous peritonitis. Clin J Gastroenterol 2 : 408-411, 2009.
 
15) Dwivedi M, et al : Value of adenosine deaminase estimation in the diagnosis of tuberculous ascites. Am J Gastroetnerol 85 : 1123-1125, 1990.
 
P.350 掲載の参考文献
1) Parfitt JR, Driman DK : Pathological effects of drugs on the gastrointestinal tract : a review. Hum Pathol 38 : 527-536, 2007.
PubMed
2) Beaugerie L, Petit JC : Antibiotic-associated diarrhoea. Best Prac Res Clin Gastroenterol 18 : 337-352, 2004.
 
3) Hogenauer C, et al : Mechanisms and management of antibiotic-associated diarrhea. Clin Infect Dis 27 : 702-710, 1998.
PubMed
4) Dubberke ER, Wertheimer AI : Review of current literature on the economic burden of Clostridium difficile infection. Infect Control Hosp Epidemiol 30 : 57-66, 2009.
PubMed
5) Boyce JM, Havill NL : Nosocomial antibiotic-associated diarrhea associated with enterotoxin-producing strains of methicillin-resistant Staphylococcus aureus. Am J Gastroenterol 100 : 1828-1834, 2005,
PubMed
6) Carroll KC, Bartlett JG : Biology of Clostridium difficile : Implications for epidemiology and diagnosis. Annu Rev Microbiol 65 : 501-521, 2011.
PubMed
7) Sakurai Y, et al : Acute right-sided hemorrhagic colitis associated with oral administration of ampicillin. Dig Dis Sci 24 : 910-915, 1979.
PubMed
8) Beaugerie L, et al : Klebsiella oxytoca as an agent of antibiotic-associated hemorrhagic colitis. Clin Gastroenterol Hepatol 1 : 370-376, 2003.
PubMed
9) Hogenauer C, et al : Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis. N Engl J Med 355 : 2418-2426, 2006.
PubMed
10) Dittmar E, et al : Necrotizing enterocolitis of the neonate with Clostridium perfringens : diagnosis, clinical course, and role of alpha toxin. Eur J Pediatr 167 : 891-895, 2008.
PubMed
11) Gorkiewicz G : Nosocomial and antibiotic-associated diarrhoea caused by organisms other than Clostridium dtfficile. Int J Antimicrob Agents 33 : S37-S41, 2009.
PubMed
12) Raj HD, Bergdoll MS. : Effect of enterotoxin B on human volunteers. J Bacteriol 98 : 833-834, 1969.
PubMed
13) Gravet A, et al : Predominant Staphylococcus aureus isolated from antibiotic-associated diarrhea is clinically relevant and produces enterotoxin A and the bicomponent toxin LukE-lukD. J Clin Microbiol 37 : 4012-4019, 1999.
PubMed
14) Lo TS, Borchardt SM : Antibiotic-associated diarrhea due to methicillin-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis 63 : 388-389, 2009.
PubMed
15) Krause R, et al : Role of Candida in antibiotic-associated diarrhea. J Infect Dis 184 : 1065-1069, 2001.
PubMed

V 尿路感染症, 男性性器感染症

P.356 掲載の参考文献
1) Schaeffer AJ, Schaeffer EM : Infection of urinary tract. In : Canpbell-Walsh Urology (ed by Wein AJ. et al), 10th ed, p 257-326, Saunders Elsevior, Philadelphia, 2011.
 
2) Matsumoto T, et al : Nationwide survey of antibacterial activity against clinical isolates from urinary tract infections in Japan (2008). Int J Antimicrob Agents 37 (3) : 210-218, 2011.
PubMed
3) Nicolle LE, et al : The quantitative urine culture for the diagbosis of urinary tract infection. In : Urogenital Infections, Edition 2010 (ed by Naber KG, et al), p 160-169, European Association of Urology, Stockholm, 2010.
 
4) Yasuda M, et al : Japanese guideline for clinical research of antimicrobial agents on urogenital infections : the first edition. J Infect Chemother 17 (4) : 579-594, 2011.
PubMed
5) Colgan R, et al : Diagnosis of uncomplicated urinary tract infections. In : Urogenital Infections, Edition 2010 (ed by Naber KG, et al), p151-159, European Association of Urology, Stockholm, 2010.
 
6) Naber KG, et al : Antibiotic treatment of uncomplicted urinary tract infetion in premenopausal women, Urogenital Infection, Edition 2010 (ed by Naber KG, et al), p 170-199, European Association of Urology, Stockholm, 2010.
 
7) JAID/ISC感染症治療ガイド委員会 : JAID/ISC感染症治療ガイド 2011, ライフサイエンス社, 2012.
 
8) 松本哲朗ほか : 尿路感染症主要原因菌の各種抗菌薬に対する感受性. 日化療会誌 58 (4) : 466-482, 2010.
 
9) Ferry SA, et al : The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study. Scand J Infect Dis 36 (4) : 296-301, 2004.
PubMed
P.359 掲載の参考文献
1) 松本哲朗ほか : 尿路性器感染症に関する臨床試験実施のためのガイドライン (第1版). 日化療会誌 57 : 511 -525, 2009.
 
2) Rubin RH, et al : Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 15 (Suppl 1) : S216-227, 1992.
 
3) Villar J, et al : Nutritional and antimicrobial interventions to prevent preterm birth : an overview of randomized controlled trials. Obstet Gynecol Survey 53 : 575-585, 1998.
 
4) 松本哲朗ほか : 尿路感染症じ要原因菌の各種抗菌薬に対する感受性. 日化療会誌 58 : 466-482, 2010.
 
5) Takahashi S, et al : Current survey of urinary tuberculosis in Hokkaido, Japan. J Infect Chemother 13 : 105-108, 2007.
PubMed
6) JAID/JSC感染症治療ガイド委員会編 : 尿路性器感染症. JAID/JSC感染症治療ガイド 2011, p152-169, 日本感染症学会・日本化学療法学会, 2012.
 
P.362 掲載の参考文献
1) Green M, et al : Adenovirus infection in solid organ transplantation. In : Transplant Infections (ed by Bowden RA, et al), p 459-464, LWW, Philadelphia, 2010.
 
2) Yagisawa T, et al : Acute hemorrhagic cystitis caused by adenovirus after kidney transplantation. Urol Int 54 : 142-146, 1995.
PubMed
3) Hatakeyama N, et al : Detection of BK virus and adenovirus in the urine from children after allogeneic stem cell transplantation. Pediatr Infect Dis J 25 : 84-85, 2006.
PubMed
4) Mori Y, et al : Different risk factors related to adenovirus-or BK-associated hemorrhagic cystitis following allogeneic stem cell transplantation. Biol Blood Marrow Transplant 18 : 458-465, 2012.
PubMed
5) Hassan Z : Management of refractory hemorrhagic cystitis following hematopoietic stem cell transplantation in children. Pediatr Transplant 15 : 348-361, 2011.
PubMed
6) Abe T, et al : Sequential adenovirus infection of type 14 hemorrhagic cystitis and type 35 generalized infection after cord blood transplantation. Int J Hematol 90 : 421-425, 2009.
PubMed
7) Ferreira G, et al : Hemorrhagic cystitis secondary to adenovirus or herpes simplex virus infection following renal transplantation : four case reports. Transplant Proc 41 : 4416-4419, 2009.
PubMed
8) Yuzawa Y, et al : Acute renal failure and degenerative tubular lesions associated with in situ formation of adenovirus immune complexes in apatient with allogeneic bone marrow transplantation, Transplantation 55 : 67-72, 1993.
 
9) Ito M, et al : Necrotizing tubulointerstitial nephritis associated with adenovirus infection. Hum Pathol 22 : 1225-1231, 1991.
PubMed
10) Yusuf U, et al : Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients. Transplantation 27 : 1398-1404, 2006.
 
11) Hoffman JA : Adenovirus infections in solid organ transplant recipients. Curr Opin Organ Transplant 14 : 625-633, 2009.
PubMed
12) Laszlo D, et al : Prostaglandin E2 bladder instillation for the treatment of hemorrhagic cystitis after allogeneic bone marrow transplantation. Hematologica 80 : 421-425, 1995.
 
13) Cipe FE, et al : Late onset hemorrhagic cystitis in a hematopoietic stem cell recipient : treatment with intravesical hyaluronic acid. Pediatr Transplant 14 : E79-82, 2010.
 
14) Nakazawa Y. et al : Urinary excretion of ganciclovir contributes to improvement of adenovirus-associated hemorrhagic cystitis after bone marrow transplantation. Pediatr Transplant 13 (5) : 632-635, 2009.
PubMed
15) Bil-Lula I, et al : Hematuria due to adenoviral infection in bone marrow transplant recipients. Transplant Proc 42 : 3729-3734, 2010.
PubMed
P.368 掲載の参考文献
1) 日本感染症学会, 日本化学療法学会 : 尿路・性器感染症. JAID/JSC感染症治療ガイド (日本感染症学会, 日本化学療法学会編), p 152-169, ライフサイエンス社.
 
2) Yoshimura K, et al : Emergency drainage for urosepsis associated with upper urinary tract calculi. J Urol 173 : 458-462, 2005.
PubMed
3) Schultz EH Jr, Klorfein EH : Emphysematous pyelonephritis. J Urol 87 : 762-766, 1962.
PubMed
4) Wan YL, et al : Acute gas producing bacterial renal infection : correlation between imaging and clinical outcome. Radiology 198 : 433-438, 1996.
PubMed
5) Loffroy R, et al : Xanthogranulomatous pyelonephritis in adults : clinical and radiological findings and focal forms. Clin Radiol 62 : 884-890, 2007.
PubMed
P.372 掲載の参考文献
1) Hellstrom A, et al : Association between urinary symptoms at 7 years old and previous urinary tract infection. Arch Dis Child 66 (2) : 232-234, 1991.
PubMed
2) National Institute for Health and Clinical Excellence : Urinary tract infection in children : diagnosis, treatment and long-term management. August 2007.
 
3) American Academy of Pediatrics, Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management, Roberts KB : Urinary tract infection : clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 128 (3) : 595-610, 2011.
 
4) Peters CA, et al : Summary of the AUA Guideline on Management of Primary Vesicoureteral Reflux in Children. J Urol 184 (3) : 1134-1144, 2010.
 
5) Li PS, et al : Is bag urine culture useful in monitoring urinary tract infection in infants? J Paediatr Child Health 38 (4) : 377, 2002.
PubMed
6) American Academy of Pediatrics, Committee on Quality Improvement, Subcommittee on Urinary Tract Infection : Practice parameter : the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. Pediatrics 103 (4) : 843-851, 1999.
 
7) Maizels M, et al : Grading nephroureteral dilation detected in the first year of life : correlation with obstruction. J Urol 148 : 609, 1992.
PubMed
8) Tse NK, et al : Imaging studies for first urinary tract infection in infants less than 6 months old : can they be more selective? Pediatr Nephrol 24 (9) : 1699-1703, 2009.
PubMed
9) Preda I, et al : Normal dimercaptosuccinic acid scintigraphy makes voiding cystourethrography unnecessary after urinary tract infection. J Pediatr 151 (6) : 581-584, 2007.
PubMed
10) Hoberman A, et al : Imaging studies after a first febrile urinary tract infection in young children. N Engl J Med 348 (3) : 195-202, 2003.
PubMed
11) Conway PH, et al : Recurrent urinary tract infections in children : risk factors and association with prophylactic antimicrobials. JAMA 298 : 179, 2007.
PubMed
12) Pennesi M, et al ; North East Italy Prophylaxis in VUR study group : Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics 121 (6) : e1489-1494, 2008.
 
13) Roussey-Kesler G, et al : Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux : results from a prospective randomized study, J Urol 179 (2) : 674-679, 2008.
PubMed
14) Craig JC, et al : Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl J Med 361 (18) : 1748-1759, 2009.
PubMed
15) Wennerstrom M, et al : Renal function 16 to 26 years after the first urinary tract infection in childhood. Arch Pediatr Adolesc Med 154 : 339-345, 2000.
PubMed
P.378 掲載の参考文献
1) Bradshaw CS, et al : Etiologies of nongonococcal urethritis : bacteria, viruses, and the association with orogenital exposure. J Infect Dis 193 (3) : 336-345, 2006.
PubMed
2) Hamasuna R : Identification of treatment strategies for Mycoplasma genitalium-related urethritis in male patients by culturing and antimicrobial susceptibility testing. J Infect Chemother 19 (1) : 1-11, 2013.
 
3) 健康局結核感染症課情報管理係 : 厚生労働省性感染症報告数 [http://www.mhlw.go.jp/topics/2005/04/tp0411-1.html]
 
4) 庄武彦ほか : 北九州地区における性感染症の動向. 日性感染症会誌 22 (1) : 56-61, 2011.
 
5) 濱砂良一ほか : 宮崎県泌尿器科医会における7年間の性感染症患者の検討. 宮崎医師会誌 26 (2) : 129-134, 2002.
 
6) 保科眞二, 保田仁介 : 性産業従事者 Commercial Sex Workers (CSW) における咽頭と子宮頸管の淋菌, Chlamydia trachomatis検査, 陽性率の比較検討. 日性感染症会誌 15 (1) : 127-134, 2004.
 
7) 濱砂良一 : 耳鼻咽喉科領域のSTD : 泌尿器科よりみたクラミジア, 淋菌性咽頭炎. ENTONI 43 : 37-44, 2004.
 
8) 余田敬子ほか : 淋菌およびクラミジアの咽頭および性器感染 : 性感染症クリニック受診者からみた現状. 口腔・咽頭科 23 (2) : 207-212, 2010.
Medical*Online
9) 松本哲朗ほか : 淋菌感染症 : 性感染症診断・治療ガイドライン 2011. 日性感染症会誌 22 (1 Suppl) : 52-59, 2011.
 
10) 三鴨廣繁ほか : 性器クラミジア感染症 : 性感染症診断・治療ガイドライン 2011. 日性感染症会誌 22 (1 Suppl) : 60-64, 2011.
 
11) Chisholm SA, et al : Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales. J Antimicrob Chemother 64 (2) : 353-358, 2009.
 
12) Starnino S, Stefanelli P : Neisseria gonorrhoeae Italian Study Group : Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy. J Antimicrob Chemother 63 (6) : 1200-1204, 2009.
 
13) Ohnishi M, et al : Ceftriaxone-resistant Neisseria gonorrhoeae, Japan. Emerg Infect Dis 17 (1) : 148-149, 2011.
PubMed
P.382 掲載の参考文献
1) 大津寧, 伊藤雄平 : 腎尿路感染症の全て 最近の動向 : 話題 無症候性細菌尿. 腎と臨牀 55 : 142-145, 2003.
 
2) Nicolle LE, et al : Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 40 : 643-654, 2005.
 
3) Grabe M, et al : Guidelines on Urological infection. European Association of Urology, 2013. [http://www.uroweb.org/gls/pdf/18_Urological%20infections_LR.pdf]
 
4) Nicolle LE : Asymptomatic bacteriuria : when to screen and when to treat. Infect Dis Clin North Am 17 : 367-394, 2003.
PubMed
5) Zhanel GG, et al : Asymptomatic bacteriuria in patients with diabetes mellitus. Rev Infect Dis 13 : 150-154, 1991.
PubMed
6) O'Dell KK : Pharmacologic management of asymptomatic bacteriuria and urinary tract infections in women. J Midwifery Womens Health 56 : 248-265, 2011.
PubMed
7) Childs SJ, Egan RJ : Bacteriuria and urinary infections in the elderly. Urol Clin North Am 23 : 43-54, 1996.
PubMed
8) Ariathianto Y : Asymptomatic bacteriuria-prevalence in the elderly population. Aust Fam Physician 40 : 805-809. 2011.
PubMed
9) Truzzi JC, et al : Residual urinary volume and urinary tract infection-when are they linked? J Urol 180 : 182-185. 2008.
PubMed
10) Ferris TF : Medical disorders during pregnancy. In : Harrison's Principles of Internal Medicine (ed by Isselbacher KJ), p 18-25, McGraw-Hill, New York, 1994.
 
11) Chung A, et al : Bacterial cystitis in women. Aust Fam Physician 39 : 295-298, 2010.
PubMed
12) Boscia JA, et al : Pyuria and asymptomatic bacteriuria in elderly ambulatory women. Ann Intern Med 110 : 404-405, 1989.
PubMed
13) Cafferkey MT, et al : Antibiotics for the prevention of septicaemia in urology. J Antimicrob Chemother 9 : 471-477, 1982.
PubMed
P.386 掲載の参考文献
1) Bone RC, et al : Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101 (6) : 1644-1655, 1992.
PubMed
2) Bone RC, et al : Definitions for sepsis and organ failure. Crit Care Med 20 (6) : 724-726, 1992.
PubMed
3) Levy MM. et al : SCCM/ESICM/ACCP/ATS/SIS. SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference, 2001.
 
4) Martin GS, et al : The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348 (16) : 1546-1554, 2003.
PubMed
5) Esteban A, et al : Sepsis incidence and outcome : contrasting the intensive care unit with the hospital ward. Crit Care Med 35 (5) : 1284-1289, 2007.
PubMed
6) Rosser CJ, et al : Urinary tract infections in the critically ill patient with a urinary catheter. Am J Surg 177 (4) : 287-290, 1999.
PubMed
7) Hofmann W, et al : Urosepsis-from the view of the urologist. Int J Antimicrob Agents 38 (Suppl) : 51-57, 2011.
 
8) Dinarello CA : The endogenous pyrogens in host-defense interactions. Hosp Pract (Off Ed) 24 (11) : 111-115, 118, 121 passim, 1989.
PubMed
9) Hoddick W, et al : CT and sonography of severe renal and perirenal infections. Am J Roentgenol 140 (3) : 517-520. 1983.
 
10) Cruz DN, et al : Early use of polymyxin B hemoperfusion in abdominal septic shock : the EUPHAS randomized controlled trial. JAMA 301 (23) : 2445-2452, 2009.
PubMed
11) Huang JJ, Tseng CC : Emphysematous pyelonephritis : clinicoradiological classification, management, prognosis, and pathogenesis. Arch Intern Med 160 (6) : 797-805, 2000.
PubMed
12) Yeniyol CO, et al : Fournier's gangrene : experience with 25 patients and use of Fournier's gangrene severity index score. Urology 64 (2) : 218-222, 2004.
PubMed
P.394 掲載の参考文献
1) Manjon CC, et al : Retroperitoneal Abscesses. Scand J Urol Nephrol 37 (2) : 139-144, 2003.
 
2) Walsh PC, et al : Campbell's Urology, 8th ed, p 557, Saunders, Philadelphia, 2002.
 
3) Falagas ME, et al : Risk factors for mortality in patients with emphysematous pyelonephritis : a meta-analysis. J Urol 178 (3) : 880-885, 2007.
 
4) Somani BK et al ; ABACUS Research Group : Is percutaneous drainage new gold standard in management of emphysematous pyelonephritis? Evidence from systematic review? J Urol 179 : 1844-1849, 2008.
 
5) Aswathaman K, et al : Emphysematous pyelonephritis : outcome of concervative management. Urology 71 (6) : 1007-1009, 2008.
 
6) Huang JJ, Tseng CC : Emphysematous pyelonephritis : clinicoradiological classification, management, prognosis, and pathogenesis. Arch Intern Med 160 (6) : 797-805, 2000.
PubMed
7) 荒川創一ほか : 泌尿器科領域感染症-腎周囲膿瘍など-. 日外感染症会誌 8 (3) : 219-224, 2011.
Medical*Online
P.398 掲載の参考文献
1) 吉澤信行, 尾田高志 : 急性糸球体腎炎症候群 (荒川正昭, 長澤俊彦編). 最新内科学大系 56, p3-30, 中山書店, 1995.
 
2) Kanjanabuch T, et al : An update on acute postinfectious glomerulonephritis worldwide. Nat Rev Nephrol 5 : 259-269, 2009.
PubMed
3) Vernon KA, et al : Acute presentation and persistent glomerulonephritis following streptococcal infection in a patient with heterozygous complement factor H-related protein 5 deficiency. Am J Kidney Dis 60 : 121-125, 2012.
 
4) Sethi S, et al : Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement, Kidney Int 83 : 293-299, 2013.
PubMed
5) Rodriguez-Iturbe B, Musser JM : The current state of poststreptococcal glomerulonephritis. J Am Soc Nephrol 19 : 1855-1864, 2008.
 
6) Cu GA, et al : Immunohistochemical and serological evidence for the role of streptococcal proteinase in acute post-streptococcal glomerulonephritis. Kidney Int 54 : 819-826, 1998.
PubMed
7) Rodriguez-Iturbe B, Batsford S : Pathogenesis of poststreptococcal glomerulonephritis a century after Clemens von Pirquet, Kidney Int 71 : 1094-1104, 2007.
 
8) Yamakami K, et al : The potential role for nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis. Methods 21 : 185-197, 2000.
PubMed
9) Yoshizawa N, et al : Nephritis-associated plasmin receptor and acute poststreptococcal glomerulonephritis : characterization of the antigen and associated immune response. J Am Soc Nephrol 15 : 1785-1793, 2004.
PubMed
10) Oda T, et al : Glomerular plasmin-like activity in relation to nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis. J Am Soc Nephrol 16 : 247-254, 2005.
PubMed
11) Oda T, et al : The role of nephritis-associated plasmin receptor (NAPlr) in glomerulonephritis associated with streptococcal infection. J Biomed Biotechnol 2012 : 417675, 2012.
PubMed
12) Oda T, et al : Elevated urinary plasmin activity resistant to alpha2-antiplasmin in acute poststreptococcal glomerulonephritis. Nephrol Dial Transplant 23 : 2254-2259, 2008.
PubMed
13) Oda T, et al : Localization of nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis. Hum Pathol 41 : 1276-1285, 2010.
PubMed
14) Hoy WE, et al : Post-streptococcal glomerulonephritis is a strong risk factor for chronic kidney disease in later life. Kidney Int 81 : 1026-1032, 2012.
 
15) 尾田高志ほか : 溶連菌感染後急性糸球体腎炎. EBM腎臓病の治療 (富野康日己ほか編), p33-38, 中外医学社, 2011.
 
P.404 掲載の参考文献
1) 吉矢邦彦ほか : 小児期急性腎不全90症例の臨床病理学的検討. 日腎会誌 39 : 483 -489, 1997.
 
2) Tarr PI, Gordon WL : Chandler, Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365 : 1073-1086, 2005.
 
3) Frank, et al : Epidemic profile of Shiga-toxin-producing Escherichia coli O104 : H4 outbreak in Germany. N Engl J Med 365 : 1771-1780, 2011.
PubMed
4) Gould LH, et al : Hemolytic uremic syndrome and death in persons with Escherichia coli O157 : H7 infection, foodborne diseases active surveillance network sites, 2000-2006. Clin Infect Dis 49 : 1480-1485, 2009.
PubMed
5) Johnson S, Taylar CM : Hemolytic uremic syndrome. In : Pediatric Nephrology (ed by Avner ED, et al), p 1155-1180, Springer, Heidelberg, 2009.
 
6) Copelovitch L Kaplan BS : Streptococcus pneumoniae-associated hemolytic uremic syndrome. Pediatr Nephrol 23 : 1951-1956, 2008.
PubMed
7) Pennington H : Escherichia coli O157. Lancet 376 : 1428-1435, 2010.
PubMed
8) 吉矢邦彦ほか : 溶血性尿毒症症候群の疫学, 治療成績に関する統計 (全国調査研究より). 小児感染免疫 19 : 59-64, 2007.
 
9) Mark Taylor C : Enterohaemorrhagic Escherichia coli and Shigella dysenteriae type 1-induced haemolytic uraemic syndrome. Pediatr Nephrol 23 : 1425-1431, 2008.
PubMed
10) Scheiring J, et al : Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS), Pediatr Nephrol 23 : 1749-1760, 2008.
PubMed
11) Zhang X, et al : Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J Infect Dis 181 : 664-670, 2000.
PubMed
12) Kurioka T, et al : Efficacy of antibiotic therapy for infection with Shiga-like toxin-producing Escherichia coli O157 : H7 in mice with protein-calorie malnutrition. Eur J Clin Microbiol Infect Dis 18 : 561-571, 1999.
PubMed
13) Bennish ML, et al : Low risk of hemolytic uremic syndrome after early effective antimicrobial therapy for Shigella dysenteriae type 1 infection in Bangladesh. Clin Infect Dis 42 : 356-362, 2006.
PubMed
14) Bitzan M, et al : Treatment of typical (enteropathic) hemolytic uremic syndrome. Semin Thromb Hemost 36 : 594-610, 2010.
PubMed
15) Oakes RS, et al : Duration of oliguria and anuria as predictors of chronic renal-related sequelae in post-diarrheal hemolytic uremic syndrome. Pediatr Nephrol 23 : 1303-1308, 2008.
PubMed
16) Nathanson S, et al : Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 5 : 1218-1228, 2010.
PubMed
P.410 掲載の参考文献
1) Nickel JC, et al : Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. J Urol 165 : 842-845, 2001.
 
2) Drach GW, et al : Classification of benign diseases associated with prostatic pain : prostatitis or prostatodynia? J Urol 120 : 266, 1978.
PubMed
3) Krieger JN, et al : NIH consensus definition and classification of prostatitis. JAMA 282 : 236-237, 1999.
PubMed
4) Meares EM, Stamey TA : Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol 5 : 492-518, 1968.
PubMed
5) Nickel JC : Practical approach to the management of prostatitis. Tech Urol 1 : 162-167, 1995.
 
6) Nickel JC : The Pre and Post Massage Test (PPMT) : a simple screen for prostatitis. Tech Urol 3 : 38-43, 1997.
PubMed
7) Mandar R, et al : Mycoplasmas in semen of chronic prostatitis patients. Scand J Urol Nephrol 39 (6) : 479-482, 2005.
PubMed
8) Meares EM : Long-term therapy of chronic bacterial prostatitis with trimethoprim-sulfamethoxazole. Can Med Assoc J 112 : 22-25, 1975.
PubMed
9) Tugcu V, et al : A placebo-controlled comparison of the efficiency of triple-and monotherapy in category III B chronic pelvic pain syndrome (CPPS). Eur Urol 51 : 1113-1117, 2007.
PubMed
10) Lim JY, et al : Therapeutic efficacy of bipolar radiofrequency thermotherapy for patients with chronic prostatitis : a retrospective analysis of 26 cases. Korean J Urol 53 : 497-501, 2012.
PubMed
11) Kogan MI, et al : Efficacy of magnetolaser therapy of patients with an inflammatory form of chronic abacterial prostatitis. Urologiia 2 : 42-44, 2010.
PubMed
12) Weinberger M, et al : Prostate abscess in the antibiotic era. Rev Infect Dis 10 : 239-249, 1998,
 
13) Papanicolaou. N, et al : Prostatic abscess : imaging with transrectal sonography and MR. Am J Roentaenol 149 : 981-982, 1987.
 
14) Granados EA, et al : Prostatic abscess : diagnosis and treatment. J Urol 148 : 80-82, 1992.
PubMed
15) 寺川智章ほか : 転移性精巣腫瘍に対する化学療法施行中に発症した前立腺膿瘍に経尿道的前立腺切除による外科的ドレナージを行った1例. 泌尿器科紀要 53 : 725-728, 2007.
 
16) Kadmon D, et al : Percutaneous drainage of prostatic abscesses. J Urol 135 : 1259-1260, 1986.
PubMed
17) 松本穣ほか : 敗血症, 感染性心内膜炎, 化膿性脊椎炎を合併した前立腺膿瘍の1例. 泌尿器科紀要 58 : 565 -568, 2012.
 
P.415 掲載の参考文献
1) Luzzi GA, O'Brien TS : Acute epididymitis. BJU Int 87 (8) : 747-755, 2001.
PubMed
2) National Center for Health Statistics. National Ambulatory Medical Care Survey, 2002. [http://www.cdc.gov/nchs/about/major/ahcd/ahcd1.htm]
 
3) Manavi K, et al : Audit on the management of epididymoorchitis by the Department of Urology in Edinburgh. Int J STD AIDS 16 (5) : 386-387, 2005.
PubMed
4) Leslie TA, et al : The incidence of chronic scrotal pain after vasectomy : a prospective audit. BJU Int 100 : 1330-1333, 2007.
PubMed
5) Chan PT, Schlegel PN : Inflammatory conditions of the male excurrent ductal system. Part I. J Androl 23 : 453 -460, 2002.
 
6) JAID/JSC感染症治療ガイド 2011, 日本感染症学会・日本化学療法学会, 2012.
 
7) Kadish HA, Bolte RG : A retrospective review of pediatric patients with epididymitis, testicular torsion, and torsion of testicular appendages. Pediatrics 102 (1 pt 1) : 73-76, 1998.
 
8) Ludwig M : Diagnosis and therapy of acute prostatitis, epididymitis and orchitis. Andologia 40 : 76-80, 2008.
PubMed
P.420 掲載の参考文献
1) 財団法人厚生統計協会 : 国民衛生の動向. 厚生の指標 (増刊) 54 : 137-141, 2007.
 
2) Kresowik TP, Griffith TS : Bacillus Calmette-Guerin immunotherapy for urothelial carcinoma of the bladder. Immunotherapy 1 : 281-288, 2009.
PubMed
3) 吉山崇 : 結核診療の新展開. 呼吸 27 : 851-858, 2008.
Medical*Online
4) 中澤靖, 柴孝也 : 見落としやすい感染症 腎尿路-性感染症. 診断と治療 95 : 1051-1054, 2007.
Medical*Online
5) Wise GJ, Marella VK : Genitourinary manifestations of tuberculosis. Urol Clin North Am 30 : 111-121, 2003.
PubMed
6) 沼田功 : 尿路-性器の炎症性疾患 尿路性器結核. 臨泌尿器科 (増刊) 59 : 78-81, 2005.
 
7) 遠藤勝久 : 尿路-性器の炎症性疾患 尿路性器結核. 臨泌尿器科 (増刊) 62 : 75-77, 2008.
 
8) 早野敏郎ほか : 泌尿器感染症の画像診断. 排尿障害プラクティス 14 : 165-169, 2006.
Medical*Online
9) 和田雅子 : 結核症の化学療法. 結核 82 : 771-781, 2007.
 
10) 久米春喜 : 尿路性器結核の手術療法. 泌尿器外科 21 : 461-463. 2008.
Medical*Online
11) Ramanathan R, et al : Relief of urinary tract obstruction in tuberculosis to improve renal function. Analysis of predictive factors. Br J Urol 81 : 199-205, 1998.
PubMed
12) Williams SK, et al : Intravesical therapy for bladder cancer. Expert Opin Pharmacother 11 : 947-958, 2010.
PubMed
13) 大島勝利ほか : イムノブラダー膀注用 (乾燥BCG膀胱内用「日本株」) の市販後調査成績. 泌尿器外科 19 : 1409-1420, 2006.
 
14) 新美文彩, 冨田京一 : BCGの役割と副作用対策. 泌尿器外科 22 : 437-444, 2009.
Medical*Online
15) Durek C, et al : Interference of modern antibacterials with bacillus Calmette-Guerin viability. J Urol 162 : 1959-1962, 1999.
PubMed

VI 女性生殖器感染症 ( 産婦人科領域感染症 )

P.427 掲載の参考文献
1) Mikamo H, et al : Studies on the clinical implications of anaerobes, especially Prevotella bivia, in obstetrics and gynecology. J Infect Chemother 4 : 177-187, 1998.
 
2) 松田静治 : 産婦人科感染症, 抗菌薬使用のガイドライン (日本感染症学会・日本化学療法学会編), p199-203, 協和企画, 2005.
 
3) Ross JD : European Branch of the International Union against Sexually Transmitted Infection and the European Office of the World Health Organization. European guideline for the management of pelvic inflammatory disease and perihepatitis. Int J STD AIDS 12 (Suppl 3) : 84-87, 2001.
 
4) Workowski KA, Berman S : Sexually transmitted diseases treatment guidelines-2010. MMWR Morb Mortal Wkly Rep 59 : 1-110, 2010.
 
5) 日本性感染症学会編 : 性感染症 診断・治療ガイドライン 2011, 日性感染症会誌 22 (1) Suppl : 5-115, 2008.
 
6) 深在性真菌症のガイドライン作成委員会編深在性真菌症の診断・治療ガイドライン 2007, p16-23, p87-108, 協和企画, 2007.
 
7) 三鴨廣繁ほか : 抗菌薬を選択する上で知っておきたい嫌気性菌感染症と嫌気性菌の耐性化. 感染症 37 (2) : 41-48, 2007.
 
8) 三鴨廣繁ほか : 日常診療に役立つ抗感染症薬のPK-PD改訂版, p 1-151, ユニオンエース, 2012.
 
9) 三鴨廣繁 : 特殊病態における抗菌化学療法 妊婦, 日内科学会誌 95 (11) : 2208-2213, 2006.
 
P.433 掲載の参考文献
1) 三鴨廣繁, 山岸由佳 : 女性性器感染症治療の基礎的知識. 女性性器感染症 (岩破一博編), p11-24, 医薬ジャーナル社, 2012.
 
2) McCormack WM : Pelvic inflammatory diease. N Engl J Med 330 : 115-119, 1994.
 
3) Sweet RL, Gibbs S : Soft Tissue Infection and Pelvic Abscess Postoperative Abscess. Infectious Diseases of the Female Genital Tract, 5th ed, p95-112, Lippincott Williams & Wilkins, Philadelphia, 2009.
 
4) 保田仁介 : 付属器炎・PIDの起炎菌. 臨床婦人科産科 55 : 32-34, 2001.
 
5) 岩破一博 : 第60回日本化学療法学会総会特集号. 日化療会誌 60 (S-A) : 114, 2012.
 
6) CDC : Sexually transmitted disease treatment guidelines, 2006. MMWR Recomm Rep 55 : 55-61, 2006.
 
7) 日本産科婦人科学会/日本産婦人科医会 (編) : 骨盤内炎症性疾患 (PID) の診断. 産婦人科診療ガイドライン婦人科外来編 2011, p20-23, 2011.
 
8) Beigi RH, Wiesenfeld HC : Pelvic inflammatory disease : new diagnostic criteria and treatment. Obstet Gynecol Clin N Am 30 : 777-793, 2003.
 
9) Mikamo H, et al : Efficacy and safety of azithromycin intravenous formulation (AZM-IV) for the treatment of acute pelvic inflammatory disease (PID) and perihepatitis in Japan. 51st Intersience Conference on Antimicrobial Agents and Chemotherapy, CHUCAACGO, 2011.
 
10) 藤原道久 : 骨盤内炎症性疾患. 女性性器感染症 (岩破一博編), p88-99, 医薬ジャーナル社, 2012.
 
11) 社団法人日本産科婦人科学会 (編) : 婦人科感染症. 産婦人科研修の必須知識 2011, p505-523, 2011.
 
12) 保田仁介 : 注目される抗菌薬の使い分け注射薬 (カルバペネム系抗菌薬) 産婦人科. 臨床と微生物 32 : 709-713, 2005.
 
13) 藤村亭滋ほか : Doripenemのin vitro抗菌力. 日化療会誌 53 (S-1) : 57-70, 2005.
 
14) 岩破一博 : 子宮傍結合織炎. 女性性器感染症 (岩破一博編), p111-115, 医薬ジャーナル社, 2012.
 
P.437 掲載の参考文献
1) 松崎慎哉 : 骨盤腹膜炎とSTD感染. 産婦人科治療 99 (2) : 169-174, 2009.
Medical*Online
2) 三鴨廣繁 : 臨床編産婦人科感染症. 臨床と微生物 35 (4) : 73-78, 2008.
 
3) 保田仁介 : 産婦人科領域の感染症. 総合臨牀 52 (増刊) : 130-135, 2003.
 
4) 門脇淳 : ドレーンの挿入と管理. 外科治療 78 (6) : 1050-1055, 1998.
Medical*Online
5) 高良博明 : 子宮溜膿腫・卵管溜膿腫. マルチスライスCTによる腹部救急疾患の画像診断, p132, 秀潤社, 2007.
 
P.440 掲載の参考文献
1) 日本産科婦人科学会 (編) : 産科婦人科用語集・用語解説集 (改訂第2版), p180, 金原出版, 2008.
 
2) 三鴨廣繁, 山岸由佳 : 産婦人科領域におけるマイコプラズマ属の臨床的意義. 化学療法の領域 26 (11) : 2226-2232, 2010.
 
3) 澤村正之ほか : 女性性器感染症におけるMycoplasma, Ureaplasmaの検討. 日性感染症会誌 20 (1) : 147-153, 2009.
 
4) 日本性感染症学会 : 性感染症診断・治療ガイドライン 2011, 帯下. 日性感染症会誌 22 (1, Suppl) : 30-32, 2011.
 
5) 日本性感染症学会 : 性感染症診断・治療ガイドライン 2011, 性器クラミジア感染症. 日性感染症会誌 22 (1, Suppl) : 60-64, 2011.
 
6) 日本産科婦人科学会/日本産婦人科医会 (編) : CQ102クラミジア子宮頸管炎の診断と治療は? 産婦人科診療ガイドライン-婦人科外来編 2011, p4-5, 2011.
 
7) 日本性感染症学会 : 性感染症診断・治療ガイドライン 2011, 淋菌感染症. 日性感染症会誌 22 (1, Suppl) : 52-59, 2011.
 
8) 日本産科婦人科学会/日本産婦人科医会 (編) : CQ107淋菌感染症の診断と治療は? 産婦人科診療ガイドライン-婦人科外来編 2011, p15-16, 2011.
 
9) 酒井英二 : 非クラミジア性非淋菌性子宮頸管炎58例の検討-Ureaplasam urealyticum, Mycoplasma hominisのひろがり-. 日性感染症会誌 20 (1) : 154-161, 2009.
 
10) Hamasuna R, et al : Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR. Antimicrob Agents Chemother 53 (11) : 4938-4939, 2009.
PubMed
P.444 掲載の参考文献
1) エッセンシャル産婦人科学 (秋谷清ほか編), p7-8, p159-174, 医歯薬出版, 1988.
 
2) プリンシパル産婦人科学, 婦人科編 (坂元正一ほか監修), p29-31, p357-358, メジカルビュー社, 1987.
 
3) 綜合産婦人科学 (坂元正一ほか編), p3-4, p149-151, 医学書院, 1979.
 
4) 対策産婦人科 (椹木勇編), p1-3, p377-378, 金芳堂, 1995,
 
5) 感染とパートナーシップ, 研修ノート No 69, p 87-90, 日本産婦人科医会, 2002.
 
6) 今日の治療指針 (山口徹ほか編), p 1065-1068, 医学書院, 2012.
 
P.447 掲載の参考文献
1) Monif GRG, Baker DA : Infectious Diseasese in Obstetrics and Gynecology, 6th ed, Informa Healthcare, London, 2008.
 
2) Berek and Novak's Gynecology 15th ed, Lippincott Williams & Wilkins, North American Edition, 2011.
 
3) 性感染症診断・治療ガイドライン 2011, 日本性感染症会誌 22 : 80-83, 2011.
 
4) 診療ガイドライン婦人科外来編 2011, p8-9, 日本産科婦人科学会, 2011.
 
5) Nugent RP, et al : Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 29 (2) : 297-301, 1991.
PubMed
6) Donders GGG, et al : Assessment of Vaginal Lactobacillary Flora in Wet Mount and Fresh or Delayed Gram's Stain. Infectious Dis Obstet Gynecol 4 : 2-6, 1996.
 
7) Amsel R et al : Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 74 (1) : 14-22, 1983.
PubMed
P.450 掲載の参考文献
1) Tita AT, Andrews WW : Diagnosis and management of clinical chorioamnionitis. Clin Perinatol 37 : 339-354, 2010.
PubMed
2) Gerber S, et al : Detection of Ureaplasma urealyticum in second-trimester amoniotic fluid by polymerase chain reaction correlates with subsequent preterm labor and delivery. J Infect Dis 187 : 518-521, 2003.
 
3) 斉藤滋 : 早産の予防 (2) 細菌性膣症 : わが国の現状と対策. 母子保健情報 61 : 12-16, 2010.
 
4) Cunningham FG, et al : Preterm Birth. In : Williams Obstetrics 23rd ed, p 804-831, McGraw-Hill, New York, 2010.
 
5) 西巻滋 : 周産期の炎症と未熟児特有疾患. 小児感染免疫 20 : 169-173, 2008.
 
6) Lencki SG, et al : Maternal and umbilical cord serum interleukin level in preterm labor with clinical chorioamnionitis. Am J Obstet Gynecol 170 : 1345-1351, 1994.
PubMed
7) Blanc WA : Pathology of the placenta, membranes and umbilical cord in bacterial, fungal, and viral infection in man. In : Perinatal Disease (ed by Naeye RL), p 67-132, Williams & Wilkins, Baltimore, 1981.
 
8) 中山雅弘 : 胎盤胎児面の観察とその異常. 目でみる胎盤病理, p 19-33, 医学書院, 2002.
 
9) Kim KW, et al : A rapid matrix metalloproteinase-8 bedside test for the detection of intra amniotic inflammation in women with preterm premature rupture of membranes. Am J Obstet Gynecol 197 : 292. e1-5, 2007.
 
10) Yoneda S, et al : Interleukin-8 and glucose in amoniotic fluid, fetal fibronectin in vaginalsecretions and preterm labor index based on clinical variables are optimal predictive maekers for preterm deliverly in atients with intact membranes. J Obstet Gynecol Res 33 : 38-44, 2007.
 
11) Goldenberg RL, et al : Vaginal fibronectin measurements from 8 to 2 2 week's gestation and subsequent spontaneous preterm birth. Am J Obstet Gynecol 183 : 469-475, 2000.
 
12) 岡井崇ほか : 周産期委員会報告. 日産婦会誌 61 : 1543-1557, 2009.
 
13) 細菌性腟症. 性感染症 診断・治療ガイドライン 2008年度版, p77-80, 日本性感染症学会, 2008.
 
14) Roberts D, Dalziel SR : Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 19 : CD004454, 2006.
 

VII 性感染症

P.459 掲載の参考文献
1) Holmes KK et al : Introduction and overview. In : Sexually Transmitted Diseases (ed by Holmes KK, et al), 4th ed, p xvii-xxv, The McGraw-Hill Companies, New York, 2008.
 
2) 日本性感染症学会 : 性感染症診断・治療ガイドライン 2011. 日性感染症会誌 22 (Suppl 1) : 47-115, 2011.
 
3) 厚生労働省エイズ動向委員会 : 平成23 (2011) 年エイズ発生動向-概要-. [http://api-net.jfap.or.jp/status/2011/11nenpo/h23gaiyo.pdf]
 
4) 岡部信彦, 多田有希 : 感染症発生動向調査から見たわが国の性感染症の動向. 厚生労働科学研究費助成金新型インフルエンザ等新興・再興感染症研究事業性感染症に関する予防, 治療の体系化に関する研究 (H21-新興-一般-001) 平成21年度-平成23年度総合研究報告書, p23-56, 2012.
 
P.465 掲載の参考文献
1) 熊本悦明. 橋爪壯 : クラミジア感染症の基礎と臨床, 金原出版, 1988.
 
2) 岡部信彦, 多田有希, 小野寺昭一 : 感染症発生動向調査から見たわが国の性感染症の動向. 「性感染症に関する予防, 治療の体系化に関する研究」平成23年度総括研究報告書, p21-46, 2012.
 
3) Workowski KA, Berman S ; Centers for Disease Control and Prevention (CDC) : Sexually transmitted diseases treatment guidelines, 2010, chlamydial infections. MMWR Recomm Rep 59 (RR-12) : 44-49, 2010.
 
4) 新村眞人ほか : 性感染症診断・治療ガイドライン 2011, 第2部クラミジア感染症. 日性感染症会誌 22 (1 Suppl) : 60-64, 2011.
 
5) 松田静治ほか : Transcription-mediated Amplification法を用いたRNA増幅によるChlamydia trachomatisおよびNeisseria gonorrhoeaeの同時検出 産婦人科および泌尿器科における臨床評価. 日性感染症会誌 15 (1) : 116-126, 2004.
 
6) Lau CY, Qureshi AK : Azithromycin versus doxycycline for genital chlamydial infections : a meta-analysis of randomized clinical trials. Sex Transm Dis 29 (9) : 497-502, 2002.
PubMed
P.468 掲載の参考文献
1) 非クラミジア性非淋菌性尿道炎, 性感染症診断・治療ガイドライン 2008. 日性感染症会誌 19 : 89-91, 2008.
 
2) Takahashi S, et al : Clinical efficacy of azithromycin for male nongonococcal urethritis. J Infect Chemother 14 : 409-412, 2008.
PubMed
3) Takahashi S, et al : Clinical efficacy of levofioxacin 500 mg once daily for 7 days for patients with non -gonococcal urethritis. J Infect Chemother 17 : 392-396, 2011.
 
4) 熊本悦明ほか : 日本における性感染症サーベイランス2002年度調査報告. 日性感染症会誌 15 : 17-45, 2004.
 
5) Takahashi S, et al : Analysis of clinical manifestations of male patients with urethritis. J Infect Chemother 12 : 283-286, 2006.
PubMed
6) Ito S, et al : Prevalence of genital mycoplasmas and ureaplasmas in men younger than 40 years-of-age with acute epididymitis. Int J Urol 19 : 234-238, 2012.
 
7) 濱砂良一 : Mycoplasma genitaliumが検出された急性精巣上体炎の1例, 日性感染症会誌 19 : 89-92, 2008.
 
8) Yasuda M, et al : In vitro activity of fluoroquinolones against Mycoplasma genitalium and their bacteriological efficacy for treatment of M. genitalium-positive nongonococcal urethritis in men. Clin Infect Dis 41 : 1357-1359, 2005.
PubMed
9) Hamasuna R, et al : Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR. Antimicrob Agents Chemother 53 : 4938-4939, 2009.
PubMed
10) Jensen JS, et al : Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin Infect Dis 47 : 1546-1553, 2008.
PubMed
11) Hamasuna R, et al : Effect of gatifloxacin against Mycoplasma genitalium-related urethritis : an open clinical trial. Sex Transm Infect 87 : 389-390, 2011.
PubMed
12) Jernberg E, et al : Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection : an open study. Int J STD AIDS 19 : 676-679, 2008.
 
13) Bebear CM, et al : Activity of moxifloxacin against the urogenital mycoplasmas Ureaplasma spp., Mycoplasma hominis and Mycoplasma genitalium and Chlamydia trachomatis. Clin Microbiol Infect 14 : 801-805, 2008.
PubMed
14) Ito S, et al : Clinical and microbiological outcomes in treatment of men with non-gonococcal urethritis with a 100-mg twice-daily dose regimen of sitafloxacin. J Infect Chemother 18 : 414-418, 2012.
PubMed
P.475 掲載の参考文献
1) 厚生労働省 : 性感染症の発生動向調査 2010.
 
2) Kawana T, et al : Clinical and virologic studies on female genital herpes. Obstet Gynecol 60 : 456-461, 1982.
PubMed
3) 性器ヘルペス. 性感染症 診断・治療ガイドライン 2011. 日性感染症会誌 22 (Suppl) : 65-69, 2011.
 
4) Workowski KA, Berman S ; CDC : Sexually transmitted diseases treatment Guidelines, 2010. MMWR Recomm Rep 59 (RR-12) : 1-110, 2010.
 
5) 川名尚ほか : LAMP法に簡易核酸抽出法 (PURE法) を組み合わせたPURE-LAMP法による単純ヘルペスウイルスの簡易迅速検出法の臨床評価. 産婦人科の実際 61 : 119-125, 2012.
 
6) 西澤美香ほか : 女性性器の単純ヘルペスウイルス初感染における型特異的血清診断に関する研究. 日性感染症会誌 16 : 97-103, 2005.
 
7) Rand KH, et al : Daily stress and recurrence of genital herpes simplex. Arch Intern Med 150 : 1889-1893, 1990.
PubMed
8) Patel R, et al : Valaciclovir for the suppression of recurrent genital HSV infection : a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group. Genitourin Med 73 : 105-109, 1997.
 
9) Corey L, et al : Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 350 : 11-20, 2004.
PubMed
10) 川名尚ほか : バラシクロビル塩酸塩 (バルトレックス(R) 錠500・バルトレックス(R) 顆粒50%) による性器ヘルペス再発抑制療法に関する特定使用成績調査結果報告. 日性感染症会誌 23 : 108-118, 2012.
 
11) Romanowski B, et al : Patients' preference of valacyclovir once-daily suppressive therapy versus twice-daily episodic therapy for recurrent genital herpes : a randomized study. Sex Transm Dis 30 : 226-231, 2003.
PubMed
12) Handsfield HH, et al : Suppressive therapy with valacyclovir in early genital herpes : a pilot study of clinical efflcacy and herpes-related quality of life. Sex Transm Dis 34 : 339-343, 2007.
PubMed
13) Mark KE, et al : Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults. J Infect Dis 198 : 1141-1149, 2008.
PubMed
14) Stanberry LR, et al : Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 347 : 1652-1661, 2002.
PubMed
15) Belshe RB, et al : Efficacy results of a trial of a herpes simplex vaccine. N Engl J Med 366 : 34-43, 2012.
PubMed
P.480 掲載の参考文献
1) de Villiers EM, et al : Classification of papillomaviruses. Virology 324 : 17-27, 2004.
PubMed
2) Wade TR, et al : Bowenoid papulosis of the genitalia. Arch Dermatol 115 : 306-308, 1979.
PubMed
3) 中川秀己 : 尖圭コンジローマ. 日性感染症会誌 20 : 41-44, 2009.
 
4) 小坂 (橋戸) 円, 岡部信彦 : 発生動向調査からみた性感染症の最近の動向. 日性感染症会誌 17 : 90-98, 2006.
 
5) Shafti-Keramat S, et al : Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses. J Virol 77 : 13125-13135, 2003.
PubMed
6) Ishiji T : Molecular mechanism of carcinogenesis by human papillomavirus-16. J Dermatol 27 : 73-86, 2000.
PubMed
7) DeVillez RL, et al : Bowenoid papules of the genitalia : a case progressing to Bowen's disease. J Am Acad Dermatol 3 : 149-152, 1980.
 
8) 広瀬崇興ほか : 尖圭コンジローマ. 日性感染症会誌 22 : 70-73, 2009.
 
9) Paavonen J, et al : Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women : an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 369 : 2161-2170, 2007.
PubMed
10) Villa LL et al : Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women : a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 6 : 271-278, 2005.
PubMed
P.486 掲載の参考文献
1) CDC : Sexually Transmitted DiseaseTreatment Guideline 2010. MMWR 59 : 61-62, 2010.
 
2) 小野文武, 安元慎一郎 : 性器カンジダ症. 臨床と研究 84 : 49-52, 2007.
 
3) 保田仁介 : 性器カンジダ症. 臨床と研究 80 : 45-48, 2003.
 
4) Mylonas I, Bergauer F : Diagnosis of vaginal discharge by wet mount microscopy : a simple and underrated method. Obstet Gynecol Surv 66 : 359-368, 2011.
PubMed
5) 日本性感染症学会 (編) : 性感染症診断・治療ガイドライン 2011, 帯下. 日性感染症会誌 22 : 30-32, 2011.
 
6) 日本性感染症学会 (編) : 性感染症診断・治療ガイドライン 2011, 性器カンジダ症. 日性感染症会誌 22 : 87-91, 2011.
 
7) 日本産科婦人科学会/日本産婦人科医会 (編) : カンジダ外陰腟炎の診断と治療は? 産婦人科診療ガイドライン婦人科外来編 2011, p12-14. 2011.
 
8) 吉村和晃 : 外陰腟炎. 女性性器感染症 (岩破一博編), p73-87, 医薬ジャーナル社, 2012.
 
9) Andes D : Antifungal pharmacokinetics and pharmacodynamics : understanding the implications for antifungal drug resistance, Drug Resist Updat 7 : 185-194, 2004.
PubMed
P.490 掲載の参考文献
1) WHO : Prevalence and incidence of selected sexually transmitted infections, 2011.
 
2) Sweet RL, et al : Infectious Disease of the Female Genital tract, 5th ed, p 196-199, Lippincott Williams & Wilkins, 2009.
 
3) Ginocchio CC, et al : Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay. J Clin Microbiol 50 : 2601-2608, 2012.
PubMed
4) Cudmore SL, Garber GE : Prevention or treatment : The benefits of Trichomonasvaginalis vaccine. J Infect Public Health 3 (2) : 47-53, 2010.
 
5) Lara-Torre E, Pinkerton JS : Accuracy of detection of Trichomonas vaginalis organisms on a liquid-based Papanicolaou smear, Am J Obstet Gynecol 188 (2) : 354-356, 2003.
PubMed
6) CDC : 2010 STD Treatment guidelines, p 58-61. [www.cdc.gov/std/treatment/2010/default]
 
7) 日本性感染症学会 : 腟トリコモナス症. 性感染症 診断・治療ガイドライン 2008. 日性感染症会誌 19 (1) : 74-76, 2008.
 
8) Klebanoff MA, et al : Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas Vaginalis infection, N Engl J Med 345 (7) : 487-490, 2001.
PubMed
9) Caro-Paton T, et al : Is metronidazole teratogenic? A meta-analysis. Br J Clin Pharmacol 44 : 179-182, 1997.
PubMed
10) Kissinger P, et al : A randomized treatment trial : single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women. J Acquir Immune Defic Syndr 55 : 565-571, 2010.
PubMed
11) Buve A, et al : The epidemiology of trichomoniasis in women in four African cities. AIDS 15 (Suppl 4) : S89-96, 2001.
 
12) Van Der PB, et al : Use of an adaptation of a commercially available PCR assay aimed at diagnosis of chlamydia and gonorrhea to detect Trichomonas vaginalis in urogenital specimens. J Clin Microbiol 44 : 366-373, 2006.
 
13) 日本産科婦人科学会, 日本産婦人科医会 (編) : 産婦人科診療ガイドライン : 婦人科外来編 2011, p10-11, 2011.
 
P.494 掲載の参考文献
1) 厚生省大臣官房統計情報部編 : 伝染病統計 平成10年・11年 (1-3月), p112-123.
 
2) Ronald AR, Albritton W : Chancroid and Haemophilus ducreyi. In : Sexually Transmitted Diseases, 3rd ed (ed by Holmes KK, et al), p 515-523, McGraw-Hill, New York, 1999.
 
3) Ballard RC, Morse SA : Chancroid. In : Atlas of Sexually Transmitted Diseases and AIDS, 3rd ed (ed by Morse SA, et al), p 53-71, Mosby, New York, 2003.
 
4) Mertz KJ, et al : An investigation of genital ulcers in Jackson, Mississippi, with use of a multiplex polymerase chain reaction assay : high prevalence of chancroid and human immunodeficiency virus infection. J Infect Dis 178 : 1060-1066, 1998.
PubMed
5) Blackmore CA, et al : An outbreak of chancroid in Orange County, California : descriptive epidemiology and disease-control measures. J Infect Dis 151 : 840-844, 1985.
 
6) Morse SA : Chancroid and Haemophilus ducreyi. Clin Microbiol Rev 2 : 137-157, 1989.
PubMed
7) DiCarlo RP, et al : Chancroid epidemiology in New Orleans men. J Infect Dis 172 : 446-452, 1995.
 
8) Anderson RM : Transmission dynamics of STD. In : Sexually Transmitted Diseases, 3rd ed (ed by Holmes KK, et al), p 25-38, McGraw-Hill, New York, 1999.
 
9) Kreiss JK, et al : Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes. J Infect Dis 160 : 380-384, 1989.
PubMed
10) Spinola SM, et al : Haemophilus ducreyi elicits a cutaneous infiltrate of CD4 cell during experimental human infection. J Infect Dis 173 : 394-402, 1996.
PubMed
11) 小島弘敬 : Haemophilus ducreyiを分離培養した軟性下疳症例. 日性感染症誌 9 : 76-77, 1998.
 
12) Orle KA, et al : Simultaneous PCR detection of Haemophilus ducreyi, Treponema pallidum, and herepes simplex virus types 1 and 2 from genital ulcers. J Clin Microbiol 34 : 49-54, 1996.
 
13) Dangor Y, et al : Transport medium for Haemophilus ducreyi. Sex Transm Dis 20 : 5-9, 1993.
PubMed
14) Morse SA, et al : Comparison of clinical diagnosis, standard laboratory and molecular methods for the diagnosis of genital ulcer disease in Lesotho : association with HIV infection. J Infect Dis 175 : 583-589, 1997.
PubMed
15) Ronald A : Genital ulceration and clinical acumen. Clin Infect Dis 25 : 299-300, 1997.
PubMed
16) Willcox RR : The treatment of chancroid. Br J Clin Pract 17 : 455-460, 1963.
PubMed
17) Hammond GW, et al : Antimicrobial susceptibility of Haemophilus ducreyi. Antimicrob Ag Chemother 13 : 608-612, 1978.
 
18) Marmar JL : The management of resistant chancroid in Viet Nam. J Urol 107 : 807-808, 1972.
PubMed
19) Malonza IM, et al : A randomized, double blind, placebo-controlled trial of single-dose ciprofloxacin versus erythromycin for the treatment of chancroid in Nairobi, Kenya. J Infect Dis 180 : 1886-1893, 1999.
 
20) Sexually transmitted diseases treatment guidelines 2002. Centres for Disease Control and Prevention. MMWR Recomm Rep 51 (RR-6) : 1-78, 2002.
PubMed

VIII 皮膚軟部組織感染症

P.503 掲載の参考文献
1) Leyden JJ, et al : Skin microflora. J Invest Dermatol 88 : 65-72, 1987.
 
2) 下江敬生, 荒田次郎 : 皮膚科領域細菌感染症. 化学療法の領域 9 : 2171-2176, 1993.
 
3) 西嶋攝子ほか : 皮膚感染病巣から分離された溶血性連鎖球菌について (1994年-1997年). 日皮会誌 108 : 947-952, 1998.
 
4) Melish ME, Glasgow LA : The staphylococcal scalded skin syndrolne : Development of an experimental model. N Engl J Med 282 : 1114-1119, 1970.
 
5) 伊藤輝代ほか : 市中感染型MRSAの遺伝子構造と診断 (最新の知見). 感染症誌 78 : 459-469, 2004.
 
6) 中澤晶子 : グラム陰性好気性桿菌および球菌. エッセンシャル微生物学 (内海爽ほか編), 第4版, p350-352, 医歯薬出版, 1995.
 
7) 藤本和久 : 皮膚感染症. 抗菌薬臨床ハンドブック (渡辺彰編), p242-251, ヴァンメディカル, 2006.
 
8) 島田馨ほか : 皮膚科における抗生剤の外用の問題. 皮膚病診療 14 : 161-171, 1992.
 
9) 多田釀治ほか : 抗細菌外用薬. アレルギー免疫 7 : 80-87, 2000.
 
10) Koning S, et al : Fusidic acid cream in the treatment of impetigo in general practice : double blind randomised placebo controlled trial. BMJ 324 : 203 -206, 2002.
 
11) 藤本和久 : 細菌による皮膚の病気. 皮膚科・学校保健マニュアル (山本一哉, 本田光芳編), p108-118, 診断と治療社, 1994.
 
12) Stanley JR, Amagai M : Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. N Engl J Med 355 : 1800-1810, 2006.
PubMed
13) 佐瀬裕ほか : 伝染性膿痂疹から分離された黄色ブドウ球菌のコアグラーゼ型と薬剤感受性について. 臨床皮膚科 48 : 973-976, 1994.
 
14) 加藤千草ほか : MRSAによる伝染性膿痂疹の臨床的, 細菌学的, 分子疫学的検討. 臨床皮膚科 52 (増) : 14-17, 1998.
 
15) 日野治子 : 乳児多発性汗腺膿瘍. 皮膚病診療 19 : 607-608, 1997.
 
P.509 掲載の参考文献
1) 多田譲治 : 皮膚MRSA感染対策. Medicina 40 : 968-972, 2003.
 
2) 渡辺晋一 : 皮膚科領域細菌感染症の治療法-特にMRSA対策-. 日皮会誌 120 : 5-9, 2010.
 
3) 荒島康友 : パスツレラ症. 臨床と微生物 30 : 385-389, 2003.
Medical*Online
4) 古城八寿子 : Vibrio vulnificus感染症. 綜合臨床 50 : 526-531, 2001.
 
5) 三鴨廣繁ほか : 壊死性筋膜炎. JAID/JSC感染症ガイド 2011 (JAID/JSC感染症治療ガイド委員会編), p143-147, ライフサイエンス出版, 2012.
 
P.513 掲載の参考文献
1) 馬場直子 : 小児の膿皮症. MB Derma 127 : 1-8, 2007.
 
2) Melish ME, Glasgow LA : The staphylococcal scalded-skin syndrome. N Engl J Med 282 : 1114-1119, 1970.
PubMed
3) 山崎肇ほか : 過去10年間に当科で経験したブドウ球菌性熱傷様皮膚症候群 (SSSS) 21例の臨床的検討. 鶴岡庄内病院医誌 10 : 37-44, 1998.
 
4) 山口由衣ほか : MRSAによるブドウ球菌性熱傷様皮膚症候群 (SSSS) の1例. 皮膚科の臨床 45 : 535-539, 2003.
 
5) 池田政身 : ブドウ球菌性熱傷様皮膚症候群 : SSSSはこどもだけ? おとなはならないの? Visual Dermatology 12 : 32-33, 2013.
 
6) Mockenhaupt M, et al : Epidemiology of staphylococcal scalded skin syndrome in Germany. J Invest Dermatol 124 : 700-703, 2005.
 
7) 天谷雅行 : ブドウ球菌性熱傷様皮膚症候群 : SSSS. 小児科診療 67 : 391-395, 2004.
Medical*Online
8) 山口哲央 : 院内感染型MRSAと市中感染型MRSA. Medical Technology 39 : 540-545, 2011.
Medical*Online
9) Cribier B, et al : Staphylococcal scalded skin syndrome in adults. J Am Acad Dermatol 30 : 319-324, 1994.
PubMed
10) 池田政身ほか : 成人ブドウ球菌性熱傷様皮膚症候群. 化学療法の領域 5 : 1264-1270, 1989.
 
11) 佐藤英里ほか : ブドウ球菌性熱傷様皮膚症候群 (SSSS) -5年間26例についての起因菌に関する臨床的検討-. 日小皮会誌 29 : 25-29, 2010.
 
12) 金子栄ほか : 当科における1996-2002年のブドウ球菌性熱傷様皮膚症候群 (SSSS) の入院患者の動向. 臨床皮膚科 58 : 508-511, 2004.
 
13) 池田政身 : SSSS. 小児科臨床ピクシス 17, 年代別子どもの皮膚疾患 (五十嵐隆, 馬場直子編), p170-171, 中山書店, 2010.
 
14) Patel GK, Finlay AY : Staphylococcal scalded skin syndrome, Diagnosis and management. Am J Clin Dermatol 4 : 165-175, 2003.
PubMed
P.517 掲載の参考文献
1) Todd J, et al : Toxic-shock syndrome associated with phage-group-1 staphylococci. Lancet 2 : 1116-1118, 1978.
 
2) Hajjeh RA, et al : Toxic shock syndrome in the United States : surveillance update, 1979-1996. Emerg Infect Dis 5 : 807-810, 1999.
PubMed
3) 春木宏介 : Toxic shock syndromeの臨床. 東京女子医科大学雑誌 62 : 330-336, 1991.
 
4) White J, et al : The Vβ-specific superantigen staphylococcal enterotoxin B : stimulation of mature T cells and clonal deletion in neonatal mice. Cell 56 : 27-35, 1989.
 
5) 内山竹彦 : 微生物由来スーパー抗原と感染症の発症. 科学と生物 39 : 434-439, 2001.
 
6) Shiseki M, et al : Comparison of pathogenic factors expressed by a group A streptococci isolated from patients with Streptococcal toxic syndrome and scarlet fever. Microb Pathog 27 : 243-252, 1999.
 
7) MacPhee RA, et al : Influence of the vaginal microbiota on toxic shock syndrome toxin 1 production by Staphylococcus aureus. Appl Environ Microbiol 79 : 1835-1842, 2013.
PubMed
8) Parsonnet J, et al : Prevalence of toxic shock syndrome toxin 1 (TSST-1) -producing strains of Staphylococcus aureus and antibody to TSST-1 among healthy Japanese women. J Clin Microbiol 46 : 2731-2738, 2008.
PubMed
9) Matsuda Y, et al : Early and definitive diagnosis of toxic shock syndrome by detection of marked expansion of T-cell receptor Vβ2-positive T cells. Emerg Infect Dis 9 : 387-389, 2003.
 
10) Andrews MM, et al : Recurrent nonmenstral toxic shock syndrome : clinical manifestations, diagnosis, and treatment. Clin Infect Dis 32 : 1470-1479, 2001.
PubMed
11) 中江孝ほか : Toxic shock syndrome Toxin-1 (TSST-1) に対するヒト免疫グロブリン製剤による中和作用について. 感染症誌 76 : 195-202, 2002.
 
P.522 掲載の参考文献
1) Steer AC, et al : Invasive group a streptococcal disease : epidemiology, pathogenesis and management. Drugs 72 : 1213-1227, 2012.
 
2) 大国寿士 : ヒト喰いバクテリア劇症型A群レンサ球菌感染症. Journal of Nippon Medical School 67 : 371-374, 2000.
 
3) Johansson L, et al : Getting under the skin : the immunopathogenesis of Streptococcus pyogenes deep tissue infections. Clin Infect Dis 51 : 58-65, 2010.
PubMed
4) 印出佑介ほか : B群レンサ球菌 (GBS). 周産期医学 41 : 235-244, 2011.
Medical*Online
5) Holm SE, et al : Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. J Infect Dis 166 : 31-37, 1992.
PubMed
6) 渡邉治雄 : 病原細菌の病原性遺伝子群の発現調節と病因に関する研究. 日細菌誌 66 : 1-5, 2011.
Medical*Online
7) Cole JN, et al : Molecular insight into invasive group A streptococcal disease. Nat Rev Microbiol 16 : 724-736, 2011.
 
8) 館正弘 : 壊死性筋膜炎. 形成外科 55 : 293-299, 2012.
 
9) Defining the group A streptococcal toxic shock syndrome : rationale and consensus definition. The Working Group on Severe Streptococcal Infections. JAMA 269 : 390-391, 1993.
 
10) 前田拓ほか : 壊死性筋膜炎の評価LRINEC scoreおよび予測死亡率評価ツールを用いて. 日形会誌 32 : 63-68, 2012.
 
11) Bilton BD, et al : Aggressive surgical management of necrotizing fasciitis serves to decrease mortality : a retrospective study. Am Surg 64 : 397 -400, 1998.
 
12) Zimbelman J, et al : Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J 18 : 1096-1100, 1999.
PubMed
13) Kaul R, et al : Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome : a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis 28 : 800-807, 1999.
 
14) Darenberg J, et al : Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome : a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis 37 : 333-340, 2003.
PubMed
P.526 掲載の参考文献
1) DiNubile MJ, Lipsky BA : Complicated infections of skin and skin structures : when the infections is more than skin deep. J Antimicrob Chemother 53 (Suppl 2) : ii37-50, 2004.
 
2) 井上治ほか : 文献紹介 (ガス壊疽及び壊死性筋膜炎) Clostridium性ガス壊疽, 壊死性筋膜炎, Fournier壊疽など致死性軟部感染症に対する高気圧酸素療法 (HBO) -国内外の主要な文献から. 日高気圧環境・潜水医会誌 45 : 49 -66, 2010.
 
3) Qvist G : Anaerobic cellulitis and gas gangrene. Br Med J 2 : 217, 1941.
PubMed
4) 青木眞 : 皮膚・軟部組織感染症 深部で急速に進展する病変 (皮下組織, 筋膜の感染症). レジデントのための感染症診療マニュアル, 第2版, p781-790, 医学書院, 2012.
 
5) 森永伊昭ほか : 非クロストリジウム性ガス壊疽-自験25例と報告例の検討-. 日骨関節感染研会誌 12 : 12-16, 1998.
 
6) Stevens DL Baddour LM : Necrotizing soft tissue infections Up To Date. Official reprint from UpToDate(R) www.uptodate.com 2013 This topic last updated : 228, 2013.
 
7) Active Bacterial Core Surveillance Team ; O'Loughlin RE : The epidemiology of invasive group A streptococcal infection and potential vaccine implications : United States, 2000-2004. Clin Infect Dis 45 : 853-862, 2007.
 
8) 西洋一郎ほか : 非クロストリジウム性ガス壊疽の4例. 整形外科 58 : 685-688, 2007.
 
9) 前田仁ほか : 糖尿病患者に合併した非クロストリジウム性ガス壊疽の1例. 日骨関節感染研会誌 10 : 61-63, 1996.
 
10) Powell MJ, et al : Metastatic Gas gangrene and Colonic Perforation : a case report. World J Emerg Surg 3 : 15, 2008.
PubMed
P.530 掲載の参考文献
1) 黒川一郎. 西嶋攝子 : 別冊日本臨牀 感染症症候群 (I), p576-578, 日本臨牀社, 1999.
 
2) Gunderson CG : Cellulitis : definition. etiology, and clinical features. Am J Med 124 : 1113-1122. 2011,
PubMed
3) 黒川一郎. 芝岡美枝 : 壊死性筋膜炎の診断-壊死性筋膜炎と蜂巣炎との鑑別. Visual Dermatology 12 : 229-231, 2013.
 
4) 蜂巣炎. 丹毒. JAID/JSC感染症治療ガイド 2011. p 139-141, ライフサイエンス出版, 2012.
 
5) 渡辺晋一 : 皮膚・軟部組織感染症の治療. 化学療法の領域 27 : 2271-2278, 2011.
 
6) 渡辺晋一 : 皮膚科領域細菌感染症の治療法. 日皮会誌 120 : 5-9, 2010.
 
P.535 掲載の参考文献
1) 松田保秀 : 痔核・肛門周囲膿瘍・痔瘻. 救急医学 21 : 205-215, 1997.
 
2) 松田保秀ほか ; 直腸肛門周囲膿瘍と痔瘻-分類と治療. 外科治療 105 : 37-50, 2011.
Medical*Online
3) 栗原浩幸ほか : 痔瘻の新分類-後方複雑痔瘻および低位筋間痔瘻を明確化した痔瘻分類. 日本大腸肛門病会誌 61 : 467-475, 2008.
 
4) 辻順行, 家田浩男 : 肛門疾患治療の裏技, 秘伝, 奥義 III. 痔瘻 1. 痔瘻に対する肛門超音波検査. 外科 73 : 942-947, 2011.
 
5) 松田保秀, 岩垂純一 : 壊疽性筋膜炎. 実地医家のための肛門疾患診療プラクティス. 改訂第2版, p186-189, 永井書店, 2007.
 
6) 二見太郎ほか : Crohn病に伴う痔瘻の治療. 消化器外科 34 : 343 -351, 2011.
 
7) 矢野孝明ほか : 低位筋間型肛門周囲膿瘍に対する切開排膿に関して. 日本大腸肛門病会誌 63 : 415-418, 2010.
 
8) 下島裕寛ほか : 肛門周囲膿瘍 肛門・直腸周囲膿瘍の治療. 臨床外科 66 : 1464-1470, 2011.
 
P.540 掲載の参考文献
1) Gianotti F : Rilievi di una particolare casistica tossinfettiva caratterizzata daeruzione eritemato-infiltrativa desquamativa a focolai lenticolari, a sede elettiva acroesposta. G Ital Dermatol 98 : 678-697, 1955.
 
2) Crosti A. Gianotti F : Dermatose eruptive acro-situee d' origine probablement virosique. Acta Dermatol Venereol 2 : 146-149, 1957.
 
3) De Gasperi G, et al : Au antigen in Crosti-Gianotti acrodermatitis. Lancet 1 : 1116-1117, 1970.
 
4) Gianotti F : The Australia antigen in infantile popular acrodermatitis. Proceedings of the 6th Meeting of the European Association for the study of the Liver, 2-4 September, London, communication 16, 1970.
 
5) Gianotti F : Papular acrodermatitis of childhood. An Australia antigen disease. Arch Dis Child 48 : 794-799, 1973.
PubMed
6) Gianotti F : Papular acrodermatitis of childhood and other papulovesicular acrolocated syndrome. Br J Dermatol 100 : 49-59, 1979.
PubMed
7) Caputo R, et al : Gianotti-Crosti syndrome : a retrospective analysis of 308 cases. J Am Acad Dermatol 26 : 207-210, 1992.
 
8) Ishimaru Y, et al : An epidemic of infantile papular acrodermatitis (Gianotti's disease) in Japan associated with hepatitis-B surface antigen subtype ayw. Lancet 1 : 707-709, 1976.
 
9) Colombo M, et al : Immune response to hepatitis B virus in children with papular acrodermatitis. Gastroenterology 73 : 1103-1106, 1977.
PubMed
10) Toda G, et al : Infantile papular acrodermatitis (Gianoti's disease) and intrafamilial occurence of acute hepatitis B with jaundice : age dependency of clinical manifestations of hepatitis B virus infection. J Infec Dis 138 : 211-216, 1978.
 
11) Claudy AL, et al : Papular acrodermatitis associated with hepatitis B virus infection. Arch Dermatol 115 : 931, 1979.
PubMed
12) Schneider JA, et al : Papular acrodermatitis (Gianotti-Crosti syndrome) in a child with anicteric hepatitis B, virus subtype adw. J Pediatr 101 : 219-222, 1982.
 
13) 石丸啓郎, 中野博子 : HBV感染症の皮疹 (いわゆるGianotti病) について. 感染・炎症・免疫 13 : 162-173, 1983.
 
14) Sungnack L, et al : Gianotti-Crosti syndrome associated with hepatitis B surface antigen (subtype adr). J Am Acad Dermatol 12 : 629-633, 1985.
 
15) Colombo M, et al : Acute hepatitis B in children with papular acrodermatitis. Pediatr Pathol 6 : 249-257, 1986.
PubMed
16) 森嶋隆文ほか : Gianotti-Crosti症候群. 皮膚科の臨床 35 : 571-579, 1993.
 
17) 新妻宏文ほか : 妊娠中感染したGianotti-Crosti症候群合併急性B型肝炎の1例-感染前からの経過-. 日消誌 96 : 423-426, 1999.
Medical*Online
18) Michitaka K, et al : Gianotti-Crosti syndrome caused by acute hepatitis B virus genotype D infection. Intern Med 43 : 696-699, 2004.
PubMed
19) 吉川陽子ほか : 全塩基配列の決定によりHBVの父子感染が証明されたGianotti病の1例. 小児科臨床 60 : 433-437, 2007.
Medical*Online
20) Pise GA, et al : Gianotti-Crosti syndrome associated with transfusion acquired hepatitis B virus infection in a patient of sickle cell anemia. Indian J Dermatol Venereol Leprol 73 : 123-124, 2007.
 
21) 森嶋智津子 : B型肝炎ウイルス. Gianotti病, こどもの発疹のみかた (日野治子編), 第3版, p125-134, 中外医学社, 2009.
 
22) 本間友一ほか : 成人発症のB型肝炎ウイルスに関連したGianotti-Crosti症候群の1例. 肝臓 51 (11) : 615-619, 2010.
 
23) Iorizzo LJ, et al : Gianotti-Crosti syndrome : a case report in adult. Cutis 89 : 169-172, 2012.
PubMed
24) 藤澤知雄 : Gianotti-Crosti症候群. 小児内科 42 : 185-188, 2010.
Medical*Online
25) 田尻仁 : 小児B型肝炎診療指針と日常診療. 小児感染免疫 21 : 130-136, 2009.
 
26) 加藤英行ほか : EBウイルス感染によるGianotti-Crosti症候群. 皮膚科の臨床 35 : 423-426, 1993.
 
27) 丸山智恵 : サイトメガロウイルス感染症, Gianotti-Crosti症候群. こどもの発疹のみかた (日野治子編), 第3版, p110-124, 中外医学社, 2009.
 
28) 中村美智子ほか : EBV初感染とCMVの重複感染によるGianotti-Crosti症候群の1例. 日小皮会誌 31 : 35-38, 2012.
 
29) Chuh AAT, et al : A prospective case control study of the association of Gianotti-Crosti syndrome with human herpesvirus 6 and human herpesvirus 7 infections. Pediatr Dermatol 19 : 492-497, 2002.
 
30) Dauendorffer JN, et al : Gianotti-Crosti syndrome associated with herpes simplex virus type 1 gingivostomatitis. J Am Acad Dermatol 64 : 450-451, 2011.
PubMed
31) May J, et al : Gianotti-Crosti syndrome associated with type A influenza. Pediatr Dermatol 28 : 733-734, 2011.
PubMed
32) Kroeskop A, et al : Gianotti-Crosti syndrome after HlNl-influenza vaccine. Pediatr Dermatol 28 : 595-596, 2011.
 
33) Metelisa AI, et al : Recurrent Gianotti-Crosti syndrome. J Am Acad Dermatol 65 : 876-877, 2011.
 
34) Sigmon JR, et al : Gianotti-Crosti syndrome associated with hepatitis A and influenza vaccination. J Drugs Dermatol 11 : 260-261, 2012.
PubMed
35) Atanasovski M, et al : A case report of Gianotti-Crosti post vaccination with MMR and dTaP. Int J Dermatol 50 : 609-610, 2011.
PubMed
36) Retrouvey M, et al : Gianotti-Crosti syndrome after childhood vaccination. Pediatr Dermatol 29 666-668, 2012.
PubMed
37) Karakas M : Gianotti-Crosti syndrome in a child following hepatitis B virus vaccination. J Dermatol 34 : 117-120, 2007.
 
38) Taieb A, et al : Gianotti-Crosti syndrome : a study of 26 cases. Br J Dermatol 115 : 49-59, 1986.
PubMed
39) 日野治子 : Gianotti病およびGianotti症候群. 皮膚疾患最新の治療 2001-2002 (新村眞人・瀧川雅浩編), p 149. 南江堂, 2001.
 
40) Gelmetti CM : Gianotti-Crosti syndrome. In : Harper's Textbook of Pediatric Dermatology (ed by Irvine A, et al), 3rd ed, Chap 50, p 50.1-50.6, Blackwell Pub, 2011.
 
41) Brandt O, et al : Gianotti-Crosti syndrome. J Am Acad Dermatol 54 : 136-145, 2006.
PubMed
P.548 掲載の参考文献
1) 立花隆夫, 宮地良樹 : 褥瘡と感染症. 日本臨牀 65 (増刊号 3) : 495-499, 2007.
 
2) 立花隆夫 : 褥瘡と皮膚感染症. 感染症専門医テキスト 第1部解説編 (日本感染症学会編), p755-758, 南江堂, 2011.
 
3) 日本褥瘡学会 (編) : 褥瘡予防・管理ガイドライン (第3版), 褥瘡会誌 14 (2) : 165-226, 2012.
 
4) 日本皮膚科学会 (編) : 創傷・熱傷ガイドライン, p34-103, 金原出版, 2012.
 
5) 立花隆夫 : 消毒・洗浄は? 「ガイドラインを読む」褥瘡局所治療ガイドライン編 (宮地良樹, 真田弘美編), p241-248, メディカルレビュー社, 2007.
 
6) Schulz GS, et al : Wound bed preparation : a systemic approach to wound management. Wound Repair Regen 11 (Suppl 1) : S1-28, 2003.
 
7) 立花隆夫 : 褥瘡. MB Derma 202 : 47-56, 2013.
Medical*Online

IX 骨・関節感染症

P.554 掲載の参考文献
1) 川嶌眞人ほか : 化膿性骨髄炎に対する高気圧酸素療法. 日骨関節感染研会誌 17 : 41-45, 2003.
 
2) Waldvogel FA, et al : Osteomyelitis : a review of clinical features, therapeutic considerations and unusual aspects. N Engl J Med 282 : 198-206, 1970.
PubMed
3) Morrison WB, et al : Diagnosis of osteomyelitis. Utility of fat-suppressed contrast enhanced MR imaging. Radiology 189 : 251-257, 1993.
PubMed
4) Mackowiak PA, et al : Diagnostic value of sinus-tract cultures inchronic osteomyelitis : pharmacokinetic, pharmacodynamic and bioanalytical considerations. JAMA 239 : 2772-2775, 1978.
 
5) Landersdorfer CB, et al : Penetration of antibacterials into bone. Clin Pharmacokinet 48 : 89-124, 2009.
PubMed
6) Lew DP, Waldvogel FA : Current concepts osteomyelitis. N Engl J Med 336 : 999-1007, 1997.
 
7) Liu C, et al : Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 52 : 1-38, 2011,
 
8) 川嶌眞人 : 慢性化膿性骨髄炎に対する私の持続洗浄 (灌流) 療法. 骨・関節感染症 (伊丹康人, 猪狩忠編), p118-125, 金原出版, 1990.
 
9) 東計ほか : MRSA感染股関節にバンコマイシン含有セメントスペーサーを用いた二期的人工股関節置換術. 整形外科 51 : 605-609, 2000.
 
10) 金城聡ほか : バンコマイシン含有骨セメントビーズの使用経験. 整形外科と災害外科 45 : 774-777, 1996.
Medical*Online
11) Chang N, Mathes SJ : Comparison of the effect of bacterial inoculation in musculocutaneous and random-pattern flaps. Plast Reconstr Surg 70 : 1-10, 1982.
PubMed
12) 松下和彦, 別府諸兄 : 四肢再建に対する血管柄付き腓骨移植のコツ-a. 大腿再建を中心に. MB Orthop 12 : 8-16, 1999.
 
13) 大野博史, 安井夏生 : Bone transportによる下腿骨感染性偽関節に対する治療戦略. 関節外科 19 : 368 -375, 2000,
 
14) 大西啓靖 : Papineau法による治療. 手術 45 : 1075-1084, 1991.
 
15) 松下和彦, 松本浩 : 化膿性骨髄炎, 最新・感染症治療指針-2013年改訂版- (後藤元監), p 178-183, 医薬ジャーナル社, 2013.
 
P.561 掲載の参考文献
1) 小林大介, 薩摩真一 : 化膿性骨髄炎・化膿性関節炎. NEW MOOK整形外科 15 : 186-192, 2004.
 
2) 高村和幸 : 炎症性疾患-骨髄炎, 化膿性関節炎, 仙腸関節炎. 小児内科 41 : 1050-1055, 2009.
 
3) Hobo T : Zur pathogenese der akuten hamatogenen Osteomyelitis, mit BerUcksichtigung der Vitalfarbungsleher. Acuta Scolar Med Kito 4 : 1-29, 1921.
 
4) Herring JA : Infections of the musculoskeletal system. In : Tachdjian's Pediatric Orthopaedics, p2089-2155, Saunders, Philadelphia, 2008.
 
5) McAndrew PT, Clark C : MRI is best technique for imaging acute osteomyelitis. BMJ 316 : 147, 1998.
PubMed
6) Gallagher DJ, et al : Orthopedic manifestations of acute pediatric leukemia. Orthop Clin North Am 27 : 635-644, 1996.
PubMed
7) 森本典夫ほか : Microgeodic diseaseの5症例. 整形外科と災害外科 33 : 230-233, 1984.
 
8) Dalziel RE, Leitl S : Treatment of acute osteomyelitis in childhood. J Bone Joint Surg 64B : 218-223, 1982.
 
9) 高村和幸 : 小児骨関節感染症の薬物療法. 骨・関節・靱帯 15 : 533-542, 2002.
Medical*Online
P.565 掲載の参考文献
1) Mathews CJ, et al : Bacterial septic arthritis in adults. Lancet 375 (9717) : 846-855, 2010.
PubMed
2) Mathews CJ, Coakley G : Septic arthritis : current diagnostic and therapeutic algorithm. Curr Opin Rheumatol 20 : 457-462, 2008.
PubMed
3) Horowitz DL, et al : Approach to septic arthritis. Am Fam Physician 84 (6) : 653-660, 2011.
PubMed
4) 阿部哲士 : 化膿性関節炎の診断と治療. Bone Joint Nerve 2 (3) : 465-470, 2012.
Medical*Online
5) 阿部哲士 : 整形外科的感染症 化膿性関節炎. 整形外科専門医テキスト (長野昭ほか編), 1版, p287-291, 南江堂, 2010.
 
6) Paakkonen M, Peltola H : Management of a child with suspected acute septic arthritis. Arch Dis Child 97 : 287-292, 2012.
PubMed
7) Paakkonen M, et al : Pediatric septic hip with or without arthrotomy : retrospective analysis of 62 consecutive nonneonatal culture-positive cases, J Pediatr Orthop B 19 : 264-269, 2010.
PubMed
8) Peltola H, et al ; Osteomyelitis-Septic Arthritis (OM-SA) Study Group : Prospective randomized trial of 10 days versus 30 days of antimicrobial treatment, including short term course of parenteral therapy, for childhood septic arthritis. Clin Infect Dis 48 : 1201-1210, 2009.
 
9) Kocher MS, et al : A clinical practical guideline for treatment of septic arthritis in children : efficacy in improving process of care and effect on outcome of septic arthritis of the hip. J Bone Joint Surg Am 85-A : 994-999, 2003.
PubMed
10) Coakley G, et al : BSR & BHPR, BOA, RCGP and BSAC guidelines for management of the hot swollen joint in adults. Rheumatology 45 : 1039-1041, 2006.
PubMed
11) 鳥巣岳彦 : 化膿性関節炎. 整形外科 39 (5) : 803-811, 1988.
 
12) 松下和彦 : 整形外科感染症. 抗菌薬使用のガイドライン (日本感染症学会 日本化学療法学会編), 1版, p181-185, 協和企画, 2005.
 
P.568 掲載の参考文献
1) 日本整形外科学会診療ガイドライン委員会, 骨・関節術後感染予防ガイドライン策定委員会 : 骨・関節術後感染予防ガイドライン 12, 南江堂, 2006.
 
2) Mangram AJ, et al : Guideline for Prevention of surgical site infection. Infect Control Hosp Epidemiol 20 : 247-278, 1999.
 
3) Phillips CB, et al : Incidence rates of dislocation, pulmonary embolism, and deep infection during the first six months after elective total hip replacement. J Bone Joint Surg 85-A : 20-26, 2003.
PubMed
4) Wymenga AB, et al : Perioperative factors associated with septic arthritis after arthroplasty. Prospective multicenter study of 362 knee and 2,651 hip operations. Acta Orthop Scand 63 : 665-671, 1992.
PubMed
5) Poon PC, et al : Review of total hip replacement. The Middlemore Hospital experience, 1980-1991. N Z Med J 114 : 254 -256, 2001.
 
6) Petrie RS, et al : Metal-backed patellar component failure in total knee arthroplasty : apossible risk for late infection. Am J Orthop 27 : 172-176, 1998.
 
7) Bengtson S, et al : The infected knee arthroplasty, A 6-year follow-up of 357 cases. Acta Orthop Scand 62 : 301-311, 1991.
PubMed
8) Spangehl MJ, et al : Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg 81-A : 672-683, 1999.
PubMed
9) Stuart MJ, et al : Reoperation after condylar revision total knee arthroplasty. Clin Orthop 286 : 168-173, 1993.
PubMed
10) Ammon P, et al : Allograft bone in two-stage revision of the hip for infection : is safe? J Bone Joint Surg 86-B : 962-965, 2004.
 
11) Babcock HM, et al : Postarthroscopy surgical site infections : review of the literature. Clin Infect Dis 34 : 65-71, 2002.
PubMed
12) Tsukayama DT, et al : Infection after total hip arthroplasty : A study of the treatment of one hundred and six infections. J Bone Joint Surg 78-A : 512-523, 1996.
PubMed
13) Tsukayama DT, et al : Diagnosis and management of infection after total knee arthroplasty. J Bone Joint Surg 85-A : 75-80, 2003.
 
14) Fink B, et al : The value of synovial biopsy, joint aspiration and C-reactive protein in the diagnosis of late peri-prosthetic infection of total knee replacements. J Bone Joint Surg 90-B : 874-882, 2008.
 
15) Greidanus NV, et al : Use of erythrocyte sedimentation rate and C-reactive protein level to diagnose infection before revision total knee arthroplasty : A prospective evaluation. J Bone Joint Surg 89-A : 1409-1416, 2007.
 
16) Bottner F, et al : Interleukin-6, procalcitonin and TNF-α : markers of peri-prosthetic infection following total joint replacement. J Bone Joint Surg 89-B : 94-99, 2007.
 
17) Ghanem E, et al : Cell count and Differential of Aspirated Fluid in the Diagnosis of infection at the site of total knee arthroplasty. J Bone Joint Surg 90-A : 1637-1643, 2008.
PubMed
18) Feldman DS, et al : The role of intraoperative frozen section in revision total joint arthroplasty. J Bone Joint Surg 77-A : 1807-1813, 1995.
PubMed
19) Lonner JH, et al : The reliability of analysis of intraoperative frozen section for identifying active infection during revision hip or knee arthroplasty. J Bone Joint Surg 78 -A : 1553-1558, 1996.
PubMed
20) Levitsky KA, et al : Evaluation of the painful prosthetic joint. Relative value of bone scan, sedimentation rate, and joint aspiration. J Arthroplasty 6 : 237-244, 1991.
PubMed
21) Nagoya S, et al : Diagnosis of peri-prosthetic infection at the hip using triple-phase bone scintigrraphy. J Bone Joint Surg 90-B : 140-144, 2008.
 
22) Ryan PJ, et al : Leukoscan for orthopaedic imaging in clinical practice. Nucl Med Commun 23 : 707-714, 2002.
PubMed
23) Josefsson G, et al : Systemic antibiotics and gentamicin-containing bone cement in the prophylaxis of postoperative infections in total hip arthroplasty. Clin Orthop Relat Res 159 : 194-200, 1981.
PubMed
24) Chiu FY, et al : Cefuroxime-impregnated cement in primary total knee arthroplasty : a prospective, randomized study of three hundred and forty knees. J Bone Joint Surg 84-A : 759-762, 2002.
PubMed
25) 迫間巧将ほか : 人工関節置換術後感染の治療に使用したセメントビーズへ混入した抗菌剤の検討. 日人工関節学会誌 36 : 82-83, 2006.
 

X 眼感染症

P.578 掲載の参考文献
1) 松本治恵ほか : 多施設共同による細菌性結膜炎における検出菌動向調査. あたらしい眼科 24 : 647-654, 2007.
Medical*Online
2) 小野寺昭一 : 近年のわが国における性感染症の動向. モダンメディア 58 : 210-218, 2012.
 
3) 内尾英一 : 感染症サーベイランスと眼疾患. 日本の眼科 74 : 1027, 2003.
 
4) Uchio E, et al : An epidemic of acute haemorrhagic conjunctivitis caused by enterovirus 70 in Okinawa, Japan, in 1994. Grafes Arch Clin Exp Ophthalmol 237 : 568-572, 1999.
 
5) 石古博昭ほか : 急性出血性結膜炎を起こす2つのエンテロウイルスの迅速同定. あたらしい眼科 16 : 87-89, 1999.
Medical*Online
P.583 掲載の参考文献
1) Pepose JS, Wilhelmus KR : Divergent approaches to the management of corneal ulcers. Am J Ophthalmol 114 : 630-632, 1992.
 
2) Labetoulle M, et al : Incidence of herpes simplex virus keratitis in France. Ophthalmology 112 : 888-895, 2005.
PubMed
3) Ribaric V : The incidence of herpetic keratitis among population. Ophthalmologica 173 : 19-22, 1976.
 
4) Mortensen KK, Solie AK : Keratitis dendritica : an epidemiological investigation. Acta Ophthalmol (Copenh) 57 : 750-754, 1979.
 
5) Inoue Y, et al : Multicentre clinical study of the herpes simplex virus immunochromatographic assay kit for the diagnosis of herpetic epithelial keratitis. Br J Ophthalmol, 2012. [Epub ahead of print]
 
6) 感染性角膜炎全国サーベイランス・スタディグループ : 感染性角膜炎全国サーベイランス-分離菌・患者背景・治療の現状-. 日眼会誌 110 : 961-972, 2006.
 
7) 宇野敏彦ほか : 重症コンタクトレンズ関連角膜感染症全国調査. 日眼会誌 115 : 107-115, 2011.
 
8) 石橋康久, 本村幸子 : アカントアメーバ角膜炎の診断と治療. 眼科 33 : 1355-1361, 1991.
 
9) Elder MJ, et al : A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis. Invest Ophthalmol Vis Sci 35 : 1059-1064, 1994.
PubMed
10) 田原和子ほか : Acanthamoeba cystに有効な治療薬剤の検討. 感染症誌 71 : 1025-1030, 1997.
 
11) 感染性角膜炎診療ガイドライン作成委員会 : 感染性角膜炎診療ガイドライン. 日眼会誌 111 : 769-809, 2007.
 
P.586 掲載の参考文献
1) Lingappan A, et al : Endogenous fungal endophthalmitis : causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol 153 : 162-166, 2012.
PubMed
2) Waheed S, et al : New patterns of infecting organisms in late bleb-related endophthalmitis : a ten year review. Eye 12 : 910-915, 1998.
 
3) Miller JJ, et al : Endophthalmitis caused by Bacillus species. Am J Ophthalmol 145 : 883-888, 2008.
PubMed
4) Ramakrishnan R, et al : Microbiological profile of culture-proven cases of exogenous and endogenous endophthalmitis : a 10-year retrospective study. Eye 23 : 945-956, 2009.
PubMed
5) 川崎史朗 : 眼感染症Now! 眼感染症診療におけるEBM多施設共同研究で得られたもの わが国の術後眼内炎の動向は? あたらしい眼科 26 (臨増) : 69-71, 2010.
 
6) Deramo VA, Ting TD : Treatment of Propionibacterium acnes endophthalmitis. Curr Opin Ophthalmol 12 : 225-229, 2001.
PubMed
7) Jackson TL, et al : Endogenous bacterial endophthalmitis : a 17-year prospective series and review of 267 reported cases. Surv Ophthalmol 48 : 403 -423, 2003.
 
8) 安積淳, 石橋一樹 : 点滴による静脈炎が原因と考えられた転移性眼内炎の1例. あたらしい眼科 13 : 97-100, 1996.
 
9) Aaberg TM Jr, et al : Nosocomial acute-onset postoperative endophthalmitis survey. A 10-year review of incidence and outcomes. Ophthalmology 105 : 1004-1010, 1998.
PubMed
10) Lundstrom M, et al : Endophthalmitis after cataract surgery : a nationwide prospective study evaluating incidence in relation to incision type and location. Ophthalmology 114 : 866-870, 2007.
PubMed
11) DeBry PW, et al : Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol 120 : 297-300, 2002.
PubMed
12) Imago M, et al : Optical coherence tomography for monitoring the process of Candida endophthalmitis. Acta Ophthalmol 87 : 680-682, 2009.
PubMed
13) 高瀬博 : 眼炎症性疾患-診療の進歩わかりやすい臨床講座 微量検体の網羅的解析による眼炎症性疾患の診断. 日本の眼科 83 : 1504-1509, 2012.
 
14) 安原徹 : 術後眼内炎術後眼内炎の診断と治療 治療の選択肢. 眼科プラクティス 1 : 19-25, 2005.
 
P.591 掲載の参考文献
1) Ohguro N, et al : The 2009 prospective multi-center epidemiologic survey of uveitis in Japan. Jpn J Ophthalmol 56 : 432-435, 2012.
PubMed
P.595 掲載の参考文献
眼瞼炎 1) 北川和子 : 眼瞼炎, 麦粒腫. 新図説臨床眼科講座 7 (望月學編), p22-25, メジカルビュー, 1999.
 
眼瞼炎 2) 北川和子 : 眼瞼炎. 眼感染症クリニック (臼井正彦ほか編), p8-13, 医学書院, 2000.
 
眼瞼炎 3) 木下茂 : マイボーム腺炎角膜上皮症. あたらしい眼科 18 : 307-310, 2001.
 
眼瞼炎 4) 鈴木智ほか : マイボーム腺炎に関連した角膜上皮障害 (マイボーム腺炎角膜上皮症) の検討. あたらしい眼科 17 : 423-427, 2000.
 
眼瞼炎 5) 佐々木香る : ブドウ球菌性眼瞼炎. 眼科プラクティス 28 眼感染症の謎を解く (大橋裕一編), p70-71, 文光堂, 2009.
 
涙道感染症 1) 井上幸次 : 涙小管炎. 眼科臨床クオリファイ 2 結膜炎オールラウンド (大橋裕一編), p 109-111, 中山書店, 2010.
 
涙道感染症 2) 西澤きよみ, 秦野寛 : 涙嚢炎. 眼科プラクティス 28 眼感染症の謎を解く (大橋裕一編), p213-215, 文光堂, 2009.
 
涙道感染症 3) 秦野寛 : 涙小管炎. 眼科プラクティス 28 眼感染症の謎を解く (大橋裕一編), p216-217, 文光堂, 2009.
 
涙道感染症 4) 亀山和子ほか : 放線菌による涙小管炎の臨床所見. あたらしい眼科 7 : 1783-1785, 1990.
 

XI 耳鼻咽喉感染症

P.602 掲載の参考文献
1) 鈴木賢二ほか : 第4回耳鼻咽喉科領域感染症臨床分離菌全国サーベイランス結果報告. 日耳鼻感染症研会誌 26 : 15-26, 2008.
 
2) 日本耳科学会ほか (編) : 小児急性中耳炎診療ガイドライン, 金原出版, 2006.
 
3) 日本耳科学会ほか (編) : 小児急性中耳炎診療ガイドライン 2009年版, 金原出版, 2009.
 
4) 急性鼻副鼻腔炎診療ガイドライン. 日鼻科会誌 49 (2) : 143-247, 2010.
 
5) Loos BG, et al : Determination of the epidemiology and transmission of nontypable Haemophilus influenzae in children with otitis media by comparison of total genomic DNA restriction fingerprint. Infect Immun 156 : 2751-2757, 1989.
 
6) Shimada J, et al : Household transmission of Streptococcus pneumoniae among siblings with acute otitis media. J Clin Microbiol 40 : 1851-1853, 2002.
PubMed
7) Hotomi M, et al : Genotyping of Streptococcus pneumoniae and Haemophilus inflzaenzae isolated from paired middle ear fluid and nasopharynx by pulsed-field gel electrophoresis. ORL J Otorhinolaryngol Relat Spec 66 (5) : 233-240, 2004.
PubMed
8) 工藤典代ほか : 小児の鼻汁から得られた検出菌の検討. 日鼻科会誌 47 (2) : 115-119, 2008.
 
P.607 掲載の参考文献
1) 小児急性中耳炎診療ガイドライン 2009年版 (日本耳科学会ほか編), 金原出版, 2009.
 
2) 鈴木賢二 : 小児急性中耳炎. 小児科臨床 64 (12) : 2517-2523, 2011.
Medical*Online
3) Suzuki K, Bakaletz LO : Synergistic effect of adenovirus type 1 and nontypeable Haemophilus influenzae in a chinchilla model of experimental otitis media. Infect Immun 62 (5) : 1710-1718, 1994.
 
4) 鈴木賢二ほか : 第4回耳鼻咽喉科領域感染症臨床分離菌全国サーベイランス結果報告. 日耳鼻感染誌 26 : 15-26, 2008.
 
5) Roger G, et al : Management of acute otitis media caused by resistant pneumococci in infants. Pediatr Infect Dis J 17 (7) : 631-638, 1998.
PubMed
6) Brook I, Gober AE : Microbiologic characteristics of persistent otitis media. Arch Otolaryngol Head Neck Surg 124 (12) : 1350-1352, 1998.
PubMed
7) 馬場駿吉ほか : 第2回耳鼻咽喉科領域感染症臨床分離菌全国サーベイランス結果報告. 日耳鼻感染誌 18 (1) : 48-63, 2000.
 
8) 島田純ほか : 急性中耳炎における鼻咽腔細菌検出と予後の検討. 日耳鼻感染誌 17 (1) : 56-60, 1999.
 
9) 鈴木賢二, 馬場駿吉 : 外来における抗菌点耳療法. 耳鼻臨床 88 (6) : 703-705, 1995.
 
10) 飯野ゆき子ほか : 滲出性中耳炎に対するエリスロマイシン少量長期投与療法の効果. 日耳鼻 94 : 1537, 1991.
 
11) 鈴木賢二, 馬場駿吉 : 上気道感染症. 医学と薬学 36 : 223-229, 1996.
Medical*Online
12) Brook I : Role of anaerobic bacteria in chronic otitis media and cholesteatoma. Int J Pediatr Otorhinolaryngol 31 (2-3) : 153-157, 1995.
 
P.613 掲載の参考文献
1) Leskinen K, Jero J : Acute complication of otitis media in adults. Clin Otolaryngol 30 : 511-516, 2005.
PubMed
2) 佐藤宏昭ほか : 慢性中耳炎における内耳障害. Audiology Japan 46 : 118-122, 2003.
Medical*Online
3) 日本神経感染症学会治療指針作成委員会 : 細菌性髄膜炎の診療ガイドライン. 神経治療 24 : 3-64, 2007.
 
4) 矢野寿一ほか : 内耳障害をともなった急性中耳炎症例の検討. Audiology Japan 46 : 111-117, 2003.
 
5) 飯野ゆき子 : 中耳炎による内耳障害-その臨床と機序について-. 耳鼻臨床 98 : 429-437, 2005.
 
6) Schuknecht HF : Infections. In : Pathology of the Ear, 2nd ed (ed by Schuknecht HF), p 191-253, Lea & Febiger, Philadelphia, 1993.
 
7) Goldstein NA, et al : Intratemporal complications of acute otitis media in infants and children. Otolaryngol Head Neck Surg 119 : 444-454, 1998.
PubMed
8) 曾根三千彦 : 内耳の炎症とMRI評価. 耳鼻咽喉科頭頸部外科 82 : 741-748, 2010.
 
9) Dommerby H, Tos M : Sensorineural hearing loss in chronic adhesive otitis. Arch Otolaryngol Head Neck Surg 112 : 628-634, 1986.
PubMed
10) 平川賢史, 堤裕幸 : 先天性サイトメガロウイルス感染症と抗ウイルス薬治療の最近の動向. MB ENT 139 : 33-38, 2012.
 
11) 福田諭 : ウイルス性内耳炎. 耳鼻咽喉科頭頸部外科 74 : 668-676, 2002.
 
12) 佃朋子, 工藤典代 : 近年発生した先天性風疹症候群の臨床的検討. Auditory Japan 42 : 682-688, 1999.
 
13) 藤原圭志ほか : 耳鼻咽喉科感染症の完全マスター. 病原体をマスターする. ウイルス感染症. 麻疹ウイルス. 耳鼻咽喉科頭頸部外科 83 : 169-174, 2011.
 
14) 厚生労働科学研究・急性高度難聴に関する研究 : 急性高度難聴に関する調査研究 (厚生労働科学研究・特定疾患対策研究事業) より得られたムンプス難聴の疫学調査結果. IASR 24 : 107-109, 2003.
 
15) 増田毅, 池田稔 : 急性感音難聴の最新治療戦略. Hunt症候群. JOHNS 28 : 783-785, 2012.
 
P.617 掲載の参考文献
1) 杉田麟也 : 急性外耳道炎, 急性限局性外耳道炎. CLIENT 21 (4) 外耳・中耳 (野村恭也ほか編), 中山書店, 2000.
 
2) 山野貴史, 森園哲夫 : 難治性外耳道疾患の診断と治療. 日本医事新報 4408 : 62-66, 2008.
Medical*Online
3) 新川秀一 : 慢性外耳道炎-湿疹と皮膚炎. CLIENT 21 (4) 外耳・中耳 (野村恭也ほか編), p80-中山書店, 2000.
 
4) 入問田美保子, 末武光子 : 外耳道真菌症. CLIENT 21 (4) 外耳・中耳 (野村恭也ほか編), p85-89, 中山書店, 2000.
 
5) 江上徹也, 上田成一 : 外耳道真菌症. ENTONI 92 : 63-67, 2008.
 
6) 飯野ゆき子 : 外耳・中耳真菌症. ENTONI 131 : 8-12, 2011.
 
7) 新川敦 : 外耳. CLIENT 21 (19) 感染症 (野村恭也ほか編), p 233-236, 中山書店, 2000.
 
8) 矢野寿一ほか : 耳介軟骨膜炎. JOHNS 17 : 215-218, 2001.
 
P.620 掲載の参考文献
1) Palva T, et al : Acute and latent mastoiditis in children. J Laryngol Otol 99 : 127-136, 1985.
 
2) 工藤典代, 笹村佳美 : 乳幼児の急性乳様突起炎の臨床的検討-特にペニシリン低感受性肺炎球菌のと治療について-. 日耳鼻 101 : 1075-1081, 1998.
 
3) 山本悦生 : 急性乳様突起炎, 急性錐体尖炎. 21世紀耳鼻咽喉科領域の臨床 4. 外耳・中耳 (野村恭也ほか編), p193-199, 中山書店, 2000.
 
4) 工藤典代ほか : 小児の急性乳様突起炎の臨床的検討 : 特に抗菌薬治療について. 小児耳鼻 28 : 52-57, 2007.
 
5) 東野哲也 : 中耳炎の合併症. MB ENT 131 : 31-37, 2011.
 
6) 山中昇 : 急性乳様突起炎. 今日の耳鼻咽喉科頭頸部外科治療指針, 第3版 (森山寛ほか編), p133-134, 医学書院, 2008.
 
7) 森本倫子 : 急性乳様突起炎に対する手術療法と保存的療法. JOHNS 20 : 1050-1054, 2004.
 
8) 安田京ほか : 急性乳様突起炎9例の検討. 耳鼻臨床 99 : 913 -918, 2006.
 
9) 井口芳明ほか : 急性乳様突起炎の臨床的検討. Otology Japan 11 : 577-583, 2001.
 
P.627 掲載の参考文献
1) 日本鼻科学会 (編) : 副鼻腔炎診療の手引き, 金原出版, 2007.
 
2) 日本鼻科学会, 急性鼻副鼻腔炎診療ガイドライン作成委員会 : 急性鼻副鼻腔炎診療ガイドライン 2010年版. 日本鼻科会誌 49 (2) : 143 -247, 2010.
 
3) 堺章 : 6. 気道の構造と働き-鼻腔・副鼻腔・咽頭・喉頭・気管・気管支. 目でみるからだのメカニズム 新訂版第7刷, p33, 医学書院, 2005.
 
4) Lindbaek M : Acute sinusitis : guide to selection of antibacterial therapy. Drugs 64 (8) : 805-819, 2004.
PubMed
5) 工藤典代 : 耳鼻咽喉科領域の感染症と対応 鼻副鼻腔炎. 化学療法の領域 27 (8) : 1821-1828, 2011.
 
6) 山内一真 : 12. ウイルス性鼻副鼻腔炎の症状は. 鼻副鼻腔炎のマネジメント (山中昇, 工藤典代編), p40-41, 医薬ジャーナル社, 2011.
 
7) 工藤典代ほか : 小児の鼻汁から得られた検出菌の検討. 日本鼻科会誌 47 (2) : 115-119, 2008.
 
8) 松原茂規 : 小児副鼻腔炎の病態. 耳鼻咽喉科臨床 93 (4) : 283-289, 2000.
 
9) 鈴木賢二ほか : 第4回耳鼻咽喉科領域感染症分離菌全国サーベイランス結果報告. 目耳鼻感染症研会誌 26 (1) : 15-26, 2008.
 
10) Barlan IB, et al : Intranasal budesonide spray as an adjunct to oral antibiotic therapy for acute sinusitis in children. Ann Allergy Asthma Immunol 78 (6) : 598-601, 1997.
PubMed
11) Williamson IG, et al : Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis : a randomized controlled trial. JAMA 298 (21) : 2487-2496, 2007.
PubMed
12) 羽柴基之ほか : 副鼻腔炎の治療ガイドラインについて慢性副鼻腔炎に対するマクロライド療法のガイドライン (試案). The Japanese Journal of Antibiotics 51 (増刊) : 86-89, 1998.
 
P.632 掲載の参考文献
1) 板東伸幸ほか : 成人の急性咽頭・扁桃炎における検出菌. 日耳鼻感染症研会誌 23 : 132-137, 2005.
 
2) Suzumoto M, et al : A scoring system for management of acute pharyngo-tonsillitis in adults. Auris Nasus Larynx 36 : 314-320, 2009.
PubMed
3) 鈴木賢二ほか : 第4回耳鼻咽喉科領域感染症臨床分離菌全国サーベイランス結果報告. 日耳鼻感染症研会誌 26 : 15-26, 2008.
 
4) Hotomi M, et al : Haemophilus influenzae and Haemophilus haemolyticus in tonsillar cultures of adults with acute pharyngotonsillitis. Auris Nasus Larynx 37 : 594-600, 2010.
PubMed
5) Kaplan EL, et al : Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells : clinical and pathogenetic implications. Clin Infect Dis 43 : 1398-1406, 2006.
 
6) Baldassarri L, et al : Therapeutic failures of antibiotics used to treat macrolide-susceptible Streptococcus pyogenes infections may be due to biofilm formation. J Clin Microbiol 44 : 2721-2727, 2006.
PubMed
7) 山中昇ほか : 咽頭・扁桃炎のマネジメント (山中昇編), p 12-261, 医薬ジャーナル社, 2009.
 
8) Bisno AL, et al : Diagnosis and management of group A streptococcal pharyngitis : a practice guideline. Infectious Disease Society of America. Clin Infect Dis 25 : 574-583, 1997.
 
9) 原渕保明 : 上気道薬剤耐性菌感染症に対する治療選択. 扁桃炎の重症度分類と治療選択. 薬剤耐性菌による上気道・下気道感染症に対する治療戦略 (山中昇編), p99-111, 金原出版, 2002.
 
10) Casey JR, Pichichero ME : Meta-analysis of cephalosporin versus penicillin treatment of group A streptococcus tonsillopharyngitis in children. Pediatrics 113 : 866 -882, 2004.
 
11) Sakata H : Conparative study of 5-days cefcapen-pivoxil and 10-day amoxicillin or cefcapen-pivoxil for treatment of group A streptococcal pharyngitis in children. J Infect Chemother 14 : 208-212, 2008.
 
12) Ozaki T, et al : Five-day oral cefditoren pivoxil versus 10-day oral amoxicillin for pediatric group A streptococcal pharyngotonsillitis. J Infect Chemother 14 : 213-218, 2008.
 
13) 山中昇ほか : 成人急性咽頭・扁桃炎に対するガレノキサシン (GRNX) の有効性に関する検討-スコアリングシステムを用いた重症度評価とその臨床効果-. 耳鼻咽喉科展望 53 : 138-148, 2010.
 
14) 原渕保明 : 耳鼻咽喉科感染症のトピックス 急性咽頭・扁桃炎の起炎菌と治療-β溶連菌だけが起炎菌か. 化学療法の領域 21 : 63-73, 2005.
 

XII 歯性・口腔内・頸部感染症

P.639 掲載の参考文献
1) 歯周病の診断と治療の指針 2007 (特定非営利活動法人日本歯周病学会編), p1-10, 医歯薬出版, 2007.
 
2) 重篤副作用疾患別対応マニュアルビスホスホネート系薬剤による顎骨壊死 (日本口腔外科学会, 日本病院薬剤師会, 重篤副作用総合対策検討会編), 2009年11月改訂. [http://www.info.pmda.go.jp/juutoku/file/jfm0905012.pdf]
 
3) Mavrokokki T, et al : Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 65 : 415-423, 2007.
PubMed
4) Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons : Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws : American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws. J Oral Maxillofac Surg 65 : 369-375, 2007.
 
5) 金子明寛 : 抗菌薬使用のガイドライン (歯科・口腔外科感染症日本感染症学会, 日本化学療法学会編), 第1版, p213-216, 協和企画, 2003.
 
6) 金子明寛 : 口腔感染症に対する化学療法-新しい抗菌薬を中心に-. 日口腔外会誌 56 : 1-7, 2007.
 
7) Goldstein EJ, et al : Comparative in vitro activities of DU-6859a, levofloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against 387 aerobic and anaerobic bite wound isolates. Antimicrob Agents Chemother 41 (5) : 1193-1195, 1997.
PubMed
P.647 掲載の参考文献
1) 吉原俊雄 : 成人の反復性耳下腺炎の対処. 耳鼻咽喉科・頭頸部外科クリニカルトレンド part 4 (野村恭也ほか編), p189-191, 2004.
 
2) 山村幸江, 吉原俊雄 : 顎下腺唾石70例の臨床像ならびに病理組織学的検討. 東女医大誌 67 : 808-814, 1997.
 
3) Satoh M, Yoshihara T : Clinical and ultracytochemical investigation of sialadenosis. Acta Otolaryngol Suppl 553 : 122-127, 2004.
PubMed
4) 宮本真理子, 吉原俊雄 : IgG4関連疾患としてのミクリッツ病, 慢性硬化性顎下腺炎 (キュットナー腫瘍) の血清学的および臨床病理学的検討. 耳鼻臨床 105 : 267-276, 2012.
 
5) 海野徳二 : 耳下腺炎. 口腔咽頭の臨床日本口腔咽頭科学会 (編), p86-89, 医学書院, 1998.
 
6) 富板美奈子ほか : 小児シェーグレン症候群の臨床像. リウマチ 34 : 863-870, 1994.
 
7) 内田正志, 深澤満 : 超音波検査による流行性耳下腺炎と反復性耳下腺炎の鑑別. 小児内科 37 : 59-62, 2005.
 
8) 宮本真理子ほか : HIV関連唾液腺疾患の2症例. 日耳鼻感染症誌 28 : 97-100, 2010.
 
9) 森一功, 大川正直 : 耳下腺結核の1症例. 耳鼻臨床 80 : 599-602, 1987.
 
10) 工藤典代, 笹村佳美 : 反復性耳下腺炎の臨床的検討. 小児耳鼻 19 : 50-54, 1998.
 
11) 吉原俊雄 : 唾液腺管内視鏡による診断と治療. 医学のあゆみ 235 : 934-937, 2010.
Medical*Online
P.651 掲載の参考文献
1) Miyauchi A, et al : Piriform sinus fistula : an underlying abnormality common in patients with acute suppurative thyroiditis. World J Surg 14 : 400-405, 1990.
PubMed
2) Nishihara E, et al : Acute suppurative thyroiditis after fine-needle aspiration causing thyrotoxicosis. Thyroid 15 : 1183-1187, 2005.
PubMed
3) 宮内昭 : グルココルチコイドを投与された下咽頭梨状窩瘻・急性化膿性甲状腺炎症候群10症例の特徴. ホルモンと臨床 55 (増刊号) : 88-92, 2007.
 
4) Masuoka H, et al : Imaging studies in sixty patients with acute suppurative thyroiditis. Thyroid 21 : 1075-1080, 2011.
PubMed
5) Miyauchi A, et al : Computed tomography scan under a trumpet maneuver to demonstrate piriform sinus fistulae in patients with acute suppurative thyroiditis. Thyroid 15 : 1409-1413, 2005.
 
6) Paes JE, et al : Acute bacterial suppurative thyroiditis : a clinical review and expert opinion. Thyroid 20 : 247-255, 2010.
PubMed
7) Miyauchi A : Thyroid gland : A new management algorithm for acute suppurative thyroiditis? Nat Rev Endocrinol 6 : 424-426, 2010.
PubMed
8) Nishihara E, et al : Clinical characteristics of 852 patients with subacute thyroiditis before treatment. Intern Med 47 : 725-728, 2008.
PubMed
9) Miyauchi A, et al : Evaluation of chemocauterization treatment for obliteration of pyriform sinus fistula as a route of infection causing acute suppurative thyroiditis. Thyroid 19 : 789-793, 2009.
 
P.655 掲載の参考文献
1) Chow AW : Life-threatening infections of the head and neck. Clin Infect Dis 14 : 991-1002, 1992.
PubMed
2) Kuriyama T, et al : Bacteriologic features and antimicrobial susceptibility in isolates from orofacial odontogenic infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90 : 600-608, 2000.
PubMed
3) Sakamoto H, et al : A case of brain abscess extended from deep fascial space infection. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108 : e21-25, 2009.
PubMed
4) 渡邊邦友 : いわゆる嫌気性菌が関与する感染症に関する最近の話題. 感染症誌 80 : 76-83, 2006.
 
5) Chapman R Tully A : Case report : A life-threatening sore throat. Lancet 364 : 112, 2004.
PubMed
6) Mathieu D, et al : Cervical necrotizing fasciitis : clinical manifestations and management. Clin Infect Dis 21 : 51-56, 1995.
PubMed
7) Sakamoto H, et al : Descending necrotizing mediastinitis due to odontogenic infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 89 : 412-419, 2000.
PubMed

XIII 先天性・母子感染症

P.667 掲載の参考文献
1) 森内昌子, 森内浩幸 : ウイルス性母子感染症. 化学療法の領域 24 : 1506-1511, 2008.
 
2) 森内昌子, 森内浩幸 : 話題の感染症 : 母子感染するウイルス～共生か矯正か. モダンメディア 56 : 153-158, 2010.
 
3) Torii Y, et al : Clinico-epidemiological states of mother-to-child infections : a nationwide survey in Japan. Pediatr Infect Dis J, 2013. [Epub ahead of print]
 
4) Sakikawa M, et al : Anti-toxoplasma antibody prevalence, primary infection rate, and risk factors in a study of toxoplasmosis in 4,466 pregnant women in Japan. Clin Vaccine Immunol 19 : 365-367, 2012.
 
5) Koyano S, et al : Screening for congenital cytomegalovirus infection using newborn urine samples collected on mter paper : feasibility and outcomes from a multicenter study. BMJ Open 1 : e000118, 2011.
 
6) Moore KL : Before We Are Born : Basic Embryology and Birth Defects, 2nd ed, WB Saunders, Philadelphia, 1977.
 
7) Bonthius DJ, et al : Congenital lymphocytic choriomeningitis virus infection : spectrum of disease. Ann Neurol 62 : 347-355, 2007.
PubMed
8) Chahwan C, Chahwan R : Aicardi-Goutieres syndrome : from patients to genes and beyond. Clin Genet 81 : 413-420, 2012.
PubMed
9) 先天性トキソプラズマ&サイトメガロウイルス感染症患者会「トーチの会」. [http://toxo-cmv.org/]
 
10) Tucker JD, et al : Syphilis and social upheaval in China. N Engl J Med 362 : 1658-1661, 2010.
 
11) 国立感染症研究所感染症情報センター : 風疹発生動向調査2013年第14週 ('3/4/10現在). [http://www.nih.go.jp/niid/images/idsc/disease/rubella/2013pdf/rube13-14.pdf]
 
12) CDC : Cytomegalovirus (CMV) and congenital CMV infection. [http://www.cdc.gov/cmv/]
 
P.673 掲載の参考文献
1) 小島俊行 : トキソプラズマの母子感染. 母子感染, p136-154, 金原出版, 2011.
 
2) 小島俊行ほか : 周産期感染症の診断法-トキソプラズマを中心として-. 臨床検査 56 (7) : 723-729, 2012.
 
3) 日本産婦人科医会研修委員会 (編) : トキソプラズマ. 研修ノート No. 66 新生児のプライマリケア, p 45 -46, 日本産婦人科医会, 2002.
 
P.677 掲載の参考文献
1) 厚生労働省. 感染症法に基づく医師の届出のお願い. [URL : http://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou11/01.html]
 
2) 加藤茂孝 : 風疹と先天性風疹症候群. 感染・炎症・免疫 32 : 185-193, 2002.
 
3) 多屋馨子 : 麻疹・風疹混合ワクチン-麻疹・風疹排除をめざして. 医学の歩み 244 : 71-78, 2013.
 
4) 駒瀬勝啓 : 風疹ワクチンの効果と再感染. 臨床とウイルス 36 : 32-38, 2008.
Medical*Online
5) 久保隆彦ほか : 妊娠中に注意すべきウイルス感染-風疹ウイルス. 周産期医学 37 : 1509-1513, 2007.
Medical*Online
6) Gregg NM : Congenital cataract following German measles in the mother. Trans Ophthalmol Soc Aust 3 : 35-46, 1941.
 
7) Ghidini A. Lynch L : Prenatal diagnosis and significant of fetal infection. West J Med 159 : 366-373, 1993.
PubMed
8) 植田浩司 : 風疹・先天性風疹症候群. 日本臨牀 65 (増刊号 3) : 299-303, 2007.
 
9) 風疹流行にともなう母児感染の予防対策構築に関する研究班 : 風疹流行および先天性風疹症候群の発生抑制に関する緊急提言. [URL : http://idsc.nih.go.jp/disease/rubella/rec200408rev3.pdf]
 
10) Okuda M, et al : Positive rates for rubella antibody in pregnant women and benefit of post-partum vaccination in a Japanese perinatal center. J Obstet Gynaecol Res 34 : 168-173, 2008.
 
11) 干場勉ほか : 風疹IgG抗体結合力の簡易測定法. 日産婦誌 48 : 413-418, 1996.
 
12) 種村光代 : 風疹ウイルスの母子感染, 風疹疑い妊婦の取り扱い. 周産期学シンポジウム 18 : 83-90, 2000.
 
13) 楠原浩一 : 風疹, 先天性風疹症候群. 小児内科 44 (増刊) : 306-307, 2012.
 
14) American College of Obstetricians and Gynecologists : ACOG Committee Opinion : number 281, Rubella vaccination. Obstet Gynecol 100 : 1417, 2002.
PubMed
P.684 掲載の参考文献
1) Revello MG, Gerna G : Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 15 : 680-715, 2002.
PubMed
2) Torii Y, et al : Clinicoepidemiological states of mother-to-child infections : anationwide survey in Japan. Pediatr Infect Dis J, 2013. [Epub ahead of print]
 
3) Koyano S, et al : Screening for congenital cytomegalovirus infection using newborn urine samples collected on filter paper : feasibility and outcomes from a multicenter study. BMJ Open 1 : 000118, 2011.
 
4) Morton CC, Nance WE : Newborn hearing screening-a silent revolution. N Engl J Med 354 : 2151-2164, 2006.
PubMed
5) Ogawa H, et al : Etiology and severe sensorineural hearing loss in children : independent impact of congenital cytomegalovirus infection and GJB2 mutations. J Infect Dis 195 : 782-788, 2007.
PubMed
6) Tagawa M, et al : Retrospective diagnosis of congenital cytomegalovirus infection at a school for the deaf by using preserved dried umbilical cord. J Pediatr 155 : 749-751, 2009.
 
7) Nigro G, et al : Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 353 : 1350-1362, 2005.
PubMed
8) Kimberlin DW, et al : Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system : a randomized, controlled trial. J Pediatr 143 : 16-25, 2003.
 
9) Oliver SE, et al : Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol 46 (Suppl 4) : S22 -26, 2009.
 
10) Kimberlin DW, et al : Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis 197 : 836-845, 2008.
 
11) 森内浩幸 : 先天性CMV感染治療プロトコール. 小児感染免疫 22 : 385-389, 2010.
 
12) Schleiss M : Cytomegalovirus vaccine development. Curr Top Microbiol Immunol 325 : 361-378, 2008.
PubMed
13) CDC : Cytomegalovirus (CMV) and congenital CMV infection. [http://www.cdc.gov/cmv/]
 
P.689 掲載の参考文献
1) 国立感染症研究所感染症情報センター : 年別報告数一覧. [http://idsc.nih.go.jp/idwr/ydata/report-Ja.html]
 
2) CDC : Congenital syphilis-United States, 2003-2008. MMWR Morb Mortal Wkly Rep 59 : 413-417, 2010.
PubMed
3) 堀成美, 多田有希 : 増加が懸念される先天梅毒と公衆衛生上の課題. IASR 29 : 245-246, 2008.
 
4) Sheffield JS, et al : Congenital syphilis after maternal treatment for syphilis during pregnancy. Am J Obstet Gynecol 186 : 569-573, 2007.
 
5) Simon RD, Pablo JS : Syphilis, In : Textbook of Pediatric Infectious Diseases, 6th ed (ed by Feigin RD, et al), p 1826-1846, Saunders, Philadelphia, 2009.
 
6) 米国小児科学会 (編) : 梅毒最新感染症ガイドRed Book, 27th ed (岡部信彦監), p 631-644, 日本小児医事出版社, 2007.
 
7) 厚生労働省 : 感染症法に基づく届出の基準等について. [http://www.mhlw. go.jp/bunya/kenkou/kekkaku-kansenshou11/01-05-11.html]
 
8) CDC : Sexually transmitted diseases treatment guidelines, 2010. MMWR Morb Mortal Wkly Rep 59 : 26-39, 2010. [http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5912a1.htm]
 
9) 日本性感染症学会 : 梅毒性感染症診療・治療ガイドライン 2008. 日性感染症会誌 19 (Suppl) : 46-48, 2008.
 
P.692 掲載の参考文献
1) Roizman B, et al : Herpes simplex virus. In : Fields Virology (ed by Knipe DM, Howley PM), 5th ed, p 2501-2601, Lippincott-Williams & Wilkins Publications, Philadelphia, 2007.
 
2) 森島恒雄ほか : 新生児ヘルペス全国調査. 日小児会誌 93 : 1990-1995, 1989.
 
3) Torii Y, et al : Clinicoepidemiological status of mother-to-child infections : anationwide survey in Japan. Pediatr Infect Dis J, 2013. [Epub ahead of print]
 
4) Kimberlin DW, Baley J : Guidance on management of asymptomatic neonates born to women with active genital herpes lesions. Pediatrics 131 : e635-646, 2013.
PubMed
5) Flagg EW, Weinstock H : Incidence of neonatal herpes simplex virus infections in the United States, 2006. Pediatr 127 : e1-8, 2011.
 
6) 木村宏, 森島恒雄 : ヘルペスウイルス感染の診断. 日本臨牀 64 (増刊号 3) : 55-58, 2006.
 
7) Ito Y, et al : Exacerbation of herpes simplex encephalitis after successful treatment with acyclovir. Clin Infect Dis 30 : 185-187, 2000.
PubMed
8) Kimberlin DW, et al : Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 108 : 230-238, 2001,
PubMed
9) American Academy of and Pediatrics. Herpes simplex virus. In : Red Book : 2012 Report of the Committee on Infectious Diseases (ed by Pickering LK), 29 ed, p 398-408, American Academy of Pediatrics, Elk Grove Village, 2012.
 
10) Kawada J, et al : Evaluation of systemic inflammatory responses in neonates with herpes simplex virus infection. J Infect Dis 190 : 494-498, 2004.
PubMed
11) Nagamori T, et al : Sequential changes in pathophysiology of systemic innammatory response in a disseminated neonatal herpes simplex virus (HSV) infection. J Clin Virol 53 : 265-267, 2012.
 
12) Yamada K, et al : Successful treatment of neonatal herpes simplex-type 1 infection complicated by hemophagocytic lymphohistiocytosis and acute liver failure. Tohoku J Exp Med 214 : 1-5, 2008.
PubMed
13) Kimura H, et al : Relapse of neonatal herpes simplex virus infection. Arch Dis Child Fetal Neonatal Ed 88 : F483-F486, 2003.
PubMed
14) Kimberlin DW, et al : Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med 365 : 1284-1292, 2011.
PubMed
15) Pinninti SG, et al : Neonatal herpes disease following maternal antenatal antiviral suppressive therapy : a multicenter case series. J Pediatr 161 : 134-138, 2012.
 
P.697 掲載の参考文献
1) 成瀬寛夫 : ヒトパルボウイルスB19の母子感染 予防・治療とその限界. 臨床とウイルス 40 : 82-89, 2012.
Medical*Online
2) 成瀬寛夫ほか : 3,000人の妊婦血清が語るヒトパルボウイルスB19感染の実態 感染の特徴と母子感染予防の可能性. 周産期学シンポジウム 18 : 65-71, 2000.
 
3) Yaegashi N, et al : Serologic study of human parvovirus B19 infection in pregnancy in Japan. J Infect 38 : 30-35, 1999.
PubMed
4) Enders M, et al : Current epidemiological aspects of human parvovirus B19 infection during pregnancy and childhood in the western part of Germany. Epidemiol Infect 135 : 563-569, 2007.
PubMed
5) Jensen IP, et al : An epidemic of parvovirus B19 in a population of 3596 pregnant women : a study of sociodemographic and medical risk factors. BJOG 197 : 637-643, 2000.
 
6) Gratac6s E, et al : The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J Infect Dis 171 : 1360-1363, 1995.
 
7) Torii Y, et al : Clinicoepidemiologic Status of Mother-to-Child Infections : A Nationwide Survey in Japan. Pediatr Infect Dis J 32 : 699-701, 2013.
PubMed
8) 田中敏博 : TORCH09 先天性・周産期感染症の実態調査 . 先天性パルボウイルスB19感染症. 日周産期・新生児会誌 7 : 356, 2011.
 
9) Enders M, et al : Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy : prospective evaluation of 1018 cases. Prenat Diagn 24 : 513-518, 2004.
PubMed
10) Chisaka H, et al : Clinical manifestations and outcomes of parvovirus B19 infection during pregnancy in Japan. Tohoku J Exp Med 209 : 277-283, 2006.
PubMed
11) Simms RA, et al : Management and outcome of pregnancies with parvovirus B19 infection over seven years in a tertiary fetal medicine unit. Fetal Diagn Ther 25 : 373-378, 2009.
 
12) Puccetti C, et al : Parvovirus B19 in pregnancy : possible consequences of vertical transmission. Prenat Diagn 32 : 897-902, 2012.
PubMed
13) Brown KE, et al : Erythrocyte P antigen : cellular receptor for B19 parvovirus. Science 262 : 114-117, 1993.
PubMed
14) Yaegashi N, et al : The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis following maternal infection ; report of 10 cases and meta-analysis. J Infect 37 : 28-35, 1998.
PubMed
15) Fairley CK, et al : Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19. Lancet 346 : 1335-1337, 1995.
PubMed
16) Matsuda H, et al : Intrauterine therapy for parvovirus B19 infected symptomatic fetus using B19 IgG-rich high titer gammaglobulin. J Perinat Med 33 : 561-563, 2005.
PubMed
17) Weiland HT, et al : Parvovirus B19 associated with fetal abnormality. Lancet 1 (8534) : 682-683, 1987.
PubMed
18) Miller E, et al : Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 105 : 174-178, 1998.
PubMed
19) Rodis JF, et al : Management of parvovirus infection in pregnancy and outcomes of hydrops : a survey of members of the Society of Perinatal Obstetricians. Am J Obstet Gynecol 179 : 985-988, 1998.
 
20) Dembinski J, et al : Neurodevelopmental outcome after intrauterine red cell transfusion for parvovirus B19-induced fetal hydrops. BJOG 109 : 1232-1234, 2002.
PubMed
21) Nagel HT, et al : Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection. Obstet Gynecol 109 : 42-47, 2007.
PubMed
22) De Jong EP, et al : Intrauterine transfusion for parvovirus B19 infection : long-term neurodevelopmental outcome. Am J Obstet Gynecol 206 : 204. e1-5, 2012.
 
P.702 掲載の参考文献
1) Iitsuka T, et al : Epidemiological survey of Japanese children infected with hepatitis B and C viruses. Hepatol Res 40 : 878-886, 2010.
 
2) 白木和夫 : わが国におけるB型肝炎母子感染防止の経緯とuniversal vaccinationの必要性について. 小児感染免疫 21 : 149-157, 2009.
 
3) Matsuura K, et al : Distribution of hepatitis B virus genotypes among patients with chronic infection in Japan shifting toward an increase of genotype A. J Clin Microbiol 47 : 1476-1483, 2009.
 
4) 白木和夫 : 「B型肝炎母子感染防止事業」の改定をめぐって. 日小児会誌 99 : 1075-1078, 1995.
 
5) Koyama T, et al : Prevention of perinatal hepatitis B virus transmission by combined passive-active immunoprophylaxis in Iwate, Japan (1981-1992) and epidemiological evidence for its efficacy. Hepatol Res 26 : 287-292, 2003.
PubMed
6) 日本産婦人科学会HP (2004) [http://www.jsog.or.jp/kaiin/html/information/info_27apr2004.html].
 
7) 日本小児科学会 : B型肝炎母子感染防止対策の周知徹底について. 日小児会誌 114 : 1, 2010.
 
8) WHO HP [http://www.who.int/immunization_monitoring/data/SlidesGlobalImmunization.pdf].
 
9) 大戸斉 : C型肝炎ウイルス等の母子感染防止に関する研究. 平成18年度総括・分担研究報告書, p1-18, 2007.
 
10) 村上潤, 長田郁夫 : C型肝炎ウイルス母子感染および家庭内感染とその予防対策. 日本臨牀 69 (増刊号 4) : 122-127, 2011.
 
11) Murakami J, et al : Risk factors for mother-to-child transmission of hepatitis C virus : Maternal high viral load and fetal exposure in the birth canal. Hepatol Res 42 : 648-657, 2012.
PubMed
12) European Paediatric Hepatitis C Virus Network. Three broad modalities in the natural history of vertically acquired hepatitis C virus infection. Clin Infect Dis 41 : 45-51, 2005.
PubMed
13) Tajiri H, et al : Peginterferon alpha-2b and ribavirin for the treatment of chronic hepatitis C in Japanese pediatric and young adult patients : a survey of the Japan Society of Pediatric Hepatology. Eur J Gastroenterol Hepatol 21 : 1256-1260, 2009.
 
14) Shiraki K, et al : Guidelines for care of pregnant women carrying hepatitis C virus and their infants. Pediatr Int 50 : 138-140, 2008.
PubMed
15) 日本産婦人科学会・日本産婦人科医会 : 妊娠中にHCV抗体陽性が判明した場合は? 産婦人科診療ガイドライン-産科編 2011, p253-255, 2011.
 
P.707 掲載の参考文献
1) 喜多恒和 : 研究分担報告書 HIV感染妊婦とその出生児に関するデータベースの構築およびHIV感染妊婦の疫学的・臨床的情報解析. 平成23年度 厚生労働科学研究費補助金エイズ対策研究事業 (H21-エイズ-一般-002) 平成21-23年度 (研究代表者和田裕一), p47-97, 2012 (3月).
 
2) 妊婦健康診査の実施について. 厚生労働省雇用均等・児童家庭局母子保健課長通知. 雇児母発第0227001号, 平成21年2月27日.
 
3) 吉野直人 : 研究分担報告書 妊婦HIV検査実施率およびHIV感染妊婦とその出生児の動向に関する全国調査. 平成23年度 厚生労働科学研究費補助金エイズ対策研究事業 (H21-エイズ-一般-002) 平成21-23年度 (研究代表者和田裕一), p5-30, 2012 (3月).
 
4) 山田里佳ほか : ハイリスク妊婦への情報提供実例集 HIV. 周産期医学 39 : 14-19, 2009.
 
5) 塚原優己 : HIV母子感染予防対策. 平成22年度 HIV母子感染予防対策マニュアル第6版 (研究分担者塚原優己), p21-82. 2011.
 
6) Connor EM, et al : Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol O76 Study Group. N Engl J Med 331 (18) : 1173-1180, 1994.
 
7) Read JS, et al : Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1. Cochrane Database Syst Rev (4) : CD005479, 2005.
PubMed
8) 蓮尾泰之ほか : Human Immunodeficiency virug. (HIV) 陽性妊婦への医療側の対応-HIV母子感染予防におけるHIV拠点病院の現状-. IRYO 66 : 49-54, 2012.
 
9) 和旧裕一 : 研究分担報告書 HIV感染妊婦の診療体制 (地域連携) 整備に関する教育・啓発的研究. 平成23年度 厚生労働科学研究費補助金エイズ対策研究事業 (H21-エイズ-一般-002) 平成21-23年度 (研究代表者 和田裕一), p137-139, 2012 (3月).
 
P.711 掲載の参考文献
1) 増崎英明ほか : 母乳によるHTLV-1の母児感染. 産婦人科の実際 38 : 1433-1437, 1989.
 
2) 長崎県ATLウイルス母r・感染防止研究協力事業 (APP) 報告書-20年のあゆみ-. 長崎県ATLウイルス母子感染防止研究協力事業連絡協議会, 長崎県こども政策局, 2008.
 
3) ATL (成人T細胞白血病・リンパ腫) ウイルス母子感染の予防. 指導者用テキスト, 長崎県ATLウイルス母子感染防止研究協力事業連絡協議会, 2009.
 
4) 増崎英明 : HTLV-1母子感染防止-長崎県における24年間の取り組み-. 日周産期・新生児会誌 47 : 769-771, 2011.
 
5) 増崎英明ほか : 25年間継続した妊婦のHTLV-1抗体検査から得られた母子感染予防効果の検証および高精度スクリーニングシステム開発. 厚生労働科学研究費補助金, 新型インフルエンザ等新興・再興感染症研究事業, 平成23年度総括・分担研究報告書, 2011.
 
P.715 掲載の参考文献
1) Matsubara K, et al : Early-onset and late-onset group B streptococcal disease in Japan : a nationwide surveillance study, 2004-2010. Int J Infect Dis 17 : e379-e384, 2013.
 
2) Edmond KM, et al : Group B streptococcal disease in infants aged younger than 3 months : systematic review and meta-analysis. Lancet 347 : 547-556, 2012.
 
3) Melin P : Neonatal group B streptococcal disease : from pathogenesis to preventive strategies. Clin Microbiol Infect 17 : 1294-1303, 2011.
 
4) 松原康策 : 早発型・遅発型B群溶連菌感染症の特徴と垂直感染予防方法の考察. 日小児会誌 114 : 1681-1691, 2010.
 
5) Matsubara K, et al : Seroepidemiologic studies of serotype VIII group B Streptococcus in Japan. J Infect Dis 186 : 855-858, 2002.
PubMed
6) Matsubara K, et al : Prevalence of anti-group B streptococcal type VI capsular lgG antibodies in Japan. Eur J Clin Microbiol Infect Dis 22 : 453 -454, 2003.
 
7) Kimura K, et al : Active screening of group B streptococci with reduced penicillin susceptibility and altered serotype distribution, isolated from pregnant women in Kobe, Japan. Jpn J Infect Dis 66 : 158-160, 2013.
 
8) Hoshina K, et al : Trend of neonatal group B streptococcal infection during the last 15 years. Pediatr Int 44 : 641-646, 2002.
PubMed
9) Murayama SY, et al ; Invasive Streptococcal Disease Working Group : Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections. Antimicrob Agents Chemother 53 : 2650-2653, 2009.
 
10) 日本産婦人科学会/日本産婦人科医会 (編) : 産婦人科診療ガイドライン. p239-241, 杏林舎, 2011.
 
11) Verani JR, et al ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC) : Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010. MMWR Recomm Rep 59 (RR-10) : 1-36, 2010.
 
12) Maisey HC, et al : Recent advances in understanding the molecular basis of group B Streptococcus virulence. Expert Rev Mol Med 10 : e27, 2008.
PubMed
13) Jones N, et al ; Oxford Group B Streptococcus Consortium : Enhanced invasiveness of bovine-derived neonatal sequence type 17 group B Streptococcus is independent of capsular serotype. Clin Infect Dis 42 : 915-924, 2006.
PubMed
14) Committee on Infectious Diseases ; Committee on Fetus and Newborn, Baker CJ, et al : Policy statement-recommendations for the prevention of perinatal group B streptococcal (GBS) disease. Pediatrics 128 : 611-616, 2011.
 
15) Libster R, et al : Long-term outcomes of group B streptococcal meningitis. Pediatrics 130 : e8-15, 2012.
 
P.720 掲載の参考文献
1) 高橋尚人ほか : 原因不明の早期新生児期発疹症. 日新生児会誌 31 : 371-377, 1995.
 
2) Takahashi N, et al : Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period. Lancet 351 (9116) : 1614-1619, 1998.
PubMed
3) Kikuchi K, et al : Molecular epidemiology of methicillin-resistant Staphylococcus aureus strains causing neonatal toxic shock syndrome-like exanthematous disease in neonatal and perinatal wards. J Clin Microbiol 41 : 3001-3006, 2003.
PubMed
4) Takahashi N, et al : Change of specific T cells in an emerging neonatal infectious disease induced by a bacterial superantigen. Microbiol Immunol 53 : 524-530, 2009.
 
5) Takahashi N, et al : Clinical features of neonatal toxic shock syndrome-like exanthematous disease emerging in Japan. J Infect 59 : 194-200, 2009.
PubMed
6) van der Mee-Marquet N, et al : Staphylococcal exanthematous disease in a newborn due to a virulent methicillin-resistant Staphylococcus aureus strain containing the TSST-1gene in Europe : an alert for neonatologists. J Clin Microbiol 41 : 4883-4884, 2003.
 
7) Takahashi N, et al : Immunopathophysiological aspects of an emerging neonatal infectious disease induced by a bacterial superantigen. J Clin Invest 106 : 1409-1415, 2000.
PubMed
8) Takahashi N, et al : Antibodies against superantigenic exotoxins produced by Staphylococcus aureus in sera from mothers and their infants' cord blood. Am J Perinatol 23 : 413-420, 2006.
PubMed
9) Takahashi N, et al : Selective excretion of anti-inflammatory cytokine interleukin-10 in a superantigen-inducing neonatal infectious disease. Cytokine 45 : 39-43, 2009.
 
10) 高橋尚人 : NTEDの最近の動向. 小児科診療 72 : 1627-1632, 2009.
 
11) Kato H, et al : The percentage of superantigen-reactive T cells in peripheral blood significantly decreases before massively increasing in patients with neonatal TSS-like exanthematous disease in the early acute phase. J Infect Chemother 8 : 111-114, 2002.
PubMed

XIV 感染症特論

P.727 掲載の参考文献
1) Mangram AJ, et al : Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol 20 : 247-274.
 
2) SSIサーベイランス委員会 : JHAISシステムサーベイランスサマリー, No. 13, 1998. 11-2011. 12. [http://www.kankyokansen.org/modules/iinkai/index]
 
3) Bratzler DW, Hunt DR : The surgical infection prevention and surgical care improvement project : national initiatives to improve outcomes for patients having surgery. Clin Infect Dis 43 : 322-330, 2006.
PubMed
4) Bunn F, et al : Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery. Cochrane Database Syst Rev 1 : CD005360, 2012.
PubMed
5) Song F, Glenny AM : Antimicrobial prophylaxis in colorectal surgery : a systematic review of randomized controlled trials. Br J Surg 85 : 1232-1241, 1998.
PubMed
6) Harbarth S, et al : Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation 101 : 2916-2921, 2000.
PubMed
7) Imamura H, et al : Intraoperative versus extended antimicrobial prophylaxis after gastric cancer surgery : a phase 3, open-label, randomised controlled, non-inferiority trial. Lancet Infect Dis 12 : 381-387, 2012.
PubMed
8) Scher KS : Studies on the duration of antibiotic adminis tration for surgical prophylaxis. Am Surg 63 : 59-62, 1997.
 
9) Bratzler DW, et al : Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt) 14 : 73-156, 2013.
 
10) Alexander JW, et al : Updated recommendations for control of surgical site infections. Ann Surg 253 : 1082-1093, 2011.
PubMed
11) Forse RA, et al : Antibiotic prophylaxis for surgery in morbidly obese patients. Surgery 106 : 750-756, 1989.
PubMed
12) Engelman R, et al : The Society of Thoracic Surgeons practice guideline series : antibiotic prophylaxis in cardiac surgery, Part II : Antibiotic choice. Ann Thorac Surg 83 : 1569-1576, 2007.
 
13) Snydman DR, et al : Lessons learned from the anaerobe survey : historical perspective and review of the most recent data (2005-2007). Clin Infect Dis 50 : S26-33, 2010.
PubMed
14) Takesue Y, et al : Nationwide surveillance of antimicrobial susceptibility patterns of pathogens isolated from surgical site infections (SSI) in Japan. J Infect Chemother 18 (6) : 816-826, 2012.
PubMed
15) Guenaga KK, et al : Mechanical bowel preparation for elective colorectal surgery. Cochrane Database Syst Rev 9 : CD001544, 2009.
PubMed
16) Englesbe MJ, et al : A statewide assessment of surgical site infection following colectomy : the role of oral antibiotics. Ann Surg 252 : 514-519, 2010.
PubMed
17) Cannon JA, et al : Preoperative oral antibiotics reduce surgical site infection following elective colorectal resections. Dis Colon Rectum 55 : 1160-1166, 2012.
PubMed
18) Bellows CF, et al : Combination of oral non-absorbable and intravenous antibiotics versus intravenous antibiotics alone in the prevention of surgical site infections after colorectal surgery : a meta-analysis of randomized controlled trials. Tech Coloproctol 15 : 385-395, 2011.
PubMed
19) Fry DE : Colon preparation and surgical site infection. Am J Surg 202 : 225-232, 2011.
PubMed
20) Kurz A, et al : Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med 334 : 1209-1215, 1996.
 
21) Seamon MJ, et al : The effects of intraoperative hypothermia on surgical site infection : an analysis of 524 trauma laparotomies. Ann Surg 255 : 789-795, 2012.
PubMed
22) Tanner J, et al : Preoperative hair removal to reduce surgical site infection. Cochrane Database Syst Rev 11 : CD004122, 2011.
 
23) Latham R, et al : The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol 22 : 607-612, 2001.
PubMed
24) Furnary AP, et al : Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 125 : 1007-1021, 2003.
PubMed
25) Sehgal R, et al : Risk factors for surgical site infections after colorectal resection in diabetic patients. J Am Coll Surg 212 : 29-34, 2011.
PubMed
26) Ata A, et al : Postoperative hyperglycemia and surgical site infection in general surgery patients. Arch Surg 145 : 858-864, 2010.
PubMed
27) Frisch A, et al : Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care 33 : 1783-1788, 2010.
PubMed
28) American Diabetes Association : Standards of medical care in diabetes. Diabetes Care 33 (Suppl 1) : S11-S61, 2010.
 
29) van den Berghe G, et al : Intensive insulin therapy in the critically ill patients. N Engl J Med 345 (19) : 1359-1367, 2001.
 
30) NICE-SUGAR Study Investigaters ; Finfer S, et al : Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360 : 1283-1297, 2009.
 
31) Kansagara D, et al : : Intensive insulin therapy in hospitalized patients : asystematic review. Ann Intern Med 154 : 268-282, 2011.
 
32) Kao LS, et al : Peri-operative glycaemic control regimens for preventing surgical site infections in adults. Cochrane Database Syst Rev 3 : CD006806, 2009.
PubMed
P.735 掲載の参考文献
1) 「感染症法に基づく医師の届出 : 後天性免疫不全症候群」厚生労働省より. [http://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou11/01-05-07.html]
 
2) Jones JL : Surveillance for AIDS-defining opportunis tic illnesses, 1992-1997. MMWR CDC Surveill Summ 48 (SS-2), 1-22, 1999.
 
3) Palella FJ Jr, et al : Declining morbidity and mortality among Patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338 : 853-860, 1998.
 
4) エイズ予防情報ネット : エイズ動向委員会報告. [http://api-net.jfap.or.jp/status/index.html]
 
5) Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents. 'AIDSinfo' [http://aidsinfo.nih.gov/guidelines]
PubMed
6) 古西満ほか : 免疫再構築症候群の発症状態調査. 厚生労働科学研究費補助金エイズ対策事業報告書 '免疫再構築症候群診療のポイント Ver. 3', 2012. [http://www.naramed-u.ac.jp/cid/files/men-eki_ver3.pdf]
 
7) Department of Health and Human Services (DHHS) : Guidelines for the use of antiretroviral agents in HIV-1-infected adult and adolescents. February 12, 2013. [http://aidsinfo.nih.gov/contenifiles/AdultandAdolescentGL.pdf]
 
8) Makadzange AT, et al : Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub Saharan Africa. Clin Infect Dis 50 : 1532-1538, 2010.
PubMed
P.741 掲載の参考文献
1) Bouvard V, et al : A review of human carcinogens-Part B : biological agents. Lancet Oncol 10 : 321-322, 2009.
PubMed
2) Raab-Traub N : Novel mechanisms of EBV-induced oncogenesis. Curr Opin Virol 2 : 453-458, 2012.
PubMed
3) Takatsuki K : Discovery of adult T-cell leukemia. Retrovirology 2 : 16, 2005.
PubMed
4) Matsuoka M, Jeang KT : Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 7 : 270-280, 2007.
PubMed
5) Iwanaga M, et al : Adult T-cell leukemia : a review of epidemiological evidence. Front Microbiol 3 : 322, 2012.
PubMed
6) Yasunaga J, Matsuoka M : Molecular mechanisms of HTLV-1 infection and pathogenesis. Int J Hematol 94 : 435-442, 2011.
PubMed
7) Kutok JL, Wang F : Spectrum of Epstein-Barr virus-associated diseases. Annu Rev Pathol 1 : 375-404, 2006.
PubMed
8) Young LS, Rickinson AB : Epstein-Barr virus : 40 years on. Nat Rev Cancer 4 : 757-768, 2004.
PubMed
9) Schulz TF : KSHV/HHV8-associated lymphoproliferations in the AIDS setting. Eur J Cancer 37 : 1217-1226, 2001.
PubMed
10) Tsai WL, Chung RT : Viral hepatocarcinogenesis. Oncogene 29 : 2309-2324, 2010.
PubMed
11) Moody CA, Laimins LA : Human papillomavirus oncoproteins : pathways to transformation. Nat Rev Cancer 10 : 550-560, 2010.
PubMed
12) Spurgeon ME, Lambert PF : Merkel cell polyomavirus : a newly discovered human virus with oncogenic potential. Virology 435 : 118-130, 2013.
PubMed
13) Bornschein J, Malfertheiner P : Gastric carcinogenesis. Langenbecks Arch Surg 396 : 729-742, 2011.
PubMed
14) Hatakeyama M : Helicobacter pylori and gastric carcinogenesis. J Gastroenterol 44 : 239-248, 2009.
PubMed
15) Schiller JT, Lowy DR : Understanding and learning from the success of prophylactic human papillomavirus vaccines. Nat Rev Microbiol 10 : 681-692, 2012.
PubMed
P.747 掲載の参考文献
1) Sejvar JJ, et al : Population incidence of Guillain-Barre syndrome : a systematic review and meta-analysis. Neuroepidemiology 36 : 123-133, 2011.
PubMed
2) Poropatich KO, et al : Quantifying the association between Campylobacter infection and Guillain-Barre syndrome : a systematic review. J Health Popul Nutr 28 : 545-552, 2010.
PubMed
3) Chiba A et al : Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barre syndrome : clinical and immunohistochemical studies. Neurology 43 : 1911-1917, 1993.
PubMed
4) Liu JX, et al : Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles, Invest Ophthalmol Vis Sci 50 : 3226-3232, 2009.
PubMed
5) Kusunoki S, et al : Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia. Muscle Nerve 22 : 1071-1074, 1999.
PubMed
6) Yuki N : Ganglioside mimicry and peripheral nerve disease. Muscle Nerve 35 : 691-711, 2007.
PubMed
7) Yuki N, et al : A bacterium lipopolysaccharide that elicits Guillain-Barre syndrome has a GM1 ganglioside-like structure. J Exp Med 178 : 1771-1775, 1993.
 
8) Shin JE, et al : Lipo-oligosaccharides of Campylobacter jeiuni serotype O : 10. Structures of core oligosaccharide regions from a bacterial isolate from a patient with the Miller-Fisher [sic] syndrome and from the serotype reference strain. Carbohydr Res 305 : 223-232, 1997.
 
9) Yuki N, et al : Animal model of axonal Guillain-Barre syndrome induced by sensitization with GM1 ganglioside. Ann Neurol 49 : 712-720, 2001.
PubMed
10) Susuki K, et al : Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J Neurosci 27 : 3956-3967, 2007.
PubMed
11) Griffin JW, et al : Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barre syndrome. J Neurocytol 25 : 33-51, 1996.
PubMed
12) Hafer-Macko CE, et al : Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol 39 : 625-635, 1996.
PubMed
13) Koga M, et al : Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrolne after Campylobacter jejuni enteritis. J Infect Dis 193 : 547-555, 2006.
PubMed
14) Koga M, et al : Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barre syndrome. Neurology 65 : 1376-1381, 2005.
PubMed
15) Joint WHO/ISFC meeting on RF/RHD control with emphasis on primary prevention, Geneva, 7-9 September 1994. Geneva, World Health Organization, 1994.
PubMed
16) Kaplan MH : Immunologic relation of streptococcal and tissue antigens. I. Properties of an antigen in certain strains of group A streptococci exhibiting an immunologic cross-reaction with human heart tissue. J Immunol 90 : 595-606, 1963.
 
17) Zabriskie JB : Mimetic relationships between group A streptococci and mammalian tissues. Adv Immunol 7 : 147-188, 1967.
 
18) Galvin JE, et al : Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin. J Clin Invest 106 : 217-224, 2000.
PubMed
19) Ellis NM, et al : T cell mimicry and epitope specificity of cross-reactive T cell clones from rheumatic heart disease. J Immunol 175 : 5448-5456, 2005.
PubMed
20) Fae KC, et al : Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease. J Immunol 176 : 5662-5670, 2006.
PubMed
21) Cunningham MW, et al : Human and murine antibodies cross-reactive with streptococcal M protein and myosin recognize the sequence GLN-LYS-SER-LYS-GLN in M protein. J Immunol 143 : 2677-2683, 1989.
 
22) Cunningham MW, et al : Molecular analysis of human cardiac myosin-cross-reactive B- and T-cell epitopes of the group A streptococcal M5 protein. Infect Immun 65 : 3913-3923, 1997.
 
23) Krisher K, Cunningham MW : Myosin : a link between streptococci and heart. Science 227 : 413-415, 1985.
PubMed
24) Robinson JH, et al : Characterization of a conserved helper-T-cell epitope from group A Streptococcal M proteins. Infect Immun 61 : 1062-1068, 1993.
 
25) Pruksakorn S, et al : Identification of T cell autoepitopes that cross-react with the C-terminal segment of the M protein of group A streptococci. Int Immunol 6 : 1235-1244, 1994.
 
26) Pruksakorn S, et al : Conserved T and B cell epitopes on the M protein of group A streptococci. Induction of bactericidal antibodies. J Immunol 149 : 2729-2735, 1992.
 
27) Geleijns K, et al : HLA class II alleles are not a general susceptibility factor in Guillain-Barre syndrome. Neurology 64 : 44-49, 2005.
 
28) Guilherme L, et al : Association of human leukocyte class II antigens with rheumatic fever or rheumatic heart disease in a Brazilian population. Circulation 83 : 1995-1998, 1991.
 
29) Ozkan M, et al : HLA antigens in Turkish race with rheumatic heart disease [see comment]. Circulation 87 : 1974-1978, 1993.
PubMed
30) Weidebach W, et al : HLA class II antigens in rheumatic fever. Analysis of the DR locus by restriction fragment-length polymorphism and oligotyping. Hum Immunol 40 : 253 -258, 1994.
 
31) Guedez Y, et al : HLA class II associations with rheumatic heart disease are more evident and consistent among clinically homogeneous patients. Circulation 99 : 2784-2790, 1999.
PubMed
32) Visentainer JE, et al : Association of HLA-DR7 with rheumatic fever in the Brazilian population. J Rheumatol 27 : 1518-1520, 2000.
PubMed
33) Stanevicha V, et al : HLA class II associations with rheumatic heart disease among clinically homogeneous patients in children in Latvia. Arthritis Res Ther 5 : R340-346, 2003.
PubMed
P.752 掲載の参考文献
1) Chen YH, et al : Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in Asia-Pacific region according to currently established susceptibility interpretive criteria. J Infect 62 (4) : 280-291, 2011.
 
2) Tangden T, et al : Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-1actamases : a prospective study with Swedish volunteers. Antimicrob Agents Chemother 54 (9) : 3564-3568, 2010.
 
3) Nakamura T, et al : Epidemiology of Escherichia coli, Klebsiella species, and Proteus mirabilis strains producing extended-spectrum β-lactamases from clinical samples in the Kinki region of Japan. Am J Clin Pathol 137 (4) : 620-626, 2012.
 
4) Luvsansharav UO, et al : Prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae among healthy adult people in Japan. J Infect Chemother 17 (5) : 722-725, 2011.
 
5) Hisata K, et al : Dissemination of methicillin-resistant staphylococci among healthy Japanese children. J Clin Microbiol 43 (7) : 3364 -3372, 2005.
 
6) Kaier K, et al : The impact of antimicrobial drug consumption and alcohol-based hand rub use on the emergence and spread of extended-spectrum beta-lactamase-producing strains : a time-series analysis. J Antimicrob Chemother 63 (3) : 609-614, 2009.
PubMed
7) Zahar JR, et al : Is hand-rub consumption correlated with hand hygiene and rate of extended spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) -acquired infection? J Hosp Infect 80 (4) : 348-350, 2012.
PubMed
8) Guet-Revillet H, et al : Environmental contamination with extended-spectrum β-lactamase : is there any different between Eshcerichia coli and Klebsiella spp? Am J Infect Control 40 (9) : 845-848, 2012.
 

XV 上巻の補遺

P.759 掲載の参考文献
1) 牛島廣治 : ロタウイルスワクチン. 日医師会誌 138 (4) : 701-704, 2009.
 
2) Bishop RF : Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis. Lancet 2 (7841) : 1281-1283, 1973.
PubMed
3) Sato K, et al : Isolation of human rotavirus in cell cultures : brief report. Arch Virol 69 (2) : 155-160, 1981.
PubMed
4) Parashar UD, et al : Rotavirus. Emerg Infect Dis 4 : 561-570, 1998.
PubMed
5) Glass RI, et al : Rotavirus vaccines : current prospects and future challenges. Lancet 368 : 323-332, 2006.
PubMed
6) Nakagomi T, et al : Incidence and burden of rotavirus gastroenteritis in Japan, as estimated from a prospective sentinel hospital study. J Infect Dis 192 (Suppl 1) : S106-110, 2005.
 
7) Parashar UD, et al : Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 9 : 565-572, 2003.
PubMed
8) 中込修 : 胃腸炎ウイルス. ウイルスハンドブック (河野茂編), p51-53, 日本医学館, 2008.
 
9) Angel J : Rotavirus vaccines : recent developments and future considerations. Nat Rev Microbiol 5 : 529-539, 2007.
PubMed
10) 楠原浩一 : ロタウイルスワクチン. 小児科臨床 62 (10) : 2167-2175, 2009.
Medical*Online
11) Midthum K, Kapikian AZ : Rotavirus vaccines : an overview. Clin Microbiol Rev 9 : 423-434, 1996.
 
12) Denney PH : Rotavirus vaccines : an overview. Clin Microbiol Rev 21 : 198-208, 2008.
 
13) Kawamura N, et al : Efficacy, safety and immunogenicity of RD (4414 in Japanese infants during the first two years of life. Vaccine 29 (37) : 6335-6341, 2011.
 

書評

最近チェックした商品履歴

Loading...